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SUMMARY 
 
Cell division involves coordinated chromosomal and cytoskeletal rearrangements to 
ensure the faithful segregation of genetic material into the daughter cells. The chromosomal 
passenger complex (CPC) consisting of the Aurora B kinase, INCENP, Survivin, and Borealin 
has emerged as a central player at several steps in this process (Ruchaud et al., 2007). The 
complex is involved in chromosome condensation, kinetochore-microtubule interaction, the 
spindle assembly checkpoint (SAC) and cytokinesis. CPC localization parallels its functions. 
In early mitosis the complex binds to the inner centromere, translocates to the central spindle 
at the onset of anaphase and accumulates at the midbody during cytokinesis. The study of 
CPC targeting is complicated by the fact that all the subunits of the complex are 
interdependent for localization and/or protein stability. 
To overcome this situation and define individual functions of the chromosomal 
passenger proteins we established a siRNA based complementation assay. We identified a 
ternary subcomplex of the CPC comprising Survivin, Borealin, and the N-terminal 58 amino 
acids of INCENP that is essential and sufficient for centromere binding independent of the 
enzymatic core of the complex, the Aurora B kinase. Our data also suggest that, within this 
module, Borealin might target the complex to the centromere by directly binding to DNA. 
We further show that the spindle checkpoint protein PICH requires the CPC but 
remarkably not Aurora B kinase activity to localize to the centromere/kinetochore. Moreover, 
Mad2, the ultimate effector of the SAC that depends on the CPC under normal conditions, is 
present at kinetochores in CPC depleted cells treated with nocodazole and this may explain 
the mitotic arrest seen under these conditions. 
The collaborating laboratory of Elena Conti recently solved the 1.4Å resolution crystal 
structure of most of the ternary subcomplex mentioned above, revealing that Borealin and 
INCENP associate with the helical domain of Survivin to form a tight three-helical bundle 
that creates a single structural unit. Evaluation of structure-based mutants showed that the 
intertwined interactions between the core CPC components lead to functional interdependence 
essential for CPC localization to the centromere, the central spindle and the midbody. 
Moreover, the composite molecular surface of the complex presents conserved residues 
essential for central spindle and midbody localization which we found to determine CPC 
function during cytokinesis.   
In a yeast two-hybrid screen for Borealin interactors we identified components of the 
SUMO system. Subsequently, we showed that Borealin is a bona fide SUMO target and 
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preferentially modified by SUMO2/3. We demonstrate that Borealin sumoylation is high in 
early mitosis but progressively lost when cells enter anaphase. The SUMO ligase RanBP2 is 
essential for Borealin sumoylation and overexpression of its catalytic domain leads to 
chromosome missegregation during anaphase. Furthermore, the SUMO isopeptidase SENP3 
is a specific interaction partner of Borealin and catalyzes the removal of SUMO2/3 from 
Borealin. These data thus delineate a mitotic SUMO2/3 conjugation-deconjugation cycle of 
Borealin and assign a regulatory function of RanBP2 and SENP3 in the mitotic SUMO 
pathway. 
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Figure 1. The eukaryotic cell cycle.  
The different phases are denoted by capital letters (see text). Arrows indicate cell cycle checkpoints. G1, S and 
G2 phase are collectively called interphase; the time between two mitoses.   
INTRODUCTION 
 
The cell cycle and cell division 
Self-reproduction is one of the most fundamental characteristic of cells and hence of 
all living organisms. The principle “omnis cellula e cellula” (each cell stems from another 
cell), propagated by the German pathologist Rudolf Virchow in 1858, forms the basis of the 
theory that new cells are formed via division of pre-existing ones. This occurs by an orderly 
sequence of events, called the cell cycle, in which a cell first duplicates its contents and then 
divides into two. The newly formed daughter cells can themselves grow and divide, 
generating a new cell population. In unicellular life forms such as bacteria and yeasts, each 
cell division produces a complete new organism. In multicellular species, multiple and 
complex sequences of cell divisions are required to produce a functioning organism and cell 
division is an essential mechanism to replace cells that die. Cell growth and DNA replication 
take place throughout most of the cell cycle in bacteria. The single, circular DNA molecules 
are then distributed to daughter cells. In eukaryotes, this process is temporally divided into 
four sequential phases (Figure 1). The genetic material consists of a number of discrete DNA 
molecules, the chromosomes, which are replicated during S (synthesis) phase and become 
condensed and segregated equally to the daughter cells during M (mitosis) phase. A key 
concept of the eukaryotic cell cycle is that S phase must always follow M phase and that M 
phase must not start until S phase has been completed. Thus, the integrity of the genome is 
maintained. Between S and M phase two gap phases called G1 and G2 exist. During G1 phase 
the cell is responsive to both positive and negative growth signals, and during G2 the cell 
prepares for entry into mitosis. G0 refers to a state in which a cell remains metabolically 
active, but no longer proliferates unless appropriate extracelluar signals are received 
(quiescent state). 
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Figure 2. Illustration of chromatin behaviour during the metaphase to anaphase transition in M phase.
Chromatin, microtubules and spindle poles are depicted. Adapted from the book „Zellsubstanz, Kern und 
Kerntheilung“, F.C.W Vogel Verlag, Leipzig 1882. 
Movement through each phase of the cell cycle and transition from one phase to the 
next is controlled at distinct cell cycle checkpoints (Hartwell and Weinert, 1989) (Figure 1). 
At the restriction point in G1 phase a cell either becomes committed to enter the cell cycle or 
to become quiescent and enter G0. While damaged (or unreplicated) DNA is sensed late 
during G1, as well as in S and G2 phase, the proper attachment of chromosomes to the spindle 
apparatus is monitored during M phase to ensure correct segregation of the chromosomes (in 
the form of sister chromatids) to the daughter cells. Defects in cell cycle surveillance 
mechanisms contribute to chromosome instability and aneuploidy, a hallmark of cancer cells 
(Bharadwaj and Yu, 2004; Kastan and Bartek, 2004). 
Already in 1882 Walther Flemming was the first cytologist to describe chromosome 
behaviour during the cell cycle in his book “Zellsubstanz, Kern und Kerntheilung” (Figure 2) 
and the expressions he coined (e.g. chromatin, equatorial plate, aster) are still used today. 
More than 100 years later, in 2001, the discovery of the key molecular determinants 
coordinating the cell cycle by Tim Hunt, Paul Nurse and Lee Hartwell was rewarded by the 
Nobelprize in Medicine. The researchers described the cell cycle dependent rise and fall in the 
level of proteins they therefore called cyclins and demonstrated a link between these 
oscillations and the discrete cell cycle stages. Cyclins were found to bind to and activate 
cyclin-dependent kinases (Cdk´s) that subsequently coordinate various cell cycle events via 
phosphorylation of target proteins. 
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The events of mitosis 
Mitosis (nuclear division) is the time when the sister chromatids (the daughter DNA 
molecules produced in S phase) are segregated equally to the two daughter cells. This is 
achieved through a highly organized series of events which can be attributed to discrete 
phases of mitosis. 
During prophase the interphase chromatin condenses and the centrosomes, which have 
been duplicated during S phase, start to move to opposite poles. There, they start nucleating 
microtubules (MTs) to build the mitotic spindle. At prometaphase, the nuclear envelope 
breaks down allowing the MTs to capture specialized structures called the kinetochores (KTs) 
on both sister chromatids. Chromosomes, which have attached to MTs emanating from 
opposite spindle poles are moved to the equator of the cell in a process called congression. 
Metaphase is the state when all chromosomes have aligned on an equatorial plate (or 
metaphase plate) in the center of the cell. The MT arrays now form the typical bipolar spindle 
with their minus-ends proximal to the poles and their plus-ends attached to the KTs. Once all 
chromosomes are aligned, cohesion between sister chromatids is lost at the onset of anaphase 
and subsequently sister chromatids are pulled apart to opposite poles. Mitosis ends with 
telophase, during which the nuclear envelope reforms around the decondensing sister 
chromatids. 
Mitosis is followed by cytokinesis (cell division). During cytokinesis, the antiparallel 
MT arrays at the cell equator, the central spindle, is compressed into a compact midbody, the 
remnant of the midzone. Contraction of a ring-like structure containing actin and myosin II, 
which has been formed during late anaphase beneath the plasma membrane at the site of the 
central spindle, leads to furrow ingression. Finally, cell abscission takes place resulting in the 
formation of two new daughter cells.  
 
The vertebrate centromere/kinetochore region 
Each sister chromatid comprises a specialized chromatin region located at the primary 
constriction that consists of a series of α-satellite DNA repeats called the centromere. 
Specialized centromeric components are the histone H3 variants Cenp-A, H3K4 and H3K9 
(histone H3 methylated on Lysine 4 or 9, respectively) and the heterochromatin-protein-1 that 
associates with H3K9 (Cleveland et al., 2003; Sullivan and Karpen, 2004) as well as further 
centromeric proteins (Cenps) (Foltz et al., 2006). The centromere provides a structural and 
functional seed for the assembly of proteins building the KT. Although the exact boundaries 
between centromere and kinetochore are rather loosely defined, at least three different layers 
can be distinguished by electron microscopy (Brinkley and Stubblefield, 1966; McEwen et 
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Figure 3. The vertebrate centromere/kinetochore region. 
Left: Trilaminar organization of the centromere/kinetochore region as seen by electron microscopy. Adapted 
from Cleveland et al., Cell 2003.  Right: Schematic representation of the spatial distribution of centromere/ 
kinetochore proteins. Proteins present within a complex are surrounded by one box. Physical interaction 
between proteins/protein complexes is indicated by shapes that contact each other. Adapted from Chan et 
al., TRENDS in Cell Biology 2005. 
al., 2007). They are referred to as the centromere, the inner kinetochore and the outer 
kinetochore (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Besides proteins that localize constituently to the centromere (see above) a number of 
proteins associate with this layer only once mitosis has started. Among them are the 
chromosomal passenger proteins, the phosphatase PP2A, small ubiquitin-related modifiers 
(SUMO proteins), proteins involved in sister chromatid cohesion, the microtubule 
depolymerase MCAK and the ATPase PICH (Maiato et al., 2004; Cheeseman and Desai, 
2008; Dasso, 2008). Interestingly, when centromeres become stretched apart by pulling MTs 
during the early stages of mitosis, a portion of centromere components eventually extend 
outward towards the KT (Gorbsky, 2004). Proteins of the centromere crucially regulate the 
KT-MT interactions. The inner kinetochore is immediately adjacent to the centromere, also 
comprises centromeric chromatin, hMis12 and Cenps. In some cases (e.g. the Hec/Ndc80 
complex) it can be considered as a basis for proteins that extend towards the outer 
kinetochore. The outer kinetochore is a proteinaceous layer only formed after nuclear 
envelope breakdown. To date more than 80 proteins have been identified to localize to this 
layer in human cells. The outer kinetochore harbours about 20-30 end-on attachment sites for 
the MT plus-ends and is essential for MT binding. It contains structural components that are 
involved in KT-MT attachment like the Hec/Ndc80 complex or the SUMO E3 ligase RanBP2 
INTRODUCTION 
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(Joseph et al., 2004; DeLuca et al., 2005), protein kinases like Plk1 and Mps1 (Arnaud et al., 
1998; Abrieu et al., 2001), MT-dependent motor proteins like CENP-E (Yen et al., 1991) and 
components of the spindle assembly checkpoint including Mad2 and BubR1 (Musacchio and 
Hardwick, 2002). 
Using immunodepletion or protein knock-down by siRNA, hierarchic sequences of 
centromere/kinetochore assembly could be deduced. One major pathways is instructed by 
Cenp-A (Regnier et al., 2005) directing the Hec/Ndc80 complex, Cenps and BubRI to the KT. 
Another pathway depends on the Bub1 kinase that recruits CENP-E and CENP-F, Sgo1 and 
additionally also checkpoint proteins (e.g. Mad2 and BubRI) to the KT (Boyarchuk et al., 
2007). The CPC has also been implicated in KT assembly (Vigneron et al., 2004; Liu et al., 
2006). It emerges that a sophisticated crosstalk between the different branches exists and that 
centromere/kinetochore assembly occurs in a strictly linear fashion.  
The trilaminar structure of the centromere/kinetochore region mediates the MT 
dependent chromosome movements during congression in prometaphase. Furthermore, KT 
associated checkpoint proteins respond to erroneous KT-MT attachment via a mechanism 
called the spindle assembly checkpoint (SAC), thus delaying the metaphase to anaphase 
transition until all chromosomes have properly aligned on the metaphase plate. 
 
The spindle assembly checkpoint (SAC) 
In 1991, two independent screens identified various genes, mutation of which 
bypassed the ability of yeast to induce a mitotic arrest in response to spindle poisons (Hoyt et 
al., 1991; Li and Murray, 1991). The genes identified in these screens which include the MAD 
(mitotic-arrest deficient) and the BUB (budding uninhibited by benzimidazole) genes were 
later found to be conserved in all eukaryotes. They are involved in a surveillance mechanism 
termed the spindle assembly checkpoint (SAC) that is active in prometaphase to prevent the 
precocious separation of sister chromatids. 
The SAC monitors the attachment of KTs to MTs and its function is intimately linked 
to the KT. A single unattached KT can block the onset of anaphase but laser ablation of it 
relieves the arrest (Rieder et al., 1995). While checkpoint proteins become concentrated on 
unattached KTs creating a “wait anaphase signal”, they are absent from properly attached KTs 
(Chen et al., 1996; Taylor and McKeon, 1997). Indeed, the SAC should only be silenced once 
sister chromatids are attached in a bipolar (amphitelic) fashion to the MTs (each sister KT 
occupied by MTs from the opposite pole); an arrangement that ensures the equal segregation 
during anaphase (Figure 4). Monotelic attachment is characterized by the attachment of only 
one KT to MTs and represents a normal condition in prometaphase. In addition, however, 
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MTs emanating from only one pole might become attached to both sister KTs (syntelic 
attachment) or a single KT might be captured by MTs nucleating from opposite poles 
(merotelic attachment). The SAC is activated by syntelic attachments as KT-MT attachments 
are destabilized at low KT tension but stabilized by high tension between amphitelic sister 
KTs (Nicklas et al., 2001). In contrast, merotelic attachments produce sufficient occupancy 
and tension and are thus not sensed by the SAC. In both cases, however, destabilization of 
attachments is achieved by the action of Aurora B kinase, the enzymatic core of the CPC 
probably via regulation of the microtubule depolymerase MCAK. (Biggins and Murray, 2001; 
Tanaka et al., 2002; Ditchfield et al., 2003; Hauf et al., 2003; Andrews et al., 2004). If 
uncorrected, improper KT-MT attachments can produce lagging chromatids and chromosome 
missegregation in anaphase (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To which extent a complete lack of MT attachment or missing tension between KTs 
contribute to checkpoint activation in metazoan cells remains to be clarified (Pinsky and 
Biggins, 2005). The ability to sense tension once bipolar attachment is achieved seems to 
Figure 4. Illustration of correct and incorrect KT-MT attachments. 
Amphitelic attachment (3) satisfies the SAC and anaphase can commence (7). During syntelic- and monotelic 
attachment (1 and 2) the SAC remains “on” and sister separation cannot proceed. However, the SAC does not 
sense merotelic attachment (4). The correction of improper attachments to establish amphitelic orientation 
depends on the Aurora B kinase. Uncorrected attachments will result in chromosome missegregation during 
anaphase (5 and 6). Adapted from Giet et al., TRENDS in Cell Biology 2005. 
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have a significant role in turning off SAC activity by inhibiting the association of SAC 
proteins with KTs. 
One major downstream effector of the SAC is Mad2, a checkpoint protein able to 
adopt two different conformations. SAC silencing requires the transition from an inactive so-
called open conformation (O-Mad2) to an active confirmation called closed Mad2 (C-Mad2) 
(Musacchio and Salmon, 2007). The transition is probably mediated via a Mad1-Mad2 
interaction/intermediary complex formation at the KT. C-Mad2 is a potent inhibitor of Cdc20, 
a KT bound protein that acts as an activator for the APC/C, a ubiquitin ligase (Peters, 2006; 
Yu, 2007). Once the SAC is silenced, binding of C-Mad2 and Cdc20 in complex with BubRI 
and Bub3, collectively called the mitotic checkpoint complex (MCC), to the APC/C results in 
its activation. Active APC/C induces anaphase onset by degrading two key substrates: securin 
and cyclin B (Pines, 2006). Securin is an inhibitor of separase, a protease that cleaves the 
cohesin complex which holds sister chromatids together, allowing for their separation. 
Destruction of cyclin B inactivates Cdk1, the master kinase regulating early mitotic events. 
How MCC proteins cooperate to inhibit the APC/C remains to be fully understood. 
 
The chromosomal passenger complex (CPC): A concerted effort 
 The CPC is a central regulator of mitotic progression. Functions that require 
chromosomal passenger activity include chromatin modification, assembly of the 
centromere/kinetochore region, correction of KT attachment errors, aspects of the spindle 
assembly checkpoint, assembly of a stable bipolar spindle and the completion of cytokinesis 
(Vagnarelli and Earnshaw, 2004; Vader et al., 2006; Ruchaud et al., 2007) (Figure 5). 
Chromosomal passenger genes are frequently expressed at high levels in a variety of tumors, 
and the level of abnormal overexpression correlates with increased genetic instability and 
clinical outcome. Aurora B inhibition by the small molecule inhibitor VX-680 has lead to 
tumor regression in rodent xenograft models (Harrington et al., 2004). Moreover, preliminary 
clinical data from phase I trials using Aurora B kinase inhibitors have largely been consistent 
with cytostatic effects and with disease stabilization as a response achieved in solid tumors 
(Gautschi et al., 2008). 
The CPC is conserved from yeast to man and in humans comprises the inner 
centromere protein (INCENP), the BIR domain containing protein Survivin, Borealin and the 
Aurora B kinase. Expression of the chromosomal passenger proteins is cell cycle regulated 
and peaks in M phase. As implicated by its name, the complex shows a dynamic localization, 
being centromere bound from prophase to metaphase, associated with the central spindle 
during anaphase and finally accumulating at the midbody during telophase/cytokinesis 
INTRODUCTION 
 11
(Figure 5). Strikingly, members of the CPC are interdependent for localization. Thus, knock-
down of any subunit of the CPC leads to loss of the other CPC proteins from the centromere, 
the central spindle and the midbody. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. CPC localization and function during mitosis. 
The CPC is depicted in green and Aurora B phosphorylation targets in red boxes. The different functions of the 
CPC during mitotic progression are given in grey boxes. In prophase the CPC is involved in the release of 
chromosome arm cohesion and phosphorylates histone H3, a widely used mitotic marker. The CPC is required 
to build a functional kinetochore/centromere region, establish proper KT-MT attachments and regulate the SAC. 
Upon the onset of anaphase the CPC translocates to the spindle midzone where it is essential to recruit MT 
associated proteins to build the central spindle. In telophase the CPC concentrates at the cleavage furrow and 
subsequently at the midbody where it regulates cytokinesis. Adapted from Ruchaud et al., Nat.Rev. 
Mol.Cell.Biol. 2007. 
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INCENP: INCENP was the first member of the CPC to be identified in a screen for novel 
components of the chromosome scaffold (Cooke et al., 1987). It is the largest protein of the 
CPC (919 amino acids in length) and contains a 260 amino acid long coiled-coil region 
between its N- and C-terminus. Membership in the family is defined by the presence of a 
short conserved stretch of ~60–80 amino acids near the C terminus of the protein known as 
the IN-box (Adams et al., 2000). The IN-box mediates binding to Aurora B and is 
subsequently phosphorylated on a conserved TSS motif by the kinase. This leads to Aurora B 
autophosphorylation which activates the kinase in a positive feedback-loop (Bishop and 
Schumacher, 2002; Honda et al., 2003; Yasui et al., 2004). INCENP has been shown to bind 
microtubules in vitro (Kang et al., 2001; Wheatley et al., 2001). 
Aurora B: Aurora B is a serine/threonine kinase that belongs to the Aurora family of kinases, 
in mammals further comprising Aurora A and C (Meraldi et al., 2004; Giet et al., 2005). 
While Aurora A localizes to the spindle poles and regulates centrosome maturation and 
spindle assembly (Meraldi et al., 2004), Aurora C has recently been characterized as a bona 
fide chromosomal passenger protein that can compensate for the loss of Aurora B (Sasai et 
al., 2004). Aurora B kinase phosphorylates INCENP, Survivin and Borealin within the CPC. 
Furthermore, Aurora B has been demonstrated to phosphorylate proteins at the 
centromere/kinetochore region, such as CENP-A and MCAK (Zeitlin et al., 2001; Andrews et 
al., 2004; Ohi et al., 2004) and at the central spindle and midbody, e.g., the kinesin Mklp1, 
the GTPase activating protein MgcRacGap, and the intermediate filament vimentin (Goto et 
al., 2003; Minoshima et al., 2003; Neef et al., 2006). Most known phosphorylation sites of 
Aurora B match the consensus motif (R/K)1–3X(S/T) and PP1 has emerged as the major 
phosphatase opposing Aurora B function (Francisco et al., 1994; Emanuele et al., 2008). Yet, 
the molecular details of how phosphorylation by Aurora B influences its different substrates, 
is only emerging. FRAP analysis revealed that the centromeric association of Aurora B is 
dynamic and does not depend on microtubules or on its kinase activity (Murata-Hori and 
Wang, 2002). Aurora B activity is also not essential for localization of the CPC to the central 
spindle or the midzone. However, specific inhibition of Aurora B by small molecules results 
in defects, identical to the knock-down of any CPC subunit (Ditchfield et al., 2003; Hauf et 
al., 2003). 
Survivin: Survivin was originally described as an antiapoptotic protein that is overexpressed 
in a variety of human cancers (Ambrosini et al., 1997). Survivin is a highly conserved 
member of the inhibitor of apoptosis protein (IAP) family as defined by the presence of a 
single baculoviral IAP repeat (BIR) Zn2+-finger motif. Unlike other IAPs, Survivin lacks a C-
terminal RING finger motif.  X-ray crystallography of Survivin in solution shows the protein 
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to be a butterfly-shaped dimer with long alpha helices protruding laterally from the paired 
BIR motifs (Chantalat et al., 2000; Muchmore et al., 2000; Verdecia et al., 2000). It has been 
reported that Survivin can bind to caspases 3 and 7, thereby causing a block in the apoptotic 
process (Tamm et al., 1998). Survivin can also bind to the mitochondrial caspase activator 
Smac/DIABLO, apparently displacing XIAP, and freeing the XIAP to act as a caspase 
inhibitor (Song et al., 2003; Song et al., 2004). Besides its putative role in the regulation of 
apoptosis, the use of Survivin specific antibodies identified the protein to be a member of the 
CPC (Uren et al., 2000; Wheatley et al., 2001). Survivin binds MTs in vitro (Li et al., 1998) 
and overexpression or depletion of the protein affects MT stability (Rosa et al., 2006). 
Furthermore, the dynamic posttranslational modification of Survivin by ubiquitin is involved 
in centromere targeting of the CPC (Vong et al., 2005). Survivin therefore appears to be 
multifunctional protein with essential roles in the regulation of both mitosis and apoptosis 
(Altieri, 2006). 
Borealin: Borealin was discovered in a proteomic screen for mitotic chromosome scaffolds 
associated proteins (Gassmann et al., 2004) and, simultaneously, in a screen for proteins 
capable of binding to chromosomes in Xenopus extracts where it was termed Dasra B  
(Sampath et al., 2004). Borealin is conserved in vertebrates but also found in Drosophila. The 
C. elegans protein CSC-1 (Romano et al., 2003) seems to be distantly related. However, no 
Borealin orthologue seems to be expressed in yeasts. Several species, including Xenopus and 
chicken (but apparently not human), express two Borealin isoforms, the second being termed 
Borealin 2/Dasra A. In Xenopus, Dasra A is important for the assembly of mitotic spindles 
that occurs in the absence of centrosomes (Sampath et al., 2004). The protein, like Survivin 
and INCENP, is readily phosphorylated by Aurora B in vitro (Gassmann et al., 2004). 
Recently, Mps1 mediated phosphorylation of Borealin was shown to influence the activity of 
Aurora B (Jelluma et al., 2008).  
 In in vitro binding- and yeast-two hybrid assays no particular order of CPC assembly 
could be deduced. Intriguingly, the existence of different subcomplexes of the holo-CPC has 
been proposed (Gassmann et al., 2004) (see Figure 6). However, the mutual interdependency 
between members of CPC has hampered to address this hypothesis. siRNA mediated knock-
down of any subunit of the CPC leads to a delay in prometaphase, lagging chromatids in 
anaphase and subsequently results in a cytokinesis defect. Strikingly, CPC depleted cells 
show a SAC dependent arrest when cells are treated with nocodazole (no KT-MT attachment) 
but override a taxol induced mitotic arrest (KT-MT attachment but no establishment of 
tension). Thus, it has been proposed that the CPC might sense tension at the 
centromere/kinetochore region by an unknown mechanism (Cimini, 2007; Musacchio and 
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Salmon, 2007). Once the SAC has been satisfied and anaphase commences, the CPC 
translocates from the inner centromere to the central spindle. This relocation requires the 
kinesin Mklp2 (Gruneberg et al., 2004) and dephosphorylation of Cdk1 phosphorylation-sites 
on INCENP (Murata-Hori et al., 2002; Pereira and Schiebel, 2003). At the central spindle, 
phosphorylation of Mklp1 by Aurora B was shown to be crucial to allow proper cytokinesis 
(Guse et al., 2005; Neef et al., 2006). Additionally, Ipl1 (the yeast Aurora B homologue) was 
shown to negatively regulate cytokinesis by delaying cell abscission until all sister chromatids 
have moved out of the division plane (Norden et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Architecture of the CPC (out of date 2005). 
Aurora B is supposed to form different complexes with chromosomal passenger proteins. The holo-CPC 
comprises INCENP, Survivin, Borealin and Aurora B (first row). This complex might contain other, yet 
unidentified components (second row). The existence of CPC subcomplexes (bottom row) has been proposed 
recently e.g. a dimeric INCENP-Aurora B complex was detected using sequential immunprecipitations 
(Gassmann et al., 2004). Adapted and modified from Giet et al., TRENDS in Cell Biology 2005. 
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PICH, a centromere bound helicase required for the SAC 
 Another kinase central to mitotic progression is Plk1. This highly conserved kinase 
associates with the KT, the central spindle/midbody and the centrosome and it regulates 
multiple key mitotic events including mitotic entry, centrosome and spindle function, 
chromosome cohesion and cytokinesis (Barr et al., 2004). KT localization of the protein was 
reported to depend on the phosphorylation status of INCENP (Goto et al., 2006) and 
antibody-mediated inhibition of Plk1 was shown to result in a prometaphase arrest (Lane and 
Nigg, 1996). Plk1 contains a phospho-binding motif, called the Polo-box domain (PBD) 
which recruits it to proteins that are phosphorylated at a specific consensus site (Elia et al., 
2003). PICH (Plk1 interacting checkpoint helicase) was identified in a screen for PBD 
binding proteins (Baumann et al., 2007), a protein that belongs to the SNF2 family of 
helicases involved in chromatin organization (Flaus et al., 2006). The protein was shown to 
be a substrate of Plk1 and cells depleted of Plk1 show spreading of PICH to chromosome 
arms. PICH, in turn, seems to be required for Plk1 to localize to chromosome arms 
(Santamaria et al., 2007). Interestingly, a recent study reported a role for PICH in 
chromosome arm cohesion (Leng et al., 2008). PICH depleted cells fail to arrest in mitosis 
when treated with drugs that disrupt KT-MT attachments and this has been speculated to be 
due to the inability of these cells to recruit the checkpoint protein Mad2 to the KT (Baumann 
et al., 2007). In prometaphase cells, PICH is present at the centromere as well as the outer 
kinetochore. In metaphase cells, PICH localizes to numerous short threads that link sister KTs 
of the aligned chromosomes. These threads are progressively stretched and resolved as cells 
enter anaphase and shown to contain centromeric DNA (Wang et al., 2008). Interestingly, 
PICH threads are enriched in prometaphase when sister KTs are no longer held together by 
cohesion (due to Sgo1 depletion) but undetectable under conditions of cohesion loss when 
taxol (reduced tension between sister KTs) was additionally added, indicating that PICH 
somehow responds to tension. Thus, if a tension sensor exists and is utilized by the SAC, 
PICH and/or the CPC (as outlined above) are appealing candidates. 
 
The SUMO system: A multifunctional pathway and novel regulator of 
mitosis 
 Traditionally, mitotic progression has been considered to be primarily regulated by 
two posttranslational modifications, protein phosphorylation and ubiquitin mediated protein 
degradation. Recently however, the SUMOylation pathway has emerged as a novel regulator 
of mitosis (Watts, 2007; Dasso, 2008). The SUMO system is involved in the regulation of 
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several other cellular key processes, including transcriptional control, DNA repair and 
recombination and nucleo-cytoplasmic shuttling (Muller et al., 2004; Hay, 2005). The 
unifying theme of SUMO function in all pathways appears to be the SUMO-dependent 
regulation of specific protein-protein interactions (Geiss-Friedlander and Melchior, 2007). 
In humans, at least three SUMO proteins (SUMO1, 2 and 3) are expressed. SUMO2 and 
SUMO3 are highly related proteins sharing an identity of 97% (therefore collectively referred 
to as SUMO2/3), while SUMO1 shares only 43% identity with SUMO2/3. During mitosis, 
SUMO1 appears to localize to the spindle poles in prometaphase/metaphase and to the central 
spindle during anaphase/telophase. In contrast, SUMO2/3 binds to the chromatin region from 
prophase until telophase (Ayaydin and Dasso, 2004; Zhang et al., 2008) and co-localizes with 
inner centromere markers (Azuma et al., 2005). The covalent attachment of SUMO to a target 
protein is catalyzed by an enzymatic cascade involving the E1 activating enzyme 
(Aos1/Uba2), the E2 conjugating enzyme (Ubc9) and, at least in some cases, additional E3 
ligases, such as PIAS family members, hPc2 or RanBP2 (Geiss-Friedlander and Melchior, 
2007) (Figure 7). In most cases the acceptor lysine is embedded in a characteristic KXE/D 
consensus motif. SUMO chains can be formed through linkage of additional SUMO moieties 
to previously conjugated SUMO proteins. Importantly, SUMO modification is a highly 
dynamic and reversible process in which SUMO-specific proteases (SENPs) are responsible 
for catalyzing desumoylation (Hay, 2007) (Figure 7). In humans six members of this family, 
termed SENP1-3 and SENP5-7, have been identified so far. A characteristic feature of distinct 
SENPs is their distribution to specific subcellular regions, indicating that their activity is 
spatially regulated. SENPs are also responsible for the initial activation of SUMO proteins by 
catalyzing their C-terminal processing. This cleavage exposes a C-terminal glycine-glycine 
motif that mediates SUMO conjugation via the creation of an isopeptide bond to a lysine 
residue of a target protein. In addition to the covalent modification of proteins by SUMO, the 
non-covalent association of SUMO with target proteins has been described (Schmidt and 
Muller, 2003; Geiss-Friedlander and Melchior, 2007). This interaction seems to be mediated 
by a SUMO interacting motif (SIM) within the target protein. 
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Figure 7. Illustration of the SUMO pathway. 
Sumoylation is a highly dynamic process with E1 (yellow), E2 (blue) and E3 enzymes (green) regulating
SUMO conjugation and SENPs (white) regulating deconjugation. Adapted and modified from Schmidt and
Muller, Cell.Mol.Life.Sci 2003  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data from genetic studies in yeast indicate that a balanced equilibrium of SUMO 
conjugation and deconjugation is critical for mitotic events, including mitotic entry (Seufert et 
al., 1995), chromosome cohesion (Bachant et al., 2002) and proper chromosome segregation 
during anaphase (Tanaka et al., 1999). Recent work has also revealed the importance of 
sumoylation for mitotic progression in vertebrates. In Xenopus egg extracts the SUMO E3 
ligase PIASy is essential for SUMO2/3 modification of topoisomerase II, an enzyme required 
for resolution of catenated DNA strands which in turn is essential for sister chromatid 
separation. Sumoylation of topoisomerase II recruits the protein to chromatin and depletion of 
PIASy leads to chromosome missegregation during anaphase (Azuma et al., 2005). In mouse 
embryonic fibroblasts, RanBP2 has been shown to act as the SUMO E3 ligase catalyzing 
topoisomerase II sumoylation (Dawlaty et al., 2008). In the same study, adult mice with 
reduced RanBP2 expression showed an increase in skin tumor development. RanBP2 is found 
in a complex with RanGAP1 and binds to the KT region (Joseph et al., 2002; Pichler et al., 
2002). Observations indicate that the RanGAP1/RanBP2 complex has an important mitotic 
role, particularly in establishing MT-KT attachments (Salina et al., 2003; Joseph et al., 2004) 
but it has not been demonstrated that the capacity of RanBP2 to promote such attachments 
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requires its activity as a SUMO ligase. Studies involving an unmodifiable form of RanGAP1 
indicate that its sumoylation is required not only for its interaction with RanBP2 (Mahajan et 
al., 1997) but also for the interaction of the RanBP2/RanGAP1 complex with KTs and the 
mitotic spindle (Joseph et al., 2002). Additionally, the SUMO-specific protease SENP5 has 
been shown to be required for cytokinesis (Di Bacco et al., 2006). However, in higher 
eukaryotes, only few mitotic targets of SUMO and regulatory components of the SUMO 
pathway are known. 
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AIM OF THIS WORK 
 
 The chromosomal passenger complex (CPC) consisting of the Aurora B kinase, 
INCENP, Survivin and Borealin plays a key role during mitotic progression. It is asscociated 
with the centromere from prophase until metaphase and binds to the central spindle in 
anaphase before accumulating at the midbody during telophase/cytokinesis.  
We aimed to identify specific interactions between the different subunits to shed light 
on the molecular architecture of the CPC and elucidate the contribution of the individual 
members for targeting and functioning of the complex. Having identified a ternary 
subcomplex of the CPC essential and sufficient for centromere recruitment we screened for 
components of the centromere/kinetochore region that might be regulated by it.  
Recently, it has been hypothesized that various CPCs of different composition might 
exist (Vagnarelli and Earnshaw, 2004). Data on the structure of the core CPC (generated by 
the collaborating laboratory of Elena Conti) thus prompted us to engineer different 
subcomplexes and investigate their functions. 
Borealin is the most recently identified member of the CPC (Gassmann et al., 2004; 
Sampath et al., 2004). Hence, little is known about its role within the complex. We therefore 
wished to identify new interactors of the Borealin protein and analyse them in detail. 
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RESULTS 
 
I. Centromere targeting of the CPC 
 
Aurora B kinase function at the centromere is essential for proper chromosome 
segregation at the metaphase to anaphase transition via resolution of improper KT-MT 
attachments and creation of stable bipolar attachments (Giet et al., 2005; Musacchio and 
Salmon, 2007). Therefore, the first goal of this work was to gain more insight into how 
Aurora B targets to the centromere besides the known interdependence between the members 
of the CPC in localization. 
 
Production of a polyclonal Borealin antibody 
At the time this study was initiated, Borealin had only been identified as a novel 
member of the CPC (Gassmann et al., 2004) and no commercial anti-Borealin antibody was 
available. Thus, we set out to produce a polyclonal Borealin specific antibody. Two rabbits 
(#702 and #725) were immunized with full-length His-tagged Borealin produced in E.coli 
(Figure 8A). Both antibodies gave identical results. By Western blotting a band of 34kDa was 
detected (Figure 8B) and immunofluorescence showed the characteristic CPC staining pattern 
(Figure 8C). Importantly, no Western blot or immunofluorescence signal was observed when 
cells were treated with siRNA oligonucleotides targeting the Borealin transcript, 
demonstrating the specificity of the antibody. 
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The CPC targets to the centromere independent of other kinetochore/centromere 
poteins 
In order to identify components of the kinetochore/centromere region that are required 
for the CPC to localize to the centromere, candidate proteins were depleted by siRNA 
duplexes and CPC localization was monitored by immunofluorescence. Interestingly, none of 
the tested candidates did affect localization of the CPC to the centromere (Figure 9A and B). 
 
 
 
 
Figure 8. Production and evaluation of a polyclonal Borealin specific antibody. 
(A) His-tagged Borealin full-length was purified using standard conditions and eluate fractions (EL1-3) were 
recovered. Bound = remaining His-Borealin on Ni-NTA beads after elution. The recombinant protein was used 
for immunization. 
(B) HeLa cells were treated with indicated siRNA duplexes for 48hrs and cell lysates were probed with the 
produced anti-Borealin antibody (final bleed #702). 
(C) Experiment as in (B) but cells were fixed for analysis by immunofluorescence using anti-Borealin (final 
bleed #702) and anti-Aurora B antibodies. The different mitotic stages are monitored. Note that in Borealin 
knock-down Aurora B cannot localize to the centromere, the central spindle or the midbody. Scale bar = 10µM.
Throughout this work DAPI was used to visualize DNA.        
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Figure 9. Centromere localization of the CPC in cells depleted of various centromere/kinetochore 
associated proteins. 
(A and B) Indicated proteins were depleted by siRNA treatment and CPC localization was monitored by either 
anti-rabbit Borealin or anti-mouse Aurora B antibodies. Efficient depletion was verified by co-staining with the 
respective antibody. In all cases were depletion could not be monitored directly (due to the lack of respective 
antibodies) previously published siRNA duplexes have been used. – indicates absence of the CPC, + indicates 
presence of the complex at the centromere. In PP2A depletion the CPC is present at the centromere but spreads 
over chromosome arms. 
(B) Representative result. Depletion of Cenp-A is shown. Scale bar = 10µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The N-terminal 58 amino acids of human INCENP are sufficient for centromere 
targeting 
As we were unable to identify any component of the kinetochore/centromere region 
that acts upstream of the CPC at the centromere we next analysed the intrinsic requirements of 
the complex for centromere localization. Analysis of how the CPC targets to the centromere 
has so far concentrated on INCENP, the binding partner of Aurora B. For chicken INCENP, it 
has been demonstrated that amino acids 1-68 are sufficient to direct the protein to centromeres 
(Ainsztein et al., 1998). In budding yeast, the removal of Cdk1 phosphorylation sites from 
INCENP seems to be important for the transfer of INCENP from the centromere to the central 
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spindle (Pereira and Schiebel, 2003), raising the possibility that Cdk1 phosphorylation might 
play a role in the centromere targeting of INCENP. Sequence analysis of the first 68 amino 
acids of human INCENP indicated the presence of a conserved Cdk1-consensus site at 
position T59 and an in vitro kinase assay showed that T59 is the only Cdk phosphorylation 
site within INCENP1-68 (Figure 10). Similarly, we identified S72 of INCENP as a bona fide 
Aurora B phoshorylation site in vitro (data not shown).    
 
 
 
 
 
 
 
 
 
 
 
To investigate the targeting of human INCENP to the centromere and the potential 
role of Cdk1 in this process, constructs were prepared comprising residues 1-58 (lacking the 
potential Cdk1-site) and residues 59-919, tagged with an N-terminal GFP-tag. INCENP1-58 
localized to the centromere from prophase to metaphase in HeLa cells (Figure 11A). 
Conversely, the construct lacking residues 1-58 (INCENP59-919) was dispersed in the 
cytoplasm and failed to target to the centromere (Figure 11B). Neither INCENP1-58 nor 
INCENP59-919 transferred to the central spindle or the midbody, and both were cytoplasmic in 
anaphase and telophase cells or associated with the chromatin. These data indicate that the N-
terminal 58 amino acids of the INCENP protein must carry information that determines 
centromere targeting and that Cdk phosphorylation of INCENP is not required for this 
process. However, T59 of INCENP might be involved in central spindle transfer of the CPC, 
similar to what has been shown in yeast (Pereira and Schiebel, 2003). 
 
Figure 10. T59 of INCENP is a Cdk1 phosphorylation site.  
(A) MBP tagged N-terminal fragments of INCENP were purified from E.coli and eluate fractions (EL1-3) were 
recovered. 
(B) Indicated recombinant proteins were tested in kinase assays using Cdk1 (or Erk2 as control). CBB = 
Coomassie Brilliant Blue loading control.   
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Borealin and Survivin bind to the N-terminus of INCENP in vitro 
Despite the well established binding of Aurora B to the C-terminus of INCENP via the 
IN-box motif (Bishop and Schumacher, 2002; Honda et al., 2003; Yasui et al., 2004; Sessa et 
al., 2005) the molecular architecture of the CPC is largely unknown. To determine whether 
any of the other chromosomal passenger proteins bind to the N-terminus of INCENP and may 
contribute to the centromere targeting a combination of directed yeast two-hybrid analyses 
and in vitro binding assays with recombinant proteins was used. In two-hybrid assays, Aurora 
B interacted with full-length INCENP (IN1-919) and the C-terminus of INCENP (IN790-919) 
containing the IN-box domain (Figure 12A, I, top and two bottom rows) but not with the 
coiled-coil domain of INCENP (IN531-789) or its N-terminus (IN1-530) (Figure 12A, I, rows 2 
and 3). (Note that for the two-hybrid assays, an N-terminal construct of INCENP comprising 
residues 1-530 had to be used because shorter N-terminal fragments were self-activating.) An 
interaction between full-length INCENP and Borealin was found (Figure 12A, II, top row) in 
line with a previous report (Gassmann et al., 2004). This interaction was mapped to the N- 
terminus of INCENP (INCENP1-530; Figure 12A, II, second row from top). Interestingly, 
depletion of the first 58 amino acids of INCENP abolished this interaction (Figure 12A, II, 
bottom). No interaction between INCENP and Survivin was observed in the two-hybrid assay 
Figure 11. The N terminus of human INCENP (GFP-INCENP1-58) targets to the centromere. 
HeLa cells were transfected with INCENP1-58 or INCENP59-919 N-terminally fused to GFP. 
(A) GFP-INCENP1-58 targets to the centromere in prometaphase and metaphase (independently of its expression
level) but remains cytoplasmic in anaphase and telophase.  
(B) A GFP-INCENP construct lacking the first 58 amino acids (GFP-INCENP59-919) does not localize to any
defined cellular structure during mitosis. Bar, 10µm. 
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(Figure 12A, III). Borealin, in contrast, associated with Survivin (Figure 12A, V). Neither 
Survivin nor Borealin showed an interaction with Aurora B using this approach (Figure 12A, 
IV). 
 
 
Figure 12. INCENP1-58, Borealin, and Survivin form a complex. 
(A) pFBT9-Aurora B (I and IV), pFBT9-Borealin (II and V), and pFBT9-Survivin (III) were tested against 
different fragments of INCENP (I–III) and full-length Borealin or Survivin (IV and V) in pACT2 by two-hybrid 
analysis. INCENP fragments were created based on a coiled-coil prediction tool (Berger et al., 1995). 
INCENP1-58 could not be used in this assay because it was self-activating. -LW indicates plates lacking leucine 
and tryptophane, whereas QDO indicates plates lacking leucine, tryptophane, histidine and adenine. 
(B) MBP (lanes 1 and 2) or MBP INCENP1-58 (lanes 3–5) was incubated with His- Borealin immobilized on Ni-
NTA agarose (lanes 2 and 4) or Ni-NTA agarose alone (lane 5). Input and protein bound to the beads were 
analyzed by SDS-PAGE. 
(C) MBP (lanes 1, 4, 8, and 9), MBP-INCENP1- 58 (lanes 2, 5, 6, 10, and 11), and MBP-Borealin (lanes 3, 7, and 
12) were incubated with GST (lanes 4–7) or GST-His-Survivin immobilized on glutathione-Sepharose (lanes 8–
12). Zn2+ (20mM) was added to the reactions where indicated (lanes 6, 9, and 11). 
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To corroborate the yeast two-hybrid observations and explore whether Borealin and 
Survivin could bind directly to the N-terminal 58 amino acids of INCENP, in vitro binding 
assays were used. In agreement with the two-hybrid data, an interaction between His-tagged 
Borealin (His-Borealin) and MBP-tagged INCENP1-58 (MBP-IN1-58) was observed (Figure 
12B, lane 4). Furthermore, both MBP-Borealin and MBP-INCENP1-58 bound to immobilized 
GST-His-Survivin (Figure 12C, lanes 11 and 12). The interaction between MBP-INCENP1-58 
and GST-His-Survivin was only observed in the presence of excess Zn2+ (Figure 12C, 
compare lanes 10 and 11), whereas the interaction between MBP-Borealin and GST-His-
Survivin was not dependent on this (lane 12). As the yeast two hybrid data did not reveal an 
interaction between Survivin and INCENP, we presume that the yeast nucleus does not allow 
for the specific folding of Survivin required for this binding (see yeast two-hybrid data in 
Figure 12A, column III). We conclude that while Aurora B associates with the C terminus of 
INCENP via the IN-box, Survivin and Borealin interact with the N-terminal 58 amino acids of 
INCENP and bind to each other directly. 
 
Borealin and Survivin can form higher order structures in vivo 
The finding that both Borealin and Survivin interact with the first 58 amino acids of 
INCENP as well as with each other suggests the existence of a heterotrimeric complex 
assembled on the N-terminus of INCENP. Because oligomerization of Survivin as well as 
Borealin had been observed in vitro (Chantalat et al., 2000; Muchmore et al., 2000; Verdecia 
et al., 2000; Gassmann et al., 2004), we next asked whether this can also occur in vivo. To 
this end, HeLa cells were co-transfected with Flag- and Myc-tagged constructs of either 
Survivin, Borealin, or INCENP. The cells were then arrested with nocodazole to enrich for 
transfected mitotic cells. Coimmunoprecipitation of Flag- and Myc-tagged constructs was 
assessed by Western blotting. Oligomerization was observed for Borealin and Survivin but 
not INCENP (Figure 13, compare lanes 3 and 4 in I–III). Based on these experiments, we 
propose that Survivin and Borealin are prone to form higher order structures in vivo. 
However, the stochiometry of the formed complexes (e.g. with regard to INCENP binding) 
and/or their function is not assessed in this assay. 
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The N-terminus of INCENP forms a complex with Survivin and Borealin in vivo  
To verify that the N-terminal domain of INCENP can also interact with Survivin and 
Borealin in vivo, different GFP-tagged INCENP constructs were transfected into HeLa cells and 
immunoprecipitations were performed on mitotic lysates using anti-GFP antibodies. Full-length 
GFP-INCENP coprecipitated Aurora B, Borealin, and Survivin (Figure 14, lane 1). INCENP 
fragments containing the C-terminal IN-box motif of INCENP pulled down Aurora B but not 
Survivin or Borealin (Figure 14, lanes 5 and 7). In contrast, N-terminal fragments of INCENP 
containing residues 1-58 precipitated Borealin and Survivin but not Aurora B (lanes 3 and 4) 
whereas the coiled-coil domain of INCENP lacking both the N- and the C-terminus did not 
associate with any of the other CPC components (lane 6). None of the constructs coprecipitated 
the centromeric protein CENP-A (lanes 1–7, second row from bottom) or the kinetochore protein 
Hec1 (lanes 1–7, bottom row). Together, these results support data on the interaction between the 
C-terminus of INCENP containing the IN-box motif and Aurora B and show that a ternary 
complex between Borealin, Survivin, and the first 58 amino acids of INCENP (IN1-58) exists in 
vivo. 
 
 
Figure 13. Borealin and Survivin can form oligomeres in vivo. 
Myc- or Flag-tagged CPC constructs were co-overexpressed in HeLa cells arrested by nocodazole treatment 
followed by Myc and Flag pull-downs and Western blotting with anti-Flag or anti-Myc antibodies. 
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Ectopic GFP-INCENP full-length can complement for the loss of endogenous INCENP in a 
siRNA based complementation assay 
To examine the physiological relevance of these findings for the targeting of the CPC to the 
centromere in vivo, a siRNA based rescue assay was established. INCENP or Aurora B were 
effectively knocked-down by a 36hrs treatment with siRNA oligonucleotides targeting the 3´-
UTR of the corresponding transcripts. In line with previous results (Honda et al., 2003; Gassmann 
et al., 2004), the knock-down of Aurora B or INCENP resulted in the loss of all other CPC 
components from the centromere, the central spindle and the midbody (Figure 15A). Furthermore, 
Western blotting showed that knock-down of INCENP resulted in the simultaneous loss of 
Aurora B and vice versa and strong reduction of Survivin levels, whereas the protein level of 
Borealin was less affected (Figure 15B, lanes 2 and 3). Depletion of Borealin did not significantly 
affect Aurora B or INCENP levels but reduced the level of Survivin and the knock-down of 
Survivin reduced the level of all members of the CPC (Figure 15B, lanes 4 and 5). To express 
GFP-tagged INCENP constructs in the absence of the endogenous protein, cells were transfected 
Figure 14. INCENP1-58, Borealin, and Survivin form a ternary complex in vivo. 
Different fragments of INCENP fused to GFP were transfected into HeLa cells and precipitated from mitotic lysates 
with sheep anti-GFP antibodies. Coprecipitating passenger proteins or the control centromere/kinetochore proteins 
CENP-A and Hec1 were visualized by Western blotting. Asterisks indicate GFP constructs. The anti-GFP blot was cut 
into two halves to remove the strong signal of the immunoglobulin heavy chain. 
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simultaneously with INCENP siRNA oligonucleotides and the respective rescue constructs (see 
Materials and Methods for precise protocol). The effectiveness of INCENP knock-down in these 
experiments was assessed by staining with antibodies against Aurora B and was found to be close 
to 100% (Figure 15C). The transfection efficiency of the rescue constructs was typically around 
10-20%. To validate the assay, control rescue experiments using the combination of INCENP 
siRNA treatment and transfection with full-length GFP-tagged INCENP were performed. In cells 
treated with siRNA duplexes targeting endogenous INCENP, the transfected GFP-INCENP full-
length construct efficiently localized to the centromere and restored Borealin, Survivin, and 
Aurora B staining (Figure 16). In addition, phospho-S7-CENP-A staining, a marker for Aurora B 
kinase activity (Zeitlin et al., 2001), was lost completely in INCENP depleted cells but restored 
upon expression of GFP-INCENP full-length.  
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We note that phospho-S7-CENP-A staining was used as a read-out because it was 
found to be more sensitive to siRNA-mediated knockdown of chromosomal passenger 
proteins than staining with anti-phospho-S10-histone H3 antibody (Figure 17). 
 
Figure 16. Rescue of INCENP depletion by ectopic expression of GFP-INCENPfull-length. 
HeLa cells were treated with 3´-UTR siRNA oligonucleotides targeting INCENP and simultaneously 
transfected with GFP-INCENPfull-length. Transfected cells were analyzed for the presence of the other 
chromosomal passenger proteins or phospho-S7-CENP-A staining as a readout for Aurora B activity. For this 
experiment and all following CPC rescue assays usually between 8 and 25 cells could be analysed per 
experiment. Images shown are representatives of three independent experiments. Bar, 10 µm. 
Figure 15. Evaluation of 3´-UTR siRNA duplexes used to knock-down passenger protein expression. 
(A) HeLa cells were treated with siRNA oligonucleotides targeting the 3´-UTR of INCENP, Aurora B, 
Borealin, or Survivin transcripts, fixed, and then costained with antibodies against INCENP and Aurora B 
(INCENP- and Aurora B RNAi, top) or Borealin and Survivin (Borealin- and Survivin RNAi, bottom). 
Mitotic cells are indicated by arrows. Bar, 10 µm. 
(B) Cell extracts from cells depleted for the different passenger proteins by treatment with corresponding 
siRNA oligonucleotides for 36hrs were analyzed by Western blotting. The blots were reprobed with 
antibodies against CENP-A to demonstrate equal loading (bottom row).  
(C) HeLa cells treated with the indicated 3´-UTR siRNA oligonucleotides targeting chromosomal passenger 
proteins for 36hrs were stained with antibodies against Aurora B. One hundred cells were assessed in each 
case for the presence of Aurora B centromere staining. 
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Ectopic GFP-INCENP1-58 can target Survivin and Borealin but not Aurora B to the 
centromere in the absence of endogenous INCENP 
Having established the siRNA based rescue assay, this approach was used to assess the 
ability of GFP-tagged INCENP1-58 to target to the centromere in cells depleted of endogenous 
INCENP. GFP-INCENP1-58 efficiently localized to the centromere in this scenario. The 
transfected cells were also positive for Survivin and Borealin but, consistent with the 
coprecipitation data (Figure 14), neither for Aurora B nor phospho-S7-CENP-A (Figure 18A). 
 
 
 
Figure 17. phospho-S7-Cenp-A is a reliable read-out for Aurora B kinase activity. 
HeLa cells were treated with indicated siRNA duplexes and immunofluorescence was performed with Aurora B, 
phospho-S10-histone H3 and phospho-S7-CENP-A antibodies. As phospho-S7-Cenp-A but not phospho-S10-
histone H3 is absent in Aurora B siRNA in immuofluorescence we used phospho-S7-CENP-A throughout the 
course of this work as a read-out for Aurora B activity. Bar, 10 µm. 
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Biochemical analysis of cells treated as described above but enriched for transfected 
cells by puromycin selection showed that in contrast to GFP-INCENP full- length and GFP-
INCENP59-919 (both containing the Aurora B binding IN-box motif), GFP-INCENP1-58 could 
not rescue the protein levels of Aurora B (Figure 18B, compare lane 5 with lanes 3 and 4) in 
cells lacking endogenous INCENP. Interestingly, the rescue of Aurora B protein levels in the 
absence of correct localization was not sufficient to restore Aurora B function at the 
centromere as indicated by the absence of phospho-S7-CENP-A staining in cells depleted of 
endogenous INCENP and complemented with GFP-INCENP59-919 (Figure 18C). This stresses 
the importance of the first 58 amino acids of INCENP for correct Aurora B localization to the 
centromere which appears to be a pre-requisite for the phosphorylation of target proteins. 
Together, these results indicate that a complex consisting of INCENP1-58, Survivin, 
and Borealin is sufficient for centromere targeting, and, remarkably, it does not require the 
presence of the Aurora B protein. Although Western blotting showed that in INCENP siRNA-
treated cells, Aurora B was reduced to undetectable levels (Figure 15B, lane 2), the possibility 
remained that the above-mentioned observations were due to minimal residual Aurora B in 
INCENP siRNA-treated cells, which might be sufficient to mediate centromere targeting. To 
exclude this, INCENP and Aurora B were simultaneously depleted and GFP-tagged 
INCENP1-58 was expressed. The additional knock-down of Aurora B did not change the result 
that INCENP1-58, Borealin, and Survivin could target to the centromere (Figure 19, top row). 
One protein that could potentially compensate for the loss of Aurora B function is the related 
Aurora C kinase. Aurora C was shown to localize like a chromosomal passenger protein, but 
it is expressed at lower levels than Aurora B and might be functionally redundant with Aurora 
B (Li et al., 2004; Sasai et al., 2004). However, simultaneous depletion of INCENP and 
Aurora C or INCENP, Aurora C, and Aurora B followed by rescue with GFP-INCENP1-58 
Figure 18. GFP-INCENP1-58 targets to the centromere in the absence of endogenous INCENP and restores 
Survivin and Borealin but not Aurora B staining. 
(A) HeLa cells were treated with 3´-UTR siRNA oligonucleotides targeting INCENP and simultaneously 
transfected with GFP-INCENP1-58. Transfected cells were analyzed for the presence of the other chromosomal 
passenger proteins or phospho-S7-CENP-A staining as a readout for Aurora B activity. 
(B) HeLa cells were transfected with the indicated constructs in pcDNA4/TO-EGFP encoding puromycin 
resistance and treated with the indicated siRNA oligonucleotides for 36hrs. Twenty-four hours before harvesting, 
the cells were treated with 2µg/ml puromycin. Asterisks indicate GFP constructs. 
(C) INCENP siRNA-treated HeLa cells transfected with INCENP59-919 were treated as in (A) and costained for 
phospho-S7-CENP-A. Bar, 10µm. 
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resulted in centromere localization of the ternary INCENP1-58–Survivin–Borealin complex, 
excluding a compensatory role for Aurora C (Figure 19, middle and bottom rows). 
 
 
Aurora B kinase activity is not required for the maintenance of the CPC at the 
centromere 
The above-mentioned findings show that at least for the initial targeting of the CPC to 
the centromere Aurora B kinase activity is not required. However, prolonged highlevel 
expression of kinase-dead Aurora B leads to loss of Aurora B itself and the other 
chromosomal passengers from the centromere and spreading throughout the chromatin 
(Ditchfield et al., 2003; Honda et al., 2003). This suggests either a requirement for Aurora B 
kinase activity for the maintenance of the CPC at the centromere, or, alternatively, that 
overexpression of the kinase-dead Aurora B exerts a dominant-negative effect on the 
localization of the CPC. Because the prolonged direct inhibition of Aurora B kinase activity 
by a chemical inhibitor does not affect the association of Aurora B itself or the other 
chromosomal passengers with the centromere (Ditchfield et al., 2003) (Figure 20), the latter 
explanation seems more likely. 
Figure 19. GFP-INCENP1-58 targets to the centromere in the absence of Aurora B and Aurora C. 
INCENP complementation assay as established above was carried out with the additional depletion of the 
indicated proteins.  The GFP and Aurora B signals were monitored by immunofluorescence. Bar, 10µM.   
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The ternary INCENP1-58-Survivin-Borealin subcomplex cannot functionally rescue 
INCENP depletion  
Together with the results from the siRNA rescue experiments, these data demonstrate 
that Aurora B kinase activity is neither required for the initial recruitment of the chromosomal 
passenger proteins to the centromere nor for the maintenance of the proteins at the centromere 
but that a subcomplex of INCENP1-58, Survivin, and Borealin is essential for centromere 
targeting. We next tested if the ternary complex can functionally compensate for the loss of 
centromere bound Aurora B by monitoring BubR1, a spindle checkpoint protein that was 
shown to be absent from the kinetochore in cells treated with Aurora B inhibitors. BubR1 was 
present in INCENP depleted cells complemented with GFP-INCENP full-length but absent 
when complemented with GFP-INCENP1-58 (Figure 21A). Furthermore, in cells 
complemented with GFP-INCENP1-58 chromosome alignment on the metaphase plate was 
disturbed (Figure 21B). These data are consistent with the documented requirement for 
Aurora B kinase function in the recruitment of checkpoint proteins and chromosome 
congression (Ditchfield et al., 2003; Hauf et al., 2003). 
Figure 20. Inhibition of Aurora B kinase activity does not alter CPC localization to the centromere. 
Hela cells were treated with the Aurora B kinase inhibitor ZM447439 (or DMSO as control) for 2hrs and 
immunofluorescence was performed using phospho-S7-Cenp-A and Aurora B antibodies. Bar, 10µM.   
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Borealin binds to double-stranded DNA in vitro 
Because no centromere/kinetochore component so far analyzed was found to influence 
CPC recruitment to the centromere the possibility that one or more of the CPC subunits might 
be able to bind to DNA directly was considered. To test this hypothesis, purified histone H3, 
recombinant MBP-Borealin, His-Borealin, MBP-INCENP1-58, MBP, GST-Cdc20, and His-
Plk1 were incubated with native double-stranded calf-thymus DNA-cellulose. Only His-
Borealin and MBP-Borealin, as well as the positive control protein histone H3, bound to the 
DNA (Figure 22A, lanes 7, 9, and 2, respectively). The centromere/kinetochore proteins 
Cdc20 and Plk1, both of which exhibit a similar basic pI as Borealin, did not bind to the DNA 
cellulose, arguing against a non-specific charge-based association of Borealin with the 
cellulose. Furthermore, increased salt concentrations reduced binding of His-Borealin to the 
DNA (Figure 22B). Importantly, when His-Borealin, His-Survivin, and MBP-INCENP1-58 
were mixed and incubated with DNA-cellulose, His-Borealin could recruit the two other 
proteins to the DNA (Figure 22C, lane 4). 
A. B.
Figure 21. INCENP1-58 is not functional at the centromere in BubR1 recruitment and proper chromosome 
alignment. 
(A) INCENP complementation assay as described above monitoring BubR1 kinetochore recruitment.  
(B) Experiment as in (A) monitoring chromatin alignment onto the metaphase plate. 
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Figure 22. Borealin binds to double-stranded DNA in vitro. 
(A) Histone H3, His-Survivin, His-Borealin, MBP-Borealin, MBP-INCENP1-58, MBP alone, GST-Cdc20, and 
His-Plk1 were tested for DNA-binding activity by incubation with calf-thymus DNA-cellulose. Input (lanes 1, 
3, 6, 8, 10, 12, 14, and 16) and proteins bound to the cellulose (lanes 2, 4, 5, 7, 9, 11, 13, 15, and 17) were 
analyzed by SDS-PAGE. Only histone H3 (lane 2), His-Borealin (lane 7), and MBP-Borealin (lane 9) bound to 
the DNA cellulose. 
(B) His-Borealin was incubated with DNA-cellulose as in (A) in the presence of increasing NaCl 
concentrations. 
(C) His-Borealin, His-Survivin, and MBP-INCENP1-58 were mixed at equimolar concentrations and incubated 
with calf-thymus DNA-cellulose as described above. In the presence of His-Borealin, His-Survivin and MBP-
INCENP1-58 were found in the DNA-binding fraction (lane 4). 
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The integrity of the ternary INCENP1-58-Survivin-Borealin subcomplex is essential for 
its centromere binding 
The above data suggest that Borealin might be the subunit within the CPC that can 
directly bind to DNA and thus localize the CPC to the centromere. Hence, it was tested 
whether Borealin could target to the centromere in vivo independently of its binding partners 
INCENP and Survivin. Endogenous Borealin was knocked-down with siRNA duplexes 
targeting the 3´-UTR (see Figure 15B, lane 4, for Western blot) and replaced by transfected 
Myc-tagged Borealin. Myc-Borealin localized correctly to the centromere in the absence of 
endogenous Borealin and restored targeting of the other passenger proteins to the centromere 
as well as phospho-S7-CENP-A staining (Figure 23A). In contrast, centromere targeting of 
Myc-Borealin was abolished when INCENP (Figure 23B) or Survivin (Figure 23C) were 
simultaneously depleted in this assay. Thus, even though Borealin is able to bind to DNA in 
vitro, in vivo the presence of INCENP and Survivin is required for targeting to the 
centromere. Similarly, neither Myc-Survivin (Figure 23D, E and F) nor GFP-INCENP1-58 
(Figure 23G and H) were able to localize to the centromere in the absence of one of their 
binding partners in corresponding complementation assays. This provides evidence that the 
integrity of the INCENP1-58-Survivin-Borealin subcomplex must be maintained to target these 
components to the centromere. 
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Figure 23. Centromere targeting of Borealin, Survivin and INCENP1-58 depends on the integrity of the 
ternary complex. 
(A-G) HeLa cells were treated with combinations of 3´-UTR siRNA oligonucleotides targeting either Borealin, 
Survivin or INCENP and simultaneously transfected with Myc-Borealin (A-C), Myc-Survivin (D-F) or GFP-
INCENP1-58 (H-G) as indicated. Transfected cells were analyzed for the presence of other chromosomal 
passenger proteins at the centromere as outlined. Bar, 10 µm. See figure 18A for controls of H and G. 
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Conclusion 
In order to identify upstream kinetochore/centromere components that regulate CPC 
targeting to the centromere a focussed siRNA based screen was performed. None of the tested 
candidate proteins influenced the association of the complex with the centromere. This 
suggested that the CPC exhibits an intrinsic property that governs its centromere localization. 
Deletion mutants of the framework protein INCENP showed that a small N-terminal fragment 
of the protein (residues 1-58) is sufficient for centromere recruitment. This region of the 
INCENP protein was shown to bind directly to Survivin and Borealin but not to Aurora B, 
thus creating a heterotrimeric subcomplex within the holo-CPC. 
In order to overcome the mutual interdependence of passenger proteins concerning 
their localization, a siRNA based complementation assay was established. This approach 
revealed that the ternary INCENP1-58-Survivin-Borealin subcomplex is essential and sufficient 
for centromere targeting. Strikingly, Aurora B kinase, the enzymatic core of the CPC, was not 
required for this task. However, the ternary complex could not compensate for the lack of 
Aurora B kinase activity at the centromere in terms of proper chromosome alignment. We 
further show that the Borealin subunit can bind DNA in vitro and thus may directly target the 
CPC to centromeric DNA in vivo. These findings establish a functional module within the 
CPC that assembles on the N-terminus of INCENP and controls centromere recruitment. 
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II. CPC mediated recruitment of PICH to the centromere 
 
Focused screen for components that require the presence of the CPC for kinetochore/ 
centromere localization 
 CPC functions at the centromere/kinetochore have so far been assigned exclusively to 
the activity of the Aurora B kinase. The role of the remaining passenger proteins was 
speculated to consist in governing proper localization of Aurora B during mitotic progression 
(Vader et al., 2006). The lack of functional rescue potential of the ternary INCENP1-58-
Survivin-Borealin complex in the afore mentioned approach (Figure 21) prompted us to 
analyse if there is a component of the kinetochore/centromere region that relies on the 
presence of the CPC independently of Aurora B kinase activity. This component should fulfil 
two criteria: a) it should be mislocalized under conditions of CPC depletion and b) it should 
be localized correctly under conditions of Aurora B inhibition. Thus, we compared the 
localization of various kinetochore/centromere associated proteins in cells treated with siRNA 
duplexes targeting Aurora B to cells treated with the Aurora B inhibitor ZM447439 (Figure 
24). Out of all proteins analysed only one, the DNA dependent helicase PICH, fulfilled both 
criteria. Strikingly, PICH has been shown to regulate SAC function and been hypothesized to 
sense tension at the kinetochore/centromere region (Baumann et al., 2007).      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Centromere/kinetochore localization of 
proteins in cells depleted of Aurora B compared to
cells treated with the Aurora B inhibitor ZM447439. 
Cells were analysed by immunofluorescence staining with 
mouse anti-Aurora B or rabbit anti-INCENP antibodies 
(to monitor the CPC) and antibodies against the respective 
candidate protein. – indicates absence of the analysed 
protein from the kinetochore/centromere, + indicates its 
presence. Only PICH (and the CPC itself) respond 
differently to depletion of Aurora B kinase versus its 
inhibition.  
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This approach also showed that the KT recruitment of components directly involved in 
KT-MT attachments, like Hec1, Astrin and RanBP2 (Joseph et al., 2004; DeLuca et al., 2005; 
Thein et al., 2007) are not regulated by the CPC while all known checkpoint proteins rely on 
the presence of the CPC to localize to the KT. Interestingly, Plk1 was found to depend on an 
active Aurora B kinase, contrasting findings that the phosphorylation status of INCENP 
regulates Plk1 kinetochore localization (Goto et al., 2006). 
To corroborate the finding that the CPC regulates PICH at the centromere/kinetochore 
region we made use of a dominant negative Borealin fragment (Borealin1-140) that is unable to 
localize to the centromere (Gassmann et al., 2004). Similar to siRNA mediated knock-down 
of Aurora B (or any other member of the CPC; data not shown) cells transfected with 
Borealin1-140 showed mislocalization of PICH (Figure 25A). To address if the CPC might also 
positively regulate PICH at the centromere/kinetochore we depleted cells of the motor protein 
CENP-E. Under these conditions CPC levels are elevated at monooriented chromatids but 
PICH levels remained unaltered (Figure 25B).     
 
 
 
 
 
 
 
 
 
As noted before (Baumann et al., 2007) PICH is found on chromosome arms in cells 
depleted of Plk1. The observation that under conditions of Aurora B inhibition Plk1 (but not 
PICH) is absent from the kinetochore/centromere (Figure 26) indicates that cytoplasmic Plk1 
is sufficient to remove PICH from chromosome arms. 
Figure 25. CPC dependent regulation of PICH. 
(A) Different Myc-tagged versions of Borealin were transfected into HeLa cells and centromere/kinetochore 
localization of PICH was assessed.  
(B) HeLa cells were treated with siRNA duplexes targeting CENP-E for 36hrs and stained for Aurora B and 
PICH. Arrows point to AuroraB/PICH at monooriented chromatids. Bar, 10µm. 
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The finding that PICH centromere/kinetochore localization relies on the CPC but not 
Aurora B kinase activity was unique among the tested components. We therefore wished to 
confirm this result in another cell type. In agreement with the results obtained in HeLa cells, 
U2OS cells treated with siRNA duplexes against Aurora B showed mislocalization of PICH 
but ZM447439 treatment did also not affect PICH in U2OS cells (Figure 27).  
 
 
 
 
 
 
 
 
 
 
 
Figure 26. Aurora B kinase activity regulates Plk1 but not PICH at the kinetochore/centromere. 
Hela cells were treated with ZM447429 (or DMSO as control) for 2hrs, fixed and stained with indicated 
antibodies. Phospho-S7-Cenp-A staining controls for Aurora B kinase activity. In ZM447439 treated cells Plk1 
is absent from kinetochores but present at the centrosomes (bright dots) while PICH localization is unaffected.
Bar, 10µm.  
Figure 27. Aurora B depletion but not inhibition 
influences PICH in U2OS cells. 
U2OS cells were either treated with siRNA 
oligonucleotides targeting Aurora B for 36hrs or 
incubated with ZM447439 for different time points. 
Aurora B and PICH were visualized by 
immunofluorescence. Bar, 10µm.  
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INCENP1-58 cannot rescue PICH localization to the centromere/kinetochore 
 Next we analysed if PICH centromere/kinetochore localization can be restored in 
INCENP depleted cells complemented with INCENP1-58. Rescue assays were performed as 
outlined before. In cells transfected with the full-length INCENP, PICH was properly 
localized. But the INCENP1-58 fragment was unable to rescue PICH centromere/kinetochore 
binding in transfecetd cells (Figure 28). 
 
 
 
 
 
 
 
 
 
 
 
 
Mutual interplay between the CPC, PICH and Plk1 at the centromere/kinetochore 
We went on to test for interdependencies between the CPC, PICH and Plk1 in terms of 
their centromere/kinetochore localization. HeLa cells were depleted of the respective protein 
by siRNA treatment and localization of the remaining components was analysed by 
immunofluorescence (Figure 29). Plk1 depletion did not influence centromeric localization of 
the CPC but resulted in PICH spreading over chromatin arms (Figure 29, top panels). Knock-
down of PICH did not influence Plk1 or CPC in localization to the kinetochore/centromere 
(Figure 29, upper right and bottom panel).       
 
Figure 28. INCENP1-58 cannot rescue PICH at the centromere/kinetochore. 
HeLa cells were depleted of INCENP by siRNA treatment as outlined above (upper row) and transfected with 
either GFP (upper row), GFP-INCENPwt (middle row) or GFP-INCENP1-58 (bottom row). PICH localization 
was analysed by immunofluorescence. Bar, 10µm.
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Next we monitored the activity of the two kinases Aurora B and Plk1 under the above 
conditions. Aurora B activity was monitored by phospho-S7-Cenp-A staining and found to be 
unaffected by Plk1 or PICH knock-down (Figure 30A). Interestingly, staining with phospho-
S676-BubR1, a Plk1 phosphorylation site (Elowe et al., 2007) did not show any signal in 
PICH depleted cells but overall BubR1 levels were unaffected (Figure 30B). However, γ-
tubulin staining, another read-out for Plk1 activity (Santamaria et al., 2007) was unaffected in 
PICH knock-down (Figure 30C). Thus, no obvious dependencies between Aurora B, Plk1 and 
PICH seem to exist with regard to kinase activities of Aurora B and Plk1. The observed loss 
of phospho-S676-BubR1 in PICH depleted cells is likely to happen by means other than 
regulation of Plk1 activity. 
Figure 29. Interdependence between the CPC, 
PICH and Plk1 at the kinetochore/centromere. 
Hela cells were treated with siRNA duplexes 
directed against Aurora B, Plk1 or PICH, 
respectively, incubated for 48hrs and processed for 
immunofluorescene as indicated. 
Upper left panel: Plk1 regulates PICH (but not vice 
versa). Upper right panel: The CPC regulates Plk1 
(but not vice versa). Bottom panel: The CPC 
regulates PICH (but not vice versa). Bar, 10µm.  
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Figure 30. Aurora B and Plk1 kinase activity in cells depleted of Aurora B, Plk1 or PICH, respectively. 
(A) phospho-S7-CENP-A staining was assessed in HeLa cells depleted of Plk1 (or Eg5 as control), Aurora B 
or PICH. 
(B) phospho-S676-BubRI is absent in HeLa cells treated with PICH siRNA duplexes. BubR1 is shown as 
control. CPC depletion was not performed  as it displaces BubR1 protein from the KT. 
(C) γ-tubulin staining was assessed in HeLa cells depleted of Plk1 (or Eg5 as control), Aurora B or PICH. Bar, 
10µm. 
RESULTS 
 46
The CPC acts upstream of Plk1 in localizing PICH  
 In Plk1 depleted cells PICH localizes to chromosome arms (Baumann et al., 2007) 
(Figure 31 left panel). In contrast, knock-down of Aurora B led to the absence of PICH form 
the centromere/kinetochore (Figure 31 left panel). Thus, we analysed the fate of PICH in 
Plk1/Aurora B double-depletion. In these cells PICH was absent from the centromere/ 
kinetochore and did not localize to the chromosome arms (Figure 31 right panel). Hence, we 
conclude that the CPC, in addition to regulating the centromere/kinetochore localization of 
PICH, is also involved in regulating the localization of PICH to chromosome arms.  
 
 
 
   
 
 
 
 
 
 
 
The CPC might regulate SAC function via Mad2 recruitment 
 The function of the SAC has been speculated to depend on two ultimately intertwined 
mechanisms namely KT-MT attachment and the generation of tension between sister KTs. 
The CPC seems to constitute the tension sensing arm of the SAC. Cells depleted of the 
complex show a SAC dependent mitotic arrest in response to nocodazole (disrupted KT-MT 
attachment) but override a taxol induced mitotic arrest (reduced tension between sister KTs). 
The underlying determinants have not been elucidated so far. Importantly however, the 
checkpoint protein PICH (as outlined above) as well as the checkpoint protein Mad2 
(Vigneron et al., 2004) (and data not shown) are lost from the kinetochore/centromere in CPC 
depleted cells. Moreover, PICH knock-down also displaces Mad2 from the KT (Baumann et 
al., 2007) (and data not shown). To gain insight into the mitotic arrest seen in CPC depleted 
cells arrested with nocodazole, HeLa cells were knocked-down of Aurora B and treated with 
Figure 31. PICH is mislocalized in Plk1/Aurora B double-depleted cells.  
HeLa cells were treated with siRNA duplexes targeting Aurora B or Plk1 (left panel) or Aurora B plus Plk1 
(right panel) and incubated for 36hrs. PICH localization was analysed by immunofluorescence. Arrowhead
indicates lack of PICH localization in a double depleted cell. Bar, 10µm.  
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taxol or nocodazole, respectively. Treatments with either MT poison did not change the result 
that PICH was absent from the centromere/kinetochore under conditions of CPC depletion 
(Figure 32A). Strikingly, Mad2 was found to be absent from the KT in this assay when taxol 
was added (Figure 32B) but present when cells were grown in the presence of nocodazole 
(Figure 32C).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32. Mad 2 but not PICH is re-directed to KTs in Aurora B depletion under nocodazole treatment.
(A-C) Cells depleted of Aurora B were analysed in different drug treatments compared to not-depleted cells in 
the same image. 
(A) HeLa cells were depleted of Aurora B by specific siRNA oligonucleotides for 36hrs and treated with 
nocodazole 12hrs before fixation. PICH localization was monitored by immunofluorescence.  
(B) Experiment as in (A) but instead of nocodazole taxol was added and Mad2 was monitored. 
(C) Experiment as outlined for (A), but monitoring Mad2 localization. Bar 10µm.     
RESULTS 
 48
PICH threads form independently of the CPC 
  As cells start to enter anaphase Plk1 associates with the central spindle while PICH 
eventually forms thin threads that connect sister chromatids (Baumann et al., 2007) and that 
contain centromeric DNA (Wang et al., 2008). The exact nature of these threads and their 
function remain to be elucidated. We asked if Plk1 and PICH are also influenced by the CPC 
during anaphase. Depletion of Aurora B did not change Plk1 localization to the central spindle 
(Figure 33A) or PICH thread formation (Figure 33B and C). Thus, centromere/kinetochore 
localization of Plk1 and PICH does not appear to be a pre-requisite for central spindle binding 
or thread formation, respectively.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33. Plk1 and PICH localization in anaphase is independent of the CPC. 
(A) HeLa cells were treated with siRNA duplexes directed against Aurora B for 48hrs and Plk1 staining was 
assessed in anaphase cells. 
(B) Experiment as in (A), but monitoring PICH threads. 
(C) Experiment as in (B). The lower region of the image shows two metaphase cells, one being depleted of the 
CPC (see INCENP staining). In the upper region two anaphase cells are shown, again only one being depleted 
of the CPC. However, in both anaphase cells PICH threads are detected (arrow heads). Bar 10µm. 
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Conclusion 
PICH, a novel spindle checkpoint protein recently identified in our laboratory, was 
identified as a component that requires the presence of the CPC but, strikingly, not Aurora B 
kinase activity for its centromere/kinetochore localization; a behaviour that has not been 
reported for any other centromere/kinetochore associated protein so far. However, increased 
centromeric CPC levels do not elicit an increase in PICH binding to the 
centromere/kinetochore. Moreover, the INCENP1-58-Survivin-Borealin subcomplex of the 
CPC, essential and sufficient for centromere binding, did not rescue PICH localization to the 
centromere/kinetochore, indicating that INCENP59-919 and/or Aurora B must contain 
information that targets PICH to the centromere/kinetochore. Plk1, a PICH interaction partner 
and regulator of its chromosome arm recruitment, targets to the KT dependent on the Aurora 
B kinase activity of the CPC and was shown to act downstream of the CPC in localizing 
PICH.  
Remarkably, PICH was also absent from the centromere/kinetochore in Aurora B 
depleted cells that were treated with nocodazole. In contrast, Mad2 was efficiently recruited to 
the KT under these conditions. Thus, Mad2 KT localization is likely to explain the mitotic 
arrest seen under conditions of Aurora B depletion and addition of nocodazole. 
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III. Combined structural and biochemical insights into CPC targeting and 
function 
 
Structural studies on members of the CPC have so far been focused on Survivin, a BIR 
domain containing protein and on the interaction between Aurora B and INCENP. The three 
Survivin structures are largely consistent, showing Zn2+ coordination and BIR domain 
mediated dimerization of the protein (Chantalat et al., 2000; Muchmore et al., 2000; Verdecia 
et al., 2000). INCENP binding to Aurora B was shown to allosterically induce kinase 
activation via the T-loop (Sessa et al., 2005). One crucial step limiting structural studies is the 
production of the respective protein/proteins in high and pure amounts for crystallisation. 
Considering that Survivin and Borealin, as well as the N-terminus of INCENP readily could 
be purified from bacteria with high yields (e.g. Figure 10A), a collaboration with the 
laboratory of Elena Conti (EMBL, Heidelberg and MPI of Biochemistry, Munich) was 
established, with the aim of structure elucidation. CPC constructs and purification protocols 
were sent to Dr. Arockia Jeyaprakash. Subsequently, Arockia solved the solution structure of 
INCENP1-58, Survivin and Borealin10-109 at 1.4Å resolution. 
 
Characterization of Borealin10-109 
 The INCENP1-58 fragment had been characterized by us before (see Results I) and, as 
mentioned above, Survivin could be crystallized as full-length protein. Thus, we proceeded to 
analyse Borealin10-109. In directed yeast-two hybrid assays Borealin10-109 interacted with 
Survivin (Figure 34A, upper row) but not with Aurora B (Figure 34A, bottom row) and its 
binding to INCENP was mediated via the first 58 amino acids of INCENP (Figure 34A, 
middle two rows). To assess the function of Borealin10–109 in localizing the CPC, we used a 
siRNA-based complementation approach, as described before (see Result I). In this assay, 
Myc-tagged Borealin10–109 was unable to restore localization of the CPC to the centromere, 
but it targeted the CPC to the central spindle and midbody (Figure 34D). A shorter N-terminal 
fragment of Borealin (Borealin10–57) did not rescue the localization of the CPC during 
progression through mitosis (Figure 34E). We next tested if Borealin10–109 could rescue the 
cytokinesis defect observed upon CPC depletion. While Borealin depletion resulted in 33.6% 
of multinucleated cells, rescue with full-length Borealin led to a decrease to 12.8%. (Figure 
34F). Interestingly, cell division was largely restored in cells rescued with Borealin10–109 but 
not Borealin10–57 (12.9% multinucleation and 32.4% multinucleation, respectively). Cells 
expressing these fragments showed chromosome segregation defects (data not shown), as 
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would be expected from the loss of centromere-related functions of Aurora B. In 
coimmunoprecipitation experiments using the Myc-tagged Borealin constructs, Borealin10–109 
efficiently pulled down INCENP, Aurora B, and Survivin, while Borealin10–57 did not 
coimmunoprecipitate any of the other CPC subunits (Figure 34G). Thus, Borealin10–109 is 
functional in vivo to form a minimal CPC core complex that localizes to the central spindle 
and midbody and properly executes the role of the CPC during cytokinesis. 
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Figure 34. Borealin10-109 is sufficient to target the CPC to the central spindle and midzone, to execute 
cytokinesis, and to form a complex with other CPC proteins in vivo. 
(A) Yeast two-hybrid assays show an interaction of Borealin10–109 with Survivin and INCENP (via its N-
terminal 58 residues) but not with Aurora B. AD indicates the pAct2 vector, BD the pFBT9 vector. 
(B and C) Evaluation of a rescue assay for Borealin fragments/mutants as described (Result I).  
Complementation with Myc-Borealinwt rescues the localization of the CPC to the central spindle and midbody 
and leads to proper chromosome alignment and chromosome segregation. Arrowheads indicate lagging 
chromatids. 
(D) Myc-Borealin10–109 fails to restore the centromere localization of the CPC during prometaphase but rescues 
its localization to the central spindle and midbody during anaphase and cytokinesis, respectively. 
(E) Myc-Borealin10–57 fails to localize the CPC correctly throughout mitosis. For (B)–(E) between 12 and 25 
metaphase cells, between 6 and 18 anaphase cells, and between 6 and 25 cells in cytokinesis were analyzed (n 
= 3). The predominant localization (>80% of cells) is given in the images. Bar, 10µm. 
(F) Borealin full-length and Borealin10–109 but not Borealin10–57 can rescue the cytokinesis defect induced by 
Borealin siRNA.The rescue assay was performed as in (B–E). Myc-positive interphase cells were scored for 
multinucleation via DAPI and α-tubulin staining. Immunofluorescence images show the prevalent phenotype 
for the different constructs. Quantification is illustrated next to the corresponding image (90–147 cells per 
experiment, n = 3; error bar represents standard deviation). Bar, 10µm. 
(G) Different fragments of Myc-tagged Borealin were transfected into HeLa cells and precipitated using anti-
Myc antibodies. Co-precipitating passenger proteins were visualized by western blotting. Hec-1 is shown as a 
negative control. Borealin10–109 (but not Borealin10–57) interacts with INCENP, Aurora B, and Survivin. 
Asterisk denotes immunoglobulines at 30 kDa. 
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Overall structure of the INCENP1-58-Survivin-Borealin10-109 complex 
 The INCENP1–58-Survivin-Borealin10-109 complex was crystallized and its structure 
determined by single-wavelength anomalous dispersion (SAD) by Dr. Arockia Jeyaprakash. 
The structure was refined to 1.4Å resolution, with an R factor of 18.5%, Rfree of 20.2%, and 
good stereochemistry (Figure 35). 
The overall tertiary structure of Survivin in the complex is very similar to that reported 
previously in the absence of other CPC components (Chantalat et al., 2000; Muchmore et al., 
2000; Verdecia et al., 2000). Briefly, Survivin is characterized by an N-terminal globular 
domain (the BIR domain) and a long C-terminal helix spanning 11 helical turns (C helix) 
(Figure upper panels). The BIR domain (residues 15–89) consists of a three-stranded 
antiparallel ß-sheet surrounded by four helices. It includes a Zinc-ion that has a structural role. 
A short linker (residues 90–99) connects the BIR domain to the C-helix (residues 100–142). 
Borealin and INCENP bind Survivin to form a three-helix bundle. The core of the 
helical bundle is formed by an intertwined set of hydrophobic interactions with residues 
contributed by all three proteins. INCENP forms a single α-helix that stacks parallel to the 
Survivin C-helix. The interaction between Survivin and Borealin in the CPC exhibits striking 
molecular mimicry of the apo-Survivin–Survivin interaction (Chantalat et al., 2000; 
Muchmore et al., 2000; Verdecia et al., 2000). The hydrogen-bonding network engaging the 
backbone of Borealin parallels that of Survivin in the apo-structure. Formation of the complex 
involves an induced-fit rearrangement of the hydrophobic residues of Survivin, which 
undergo small but relevant changes in the positioning of their side chains to recognize 
Borealin and INCENP. Borealin is characterized by a long α-helix (αB1, residues 15–60), 
which stacks against the Survivin C-helix in an antiparallel fashion. In addition, Borealin 
contains two small α helices (αB2, residues 63–67 and αB3, residues 70–75,) arranged almost 
perpendicular to the bundle. This part of the molecule caps the first turn of the Survivin C-
helix and wraps around the linker. A structure-based sequence alignment of the human 
proteins compared to Xenopus laevis and Danio rerio CPC components revealed that residues 
forming the core of the BIR domain and the three-helix bundle are highly conserved (all 
structural data provided by Dr. Arockia Jeyaprakash).     
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Dissociation of Survivin or INCENP from Borealin impairs CPC localization 
The finding of a stable Survivin–Borealin subcomplex of the CPC in vitro (data by Dr. 
Arockia Jeyaprakash) and data on the existence of an INCENP–Aurora B subcomplex 
(Gassmann et al., 2004) prompted us to investigate the effect of disrupting specific subsets of 
protein-protein interactions. First, we analyzed the structure to identify residues of Borealin 
whose mutation would specifically disrupt its binding to either Survivin or INCENP. In the 
globular part of the CPC core structure, Borealin residues Trp70Bor and Phe74Bor dock into the 
hydrophobic pocket present on the BIR domain of Survivin (Leu6Sur, Trp10Sur, Phe13Sur, 
Phe101Sur) and have only marginal contacts with INCENP (Figure 36A and B). On the other 
hand, in the helical bundle of the CPC, Borealin Arg35Bor interacts electrostatically with 
INCENP Asp30INC, and Leu46Bor interacts hydrophobically with Phe22INC and Leu19INC 
(Figure 36A and C). However, neither Arg35Bor nor Leu46Bor contact Survivin. Therefore, in 
order to create a complex in which Borealin binds INCENP (and thus Aurora B) but not 
Survivin, we mutated residues Trp70Bor and Phe74Bor to negatively charged amino acids 
Figure 35. Overall structure of the core CPC formed by INCENP1-58, Survivin and Borealin10-109. 
Survivin (green) has a Zinc-binding globular domain (BIR domain) connected to the long C-terminal helix (C 
helix). Borealin (magenta) and INCENP (orange) interact with the Survivin C-helix to form a triple helical bundle. 
In its CPC bound form the hydrophobic pocket of Survivin mediating homodimerization is occupied by Borealin 
residues. Data Dr. Arockia Jeyaprakash.  
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(W70E, F74E). By mutating Arg35Bor with a reverse-charge substitution and Leu46Bor with a 
bulky side-chain substitution (R35E, L46Y) we attempted to generate a second complex in 
which Borealin binds Survivin but not INCENP. In line with the structural data, the full-
length Borealin W70E, F74E mutant was able to coimmunoprecipitate INCENP and Aurora B 
but not Survivin, while the Borealin R35E, L46Y mutant coimmunoprecipitated Survivin but 
not INCENP or Aurora B (Figure 36D). Being able to constitute different subcomplexes of 
the CPC in vivo we utilized the siRNA rescue assay mentioned above to evaluate their 
functionality (see controls in Figure 34B and C). Borealin W70E, F74E as well as Borealin 
R35E, L46Y did not rescue the localization of the CPC to either the centromere or to the 
central spindle and midbody (Figure 36E and F). Thus, dissociation of Survivin from the CPC 
impairs the overall localization of the CPC, and a subcomplex consisting of Survivin and 
Borealin (lacking INCENP and Aurora B) is unable to target to any defined subcellular site. 
Notably, Aurora B did not coimmunoprecipitate with Borealin and Survivin in the absence of 
INCENP (Borealin mutant R35E, L46Y, Figure 36D), while it was coimmunoprecipitated 
with Borealin and INCENP in the absence of Survivin (Borealin mutant W70E, F74E, Figure 
36D). 
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An INCENP–Aurora B subcomplex does not provide holo-CPC function in vivo 
The recent hypothesis that multiple chromosomal passenger complexes might coexist 
and fulfill different functions has attracted broad attention (reviewed in (Vagnarelli and 
Earnshaw, 2004)). In particular, it has been shown that a subcomplex of INCENP and Aurora 
B (lacking Survivin and Borealin) is present in Borealin-depleted HeLa lysates, prompting the 
speculation that this subcomplex might accomplish mitotic functions (Gassmann et al., 2004). 
Based on our structure of the core CPC, we set out to assemble an INCENP–Aurora B 
complex devoid of Survivin and Borealin. Specifically, we targeted Phe22INC and Leu34INC of 
INCENP, which participate in a network of interactions with Borealin (Phe28Bor, Ile39Bor, and 
Figure 36. Subcomplexes of the CPC lacking either Survivin or INCENP/Aurora B fail to localize 
correctly throughout mitosis. 
(A) Cartoon representation of the structure of core CPC highlighting the regions where Borealin mutations have 
been introduced. 
(B) Close-up view of the hydrophobic interaction of the Survivin hydrophobic core with Trp70Bor and Phe74Bor. 
These Borealin residues do not interact significantly with INCENP. 
(C) Close-up view of the interaction network of Borealin residues Arg35Bor and Leu46Bor with INCENP 
Asp30INC, Phe22INC, and Leu19INC. These Borealin residues do not interact significantly with Survivin. 
(D) Transfection of different Myc-tagged Borealin mutants into HeLa cells followed by respective immuno-
precipitations reveal the constitution of different subcomplexes in vivo. Coprecipitating passenger proteins were 
visualized by western blotting. Hec1 serves as a negative control. Borealin W70E, F74E mutant binds INCENP 
and Aurora B but not Survivin. Borealin R35E, L46Y binds Survivin but not INCENP/Aurora B. The Borealin 
surface mutant R17/19E, K20E (see also Figure 38) forms a holocomplex like the wild-type protein. 
(E and F) Borealin W70E, F74E mutant (E) and Borealin R35E, L46Y (F) failed to properly localize respective 
CPC subcomplexes in rescue assays. 
Quantification was done as in Figures 1A–D with equal numbers of cells analyzed. Bar, 10µm. 
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Leu46Bor) and Survivin (Thr117Sur, Phe124Sur, and Val131Sur) within the helical bundle 
(Figure 37A). Coimmunoprecipitation assays confirmed that the INCENP F22R, L34R 
mutant retained binding to Aurora B but was unable to interact with Borealin and Survivin 
(Figure 37B). To evaluate the functionality of this INCENP–Aurora B subcomplex, we again 
made use of the established siRNA rescue approach (see Results I). The INCENP F22R, 
L34R mutant neither targeted to the centromere nor the central spindle and midbody (Figure 
37E). Notably, the INCENP–Aurora B subcomplex also failed to rescue the mitotic functions 
of the holo-CPC, as determined by staining with phospho-S7-specific antibodies against 
CENP-A (Figure 37F). Thus, an engineered INCENP–Aurora B subcomplex unable to bind 
Survivin and Borealin does not target to any defined structure during mitosis and is not able to 
restore holo-CPC function on chromatin. 
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The helical bundle is essential for the central spindle and midbody localization of CPC 
Earlier work has demonstrated that INCENP residues 32–44 (Xenopus numbering) are 
essential for centromere targeting (Ainsztein et al., 1998). This observation can be 
rationalized in light of the structure, which suggests that deletion of residues 32–44 of 
INCENP might result in a considerable loss of interaction with Survivin and Borealin (Figure 
35). Interestingly, however, residues Glu35INC, Glu36INC, Glu39INC, and Glu40INC are not 
involved in structural interactions of the CPC but form a conserved negatively charged patch 
on the surface (Figure 38A). We therefore tested the effect of specifically mutating this 
conserved set of exposed glutamic acids to positively charged residues in the context of full-
length INCENP. In line with the structural analysis, the INCENP E35/36/39/40R mutant was 
able to assemble with the other CPC components to form the holo-complex in vivo (as shown 
Figure 37. An engineered INCENP–Aurora B subcomplex fails to rescue CPC localization and 
function. 
(A) Cartoon representation of the overall structure of the core CPC, highlighting the region where INCENP 
mutations were engineered to disrupt Survivin and Borealin binding. A close-up view shows that Phe22INC
and Leu34INC are engaged in multiple interactions with Survivin (Thr117, Phe124) and Borealin (Phe28, 
Leu46). 
(B) HeLa cells were transfected with GFP-tagged INCENP mutants followed by immunoprecipitations using 
GFP antibodies. Western blotting revealed the constitution of different subcomplexes in vivo. While wild-
type INCENP and the INCENP E35/36/39/40R surface mutant (see also Figure 38) form a holo-CPC, 
INCENP F22R, L34R failed to bind Borealin and Survivin but retained binding to Aurora B. 
(C-D) A rescue assay to assess the function of INCENP constructs as described (see Result I). GFP-
INCENPwt could restore CPC localization to the centromere, the central spindle, and the midbody and proper 
progression through mitosis. Arrowheads indicate lagging chromatids. 
(E) INCENP F22R, L34R mutant failed to localize to any defined subcellular structure during mitosis. 
(F) INCENP F22R, L34R failed to show phospho-S7-CENP-A signal. Bar, 10 µm. 
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by coimmunoprecipitation in Figure 37B) and localized correctly to centromeres. However, 
INCENP E35/36/39/40R did not localize to the central spindle and midbody in anaphase or 
cytokinesis but remained on the chromatin (Figure 38B). Adjacent to the INCENP negative 
cluster, at the tip of the helical bundle, Borealin features several conserved positively charged 
surface residues (Figure 38A). Remarkably, mutation of Arg17Bor, Arg19Bor, and Lys20Bor to 
glutamic acids resulted in a phenotype similar to that of the INCENP E35/36/39/40R mutant. 
The BorealinR17/R19/K20E mutant was able to bind all other CPC members in vivo 
(coimmunoprecipitation in Figure 36D) but was unable to dissociate from chromatin and 
associate with the central spindle or the midbody (Figure 38C). This phenotype might be due 
to the impairment of modifications on either the CPC or chromatin that would cause persistent 
binding to chromosomes in anaphase or to the inability to bind a factor that might promote the 
dissociation from chromatin. We next ask if INCENP E35/36/39/40R and Borealin 
R17/R19/K20E can execute the normal CPC function during metaphase and cytokinesis. Like 
the wild-type proteins, both, Borealin R17/R19/K20E and INCENP E35/36/ 39/40R restored 
chromosome alignment on the metaphase plate and phosphorylation of CENP-A (Figure 38D 
and E), suggesting that Aurora B kinase activity was not affected by these mutants. However, 
both mutants were unable to rescue the cytokinesis defect seen upon depletion of Borealin or 
INCENP (Figure 38F and G). This observation suggests that the central spindle and midbody 
binding of the CPC is required for proper execution of cytokinesis. 
 
 
 
  
 
 
A. 
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Figure 38. A conserved composite molecular surface formed by Borealin–Survivin–INCENP is crucial 
for central spindle and midbody localization of the CPC and proper cell division. 
(A) Calculation of electrostatic surface charge reveals a highly acidic (red) and basic patch (blue) on the 
molecular surface of the INCENP1–58-Survivin-Borealin10-109 complex. The two views are related by a 180° 
rotation about the vertical axis. Data Dr. Arockia Jeyaprakash. 
(C–H) Evaluation of surface charge mutants in respective rescue assays. (C) Charge reversal of a conserved 
acidic patch on INCENP affects binding of the CPC to the central spindle and midbody. (D) Charge reversal 
of a conserved basic patch on Borealin phenocopies the localization observed for the INCENP E35/36/39/40R 
mutant. Chromosome alignment onto the metaphase plate and phosphorylation of (S7)-CENP-A is unaffected 
by INCENP 35/36/39/40R (E) and Borealin R17/19E, K20E (F). (G) GFP-INCENP E35/36/39/40R and (H) 
Myc-Borealin R17/19E, K20E rescued interphase cells were analyzed for multinucleation as in Figure 34F (n 
= 3; error bar represents standard deviation). Both mutants do not rescue the cytokinesis defect observed upon 
depletion of INCENP or Borealin, respectively.
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Conclusion 
Both Survivin and Borealin were shown previously to be able to form dimers 
(Chantalat et al., 2000; Muchmore et al., 2000; Verdecia et al., 2000; Gassmann et al., 2004) 
(and see Figure 14). In the context of the core CPC, however, the proteins associate with 
INCENP in a 1:1:1 stochiometry. 
Additionally, the structural basis for the interdependence of the chromosomal 
passenger proteins becomes evident in light of the crystal structure of the core CPC. A 
complex network of intermolecular interactions observed within the passenger proteins 
stabilizes the core of the CPC and holds the subunits together. Although the function and 
regulation of Aurora B involves three different proteins, these seem to operate as a single 
structural unit. 
Besides the essential interaction between INCENP, Survivin and Borealin for 
centromere recruitment, the C-terminus of Borealin (Borealin109-280) must carry information 
that determines centromere binding. This would be in line with our earlier hypothesis that 
Borealin might bind to DNA. Specific disruption of any single passenger protein results in the 
impairment of the structural unit and in the failure of CPC targeting, leading to the defects 
seen under conditions of CPC depletion. Intriguingly, we failed to define any function of an 
engineered INCENP/Aurora B subcomplex. Moreover, results obtained with a deletion 
fragment of Borealin (Borealin10-109) and surface charge mutants (INCENP 35/36/39/40R and 
Borealin R17/19E, K20E) revealed that the CPC exerts its function in cytokinesis from the 
central spindle/midbody. 
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IV. The MAP kinase pathway and the CPC 
 
Borealin is phosphorylated by Erk kinase  
Results obtained in collaboration with the laboratory of Marsha Rosner (Ben May 
Department for Cancer Research, Chicago) suggested that the MAP kinase pathway is 
involved in CPC regulation. In particular, the Raf kinase inhibitory protein (RKIP) was shown 
to regulate centromeric Aurora B kinase activity but the mechanism has remained elusive 
(Eves et al., 2006). To analyse if MAP kinase mediated phosphorylation of the CPC might be 
involved in this regulation we tested chromosomal passenger proteins for phosphorylation by 
the Erk kinase. Interestingly, Borealin, but no other passenger protein, was readily 
phosphorylated in an in vitro kinase assay (Figure 39). Erk kinase phosphorylated Borealin 
showed an electrophoretic mobility shift indicating a strong modification and/or structural 
rearrangements. 
 
 
 
 
 
 
 
 
Figure 39. Erk2 in vitro kinase assay monitoring CPC phosphorylation. 
(A and B) Recombinant chromosomal passenger proteins were tested for phosphorylation by Erk kinase. 
Only Borealin and the positive control myelin basic protein (MyelinBP) are phosphorylated in this assay.
Phosphorylation was monitored by autoradiography (35P) and loading was controlled by Coomassie Brilliant 
Blue staining (CBB).   
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Identification of Borealin T106 as an Erk kinase phosphorylation site in vitro 
Several phosphorylation sites on the Borealin protein have been identified by our mass 
spectrometry group (personal communication by Roman Koerner). Based on these data we 
mutated corresponding residues and found that mutation of Borealin residue T106 abolished 
Erk kinase mediated phosphorylation (Figur 40A). As the consensus phosphorylation motives 
of MAP kinases and the master mitotic kinase Cdk1 are similar and residue T106 is followed 
by a lysine residue at position +3 (rather indicative of a Cdk1 site) we tested Cdk1 
phosphorylation of Borealin wild-type compared to the T106A mutant. Indeed, Borealin was 
phosphorylated by Cdk1 in in vitro kinase assays but we did not observe an electrophoretic 
shift or any influence of mutating the residue T106 (Figure 40B ). 
 
 
 
 
 
 
 
 
 
Production of a BorealinT106 phospho-specific antibody  
To address if Borealin can be assigned as an Erk kinase target in vivo we immunized 
rabbits with a peptide comprising phosphorylated T106 (H-AEAIQT(PO3H2)PLKS-OH) to 
produce a phospho-specific antibody against this site. Antibodies were purified from the final 
bleeds and the specificity tested by immunofluorescence. (Antibodies produced in two 
different rabbits #127 and #352 gave identical results). Phospho-T106-Borealin showed CPC 
characteristic centromere staining from prophase until metaphase but did not stain the central 
spindle or the midbody (Figure 41A and B). Interestingly, a few metaphase cells did not stain 
with phospho-T106-Borealin (Figure 41C), suggesting a dependency on the SAC status. 
Importantly, no signal was detected in cells treated with siRNA duplexes directed against the 
Figure 40. Borealin T106 is an Erk kinase site in vitro. 
(A) Experiment as in Figure 24. Recombinant Borealin wild-type and the BorealinT106A mutant were tested in
an in vitro kinase assay for phophorylation by Erk. Note almost complete absence of the 35P signal in the 
BorealinT106A reaction. 
(B) In vitro Cdk1 kinase assay on Borealin wild-type compared to BorealinT106A mutant. No difference in 
phosphorylation was observed for the two constructs.
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Borealin transcript (Figure 42 middle row). Attesting for the phospho-specificity of the 
antibody, no signal was observed in cells treated with calf intestine phosphatase (Figure 42 
bottom row). Next we investigated localization and function of the Borealin T106A mutant. 
As we did not observe any difference between this mutant and wild-type Borealin in 
corresponding rescue assays (data not shown) we did not proceed further to analyse this 
phosphosite of Borealin.          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41. Phospho-T106-Borealin antibody stains the centromere but not the central spindle or 
midbody. 
(A-C) HeLa cells were methanol fixed and stained for Aurora B and phospho-T106-Borealin. Individual 
mitotic stages are shown in (A). (B) shows a side-by-side comparison of metaphase to anaphase cells. (C) A 
few metaphase cells were negative for phospho-T106-Borealin. One speculative explanation for this 
observation could be that phosphorylation at T106 is SAC dependent. Bar, 10µm. 
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Figure 42. Phospho-T106-Borealin antibody responds to CPC depletion and phosphatase treatment. 
HeLa cells were treated with siRNA duplex directed against Borealin (or control) and incubated for 48hrs. 
Where indicated calf intestine phosphatase (CIP) was added for 15min before methanol fixation. Cells were 
stained with anti-Aurora B and anti-phospho-T106-Borealin antibodies. In both siRNA mediated depletion of 
Borealin and CIP treatment phospho-T106-Borealin signal was abolished. Bar, 10µm. 
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Conclusion 
 At this point it is not clear how the MAP kinase pathway regulates the CPC. Borealin 
residue T106 has been identified as an Erk kinase site in vitro and it remains to be seen if this 
can be confirmed in vivo. However, the observed phosphorylation was remarkably strong and 
led to a striking electrophoretic shift. A phosphospecific antibody directed against the 
Borealin T106 site stained the centromere region from prophase to metaphase, as expected for 
the CPC, but was undetectable at the central spindle and the midbody indicating regulation of 
this site during mitotic progression. However, this temporal regulation would also be 
consistent with Cdk1 mediated phosphorylation and would require further analysis. The 
absence of a detectable difference between the T106A mutant and wild-type Borealin in a 
rescue approach led us to abandon the project. 
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V. The CPC is linked to the SUMO system 
 
A yeast-two hybrid screen identifies SUMO pathway components as interaction partners 
of Borealin 
To obtain further insights into the role of the N-terminus of INCENP and/or the 
Borealin subunit of the CPC, we screened a yeast two-hybrid HeLa cDNA library with 
INCENP1-530 or full-length Borealin as the bait. Among interactors of the Borealin protein we 
identified several components of the ubiquitin-like SUMO modification system, e.g. the E2 
conjugating enzyme Ubc9 (Figure 43A and B). Among the (few) identified interactors of 
INCENP1-530 only heterochromatin-protein1 looked interesting to us (data not shown). 
However, this interaction has been described previously (Ainsztein et al., 1998) and was 
therefore not investigated further.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 43. Borealin interactors identified by yeast-two hybrid screening. 
(A) Putative Borealin interaction partners were tested for self-activation with the empty vector (candidate + 
pFBT9) or real interaction (candidate + pFBT9 Borealin). 
(B) Interactors identified. Numbers refer to (A). The strength of the interaction is given (w = weak, m = 
moderate, s = strong). s-a. = self-activating. ND = not determined. Kif3A (nr. 2) was found to have mitotic 
functions only after this screen has been performed (Haraguchi et al., 2006).   
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Borealin is covalently modified by SUMO 
 Next we analysed if Borealin interacts with SUMO pathway components in directed 
yeast-two hybrid assays. These assays confirmed the interaction with Ubc9 and SUMO1 and 
additionally revealed an interaction of Borealin with SUMO2 (Figure 44A and B). The other 
known members of the CPC, INCENP, Aurora B and Survivin, did not bind Ubc9 or SUMO 
forms (Figure 44A and data not shown). The binding of Borealin to both SUMO paralogs was 
dependent on the integrity of their C-terminal double-glycine motif, which is essential for 
conjugation, suggesting that SUMO is covalently attached to Borealin (Figure 44B lower two 
panels). 
To test this, we used a reconstituted in vitro SUMO modification system. 35S-labeled 
myc-tagged Borealin, generated by in vitro transcription/translation, was incubated with 
recombinant components of the sumoylation machinery, i.e. the E1 activating enzyme 
Aos1/Uba2, the E2 conjugating enzyme Ubc9, and either SUMO1 or SUMO2 in the presence 
of ATP. In the control reaction, which lacked the E1 enzyme, a single major Borealin band, 
migrating at the predicted size of 42kDa was detected (Figure 44C). In contrast, addition of 
the E1 enzyme to the reaction resulted in the formation of at least three distinct higher 
molecular-weight Borealin conjugates both with SUMO1 (Figure 44C) and SUMO2 (Figure 
44D). The major conjugates migrated at ~57, ~70 and ~83kDa, being consistent with the 
attachment of up to three SUMO moieties to Borealin. In line with the finding that only 
Borealin but no other chromosomal passenger protein interacted with SUMO pathway 
components in the yeast two-hybrid assay, neither Survivin, nor Aurora B and INCENP were 
modified by SUMO (Figure 44C). 
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To examine whether SUMO paralogs can also modify Borealin in vivo, a myc-tagged 
construct of Borealin was coexpressed with either HA or His-tagged constructs of SUMO1 or 
SUMO2. His-SUMO-conjugates were affinity purified under denaturing conditions on Ni-
NTA beads. Consistent with the result obtained in the in vitro sumoylation assay, Western 
blotting with an anti-myc antibody detected three SUMO-Borealin species in His-SUMO1 
and His-SUMO2 pull-downs (Figure 45A). Survivin, a direct binding partner of Borealin 
within the CPC (Gassmann et al., 2004) was neither conjugated to SUMO1 nor SUMO2 
(Figure 45B). SUMO mutants (SUMO1K16R and SUMO2K11R) that are unable to form chains 
Figure 44. Borealin interacts with components of the SUMO system and is modified by SUMO in vitro.  
(A and B) Interaction of Borealin with Ubc9 (A) and the conjugatable forms of SUMO1 and SUMO2 (B, upper 
two rows), but not the unconjugatable forms (B, lower two rows) in directed yeast two-hybrid assays.  
(C and D) Borealin is modified by SUMO in vitro. 35S-labelled CPC subunits, generated by in vitro
transcription/translation, were incubated with recombinant E1, E2 and either SUMO1 (C) or SUMO2 (D) in the 
presence of ATP. In control reactions the E1 enzyme was omitted. SUMO-Borealin conjugates are indicated by 
arrows. 
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(Hay, 2005) generated an identical pattern of SUMO-Borealin conjugates (Figure 45C) 
arguing for sumoylation of distinct lysine residues within Borealin. 
To determine whether Borealin is preferentially modified by either SUMO1 or 
SUMO2/3, when these modifiers are expressed at their endogenous levels, a His-tagged 
Borealin construct or an empty His-vector control were expressed in HeLa cells and proteins 
were purified on Ni-NTA beads under denaturing conditions from mitotic cell lysates. 
Western blotting with an anti-Borealin antibody allowed for the detection of higher molecular 
weight species, reminiscent of the Borealin-SUMO conjugates described above (Figure 45D). 
When blotted with SUMO2/3 specific antibodies, at least two bands were identified as 
SUMO2/3 conjugates. By contrast, antibodies directed against SUMO1 or ubiquitin did not 
detect any of the higher molecular weight bands. To test modification of endogenous Borealin 
by SUMO2/3, total cellular SUMO2/3-conjugates from mitotic cell lysates were 
immunoprecipitated by anti-SUMO2/3 antibodies (Figure 45E). We validated the 
experimental setup by monitoring sumoylation of topoisomerase II (Azuma et al., 2003; 
Azuma et al., 2005; Zhang et al., 2008), a SUMO2/3 substrate that is specifically conjugated 
in early mitosis, and PML a SUMO2/3 substrate that is unmodified at this stage (Everett et al., 
1999). Consistently, we detected topoisomerase II-SUMO2/3 conjugates, but no PML-
SUMO2/3 forms in the mitotic SUMO2/3 precipitates. Importantly, anti-Borealin reactive 
forms migrating at 50 and 64kDa were specifically enriched in the anti-SUMO2/3 pull-down 
fraction. The amount of Borealin-SUMO2/3 conjugates was comparable to the amount of 
topoisomerase II-SUMO2/3 species. In summary, these data define the CPC subunit Borealin 
as a mitotic substrate for sumoylation and indicate that it is preferentially modified by 
SUMO2/3. 
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Figure 45. Borealin is modified by SUMO in vivo and is preferentially targeted by SUMO2/3.  
(A) Myc-tagged Borealin and HA- or His-tagged versions of SUMO1 or SUMO2, respectively, were co-
expressed in COS-7 cells. His-SUMO conjugates were recovered on Ni-NTA beads and subjected to Western 
blotting using anti-myc antibody.  
(B) Myc-Survivin was tested for sumoylation as described in (A).  
(C) Myc-tagged Borealin and either wild-type (SUMO1wt, SUMO2wt) or mutant versions of His-tagged SUMO 
forms (SUMO1K16R, SUMO2K11R) were coexpressed in COS-7 cells and analyzed as in (A). 
(D) Borealin is modified by endogenous SUMO2/3 but not SUMO1. HeLa cells expressing His-tagged 
Borealin were arrested in prometaphase by taxol treatment for 16hr. His-Borealin was recovered on Ni-NTA 
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beads and immunoblotting was performed with anti-Borealin, anti-SUMO1, anti-SUMO2/3 or anti-ubiquitin 
antibodies. The Borealin reactive bands at ~45kDa (asterisk) is interpreted as a Borealin-SUMO2/3 degradation 
product. 
(E) Endogenous Borealin is conjugated to SUMO2/3. Immunoprecipitations were performed with anti-
SUMO2/3 or control IgGs from taxol arrested HeLa cells and probed by Western blotting with the indicated 
antibodies. 
 
Borealin is a target of ubiquitination 
 Modification of Survivin by ubiquitin has been shown to regulate the dynamic 
association of the CPC with the centromere and to be required for proper chromosome 
segregation (Vong et al., 2005). Ubiquitination, like sumoylation, occurs via attachment of the 
moiety to a given lysine residue and thus may block sumoylation. We therefore asked if 
Borealin is ubiquitinated and performed the assay outlined above for His-SUMO (Figure 
45A-C) using His-tagged ubiquitin. In agreement with the above mentioned study Survivin 
was readily ubiquitinated. However, only mono-ubiquitination was observed (Figure 46A). In 
the same assay Borealin showed ubiquitination (Figure 46B). 
 
 
 
 
 
 
 
 
 
 
 
Sumoylation of Borealin is independent of CPC formation 
The ability to dissociate individual members of the CPC from the complex based on 
the crystal structure described above led us to analyse if Borealin incorporation into the CPC 
is required for its sumoylation. We tested the Borealin mutants (described above in Figure 
36D) that are unable to bind INCENP/Aurora B or Survivin in the in vivo sumoylation assay. 
Figure 46. Borealin is ubiquitinated. 
(A) Myc-tagged Survivin was tested in an ubiquitination assay as outlined above for SUMO (Figure 47). A 
single Survivin-ubiquitin conjugate was detected. 
(B) Assay as in (A) testing for Borealin ubiquitination. Borealin is polyubiquitinated. 
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Notably, both mutants showed sumoylation like the wild-type protein (Figure 47). Hence, 
sumoylation of Borealin can occur independently of CPC formation. 
 
 
 
 
 
 
    
 
 
Sumoylation of Borealin is cell cycle regulated 
To address if sumoylation of Borealin is cell cycle regulated, HeLa cells expressing 
His-tagged Borealin were harvested at different stages of the cell cycle and Borealin-
SUMO2/3 conjugates were purified on Ni-NTA beads (Figure 48A). In G1 arrested cells the 
level of Borealin-SUMO2/3 conjugates was low (Figure 48A, lane 5). Strikingly, the amount 
was strongly increased in metaphase-arrested cells (Figure 48A, lane 6 and 42B), before the 
conjugates were progressively lost as cells entered anaphase (Figure 48A, lane 7 and 8). 
Proteasome inhibition by MG132 used to prepare mitotic lysates did not affect Borealin 
sumoylation (Figure 48B). We conclude that sumoylation of Borealin is dynamically 
regulated during cell cycle progression with a peak in early mitosis. 
 
 
 
 
 
 
 
 
 
 
 
Figure 47. CPC independent sumoylation of Borealin. 
Myc-tagged Borealin mutants unable to bind INCENP/Aurora B (BorealinR35E, L46Y) or Survivin (Borealin W70E, 
F74E) where tested in the in vivo sumoylation assay. Both mutants showed sumoylation (arrowheads). 
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The SUMO E3 Ligase RanBP2 is essential for sumoylation of Borealin 
The notion that Borealin sumoylation is regulated during the cell cycle led us to search 
for regulatory components that control its dynamic modification. To this end, candidate 
SUMO E3 ligases, notably PIAS family members, RanBP2 and hPC2, were analyzed for their 
ability to interact with Borealin in the yeast two-hybrid system. Binding of Borealin was 
observed to the α and β splice variants of PIAS2 and the catalytically fragment of RanBP2 
(RanBP2ΔFG) (Figure 49A). To test for these interactions in mammalian cells, endogenous 
Borealin was immunoprecipitated from mitotic HeLa cells (Figure 49B). Importantly, 
RanBP2, but not PIAS2 isoforms, were specifically detected in anti-Borealin precipitates. 
Attesting to the specificity of this interaction, coimmunoprecipitation was also observed for 
Aurora B. This indicates that RanBP2 can bind to the CPC and thus represents a potential 
SUMO E3 ligase for Borealin. In line with this assumption, RanBP2 was previously shown to 
localize to the centromere/kinetochore region and the mitotic spindle (Joseph et al., 2002). 
Figure 48. Sumoylation of Borealin is cell cycle regulated and independent of proteasome inhibition. 
(A) HeLa cells expressing His-Borealin were arrested in G1 (lane 1), metaphase (lane 2) or allowed to enter
anaphase (lane 3 and 4). His-Borealin and His-Borealin-conjugates were detected by Western blotting with anti-
Borealin and anti-SUMO2/3 antibodies (lane 5-8). Bands marked by asterisk are interpreted as Borealin-
SUMO2/3 degradation products. The mitotic status was assayed by monitoring Cyclin B1 levels.  
(B) Proteasome inhibition used for mitotic arrest does not affect sumoylation of Borealin. Experiment as in (A) 
using different drug combinations as indicated. DMSO or MG132 were added 2hrs before lysate preparation. 
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To address a putative SUMO E3 ligase function of RanBP2 towards Borealin, 
recombinant RanBP2ΔFG was added to an in vitro sumoylation reaction on Borealin, which 
was performed under limiting Ubc9 concentrations (70nM). Under these conditions basal E1-
E2 mediated sumoylation of Borealin was weak (Figure 50A, upper panel, lane 2), but 
addition of RanBP2ΔFG in a concentration range of 5nM to 50nM enhanced the formation of 
the three Borealin-SUMO conjugates (Figure 50A, lane 4 and 5), while it did not stimulate 
sumoylation of the control substrate p53 (Figure 50A, lower panel). In agreement with 
previous data (Pichler et al., 2002), higher concentrations of RanBP2 (500nM) exert an 
inhibitory effect on sumoylation (Figure 50A, upper panel, lane 3), probably reflecting a 
competitive automodification of RanBP2. To further analyze the role of RanBP2 in the 
conjugation of SUMO to Borealin in vivo, cells expressing myc-tagged Borealin and His-
SUMO2 were depleted of RanBP2 and control proteins by siRNA (Figure 50B). Sumoylation 
of Borealin was monitored by Ni-NTA pulldown of His-SUMO2 conjugates followed by anti-
myc immunoblotting. Remarkably, depletion of RanBP2 resulted in an almost complete loss 
of sumoylation and reduced the level of Borealin-SUMO conjugates to almost the same extent 
as knock-down of the essential E2 enzyme Ubc9. In contrast, Borealin sumoylation was 
unaltered in cells depleted of the α and β forms of PIAS2. Furthermore, depletion of Eg5, 
which, similar to the knock-down of RanBP2 (Joseph et al., 2004), leads to a prometaphase-
like arrest (Blangy et al., 1995), did not influence sumoylation of Borealin. Noteworthy, 
Figure 49. Borealin interacts with RanBP2. 
(A) Borealin was tested for interaction with SUMO E3 ligases in directed yeast two-hybrid assays. 
(B) Immunoprecipitations were performed with rabbit anti-Borealin antibodies or pre-immune serum from 
taxol arrested HeLa cells and probed by Western blotting with the indicated antibodies. The anti-PIAS2
antibody is directed against the α and β isoforms. Asterisk denotes an anti-PIAS2 cross-reactive band. 
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depletion of RanBP2 did not affect the level of total SUMO2/3-conjugates (Figure 50C) or 
sumoylation of the unrelated control substrate PARP-1 (Figure 50D), indicating that RanBP2 
does act on specific SUMO target proteins.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 50. RanBP2 regulates sumoylation of Borealin. 
(A) 35S-labeled Borealin or p53, generated by in vitro transcription/translation, were subjected to an in vitro 
sumoylation assay under limiting E2 concentrations. RanBP2ΔFG was added at a concentration of 500ng (lane 
3), 50ng (lane 4) and 5ng (lane 5). SUMO conjugates are indicated by arrows. Data Dr. Stefan Muller. 
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(B) Myc-tagged Borealin and His-SUMO2 were coexpressed in HeLa cells treated with siRNA oligonucleotides 
directed against indicated proteins. Depletion was verified by Western blotting. The siRNA directed against 
PIAS2 targets the α and β isoform (Yang et al. 2005). The asterisk in the anti-PIAS2 Western blot denotes a 
crossreactive band. His-SUMO2 conjugates were recovered on Ni-NTA beads and Western blotting was 
performed with anti-myc antibodies. 
(C) Depletion of RanBP2 does not lead to a general loss of SUMO2/3 conjugates. HeLa cells were treated with 
siRNA oligonucleotides directed against indicated proteins. Depletion was verified by Western blotting and 
SUMO2/3 conjugates were detected by anti-SUMO2/3 antibodies. 
(D) PARP1 sumoylation occurs independent of RanBP2. Myc-tagged PARP1 and HA- or His-SUMO constructs 
were co-expressed in HeLa cells treated with siRNA oligonucleotides directed against indicated proteins. 
Depletion was verified by Western blotting. His-SUMO conjugates were recovered on Ni-NTA beads and 
Western blotting was performed with anti-myc antibodies. 
 
To address if the observed loss of Borealin sumoylation can be assigned to the 
enzymatic activity of RanBP2, HeLa cells were depleted of endogenous RanBP2 and 
complemented with either wild-type or catalytically inactive RanBP2ΔFG (Dawlaty et al., 
2008). Importantly, the wild-type catalytically fragment of RanBP2 (RanBP2ΔFG wt), but not 
the catalytically inactive variant (RanBP2ΔFG AA) restored SUMO modification of Borealin 
(Figure 51A). Moreover, when overexpressed, wild-type RanBP2ΔFG, but not the inactive 
mutant, lead to a dramatic defect in chromosome segregation after anaphase onset (Figure 
51B - E). Taken together these data show that RanBP2 is essential for SUMO modification of 
Borealin and suggest that unbalanced RanBP2-mediated SUMO conjugation prevents the 
equal distribution of genetic material to daughter cells. The critical role of RanBP2 in mitosis 
is further supported by the observation that its protein level is strongly elevated upon onset of 
mitosis (Figure 51F). This effect is due to posttranscriptional regulation, since the mRNA 
level of RanBP2 does not significantly change during cell cycle progression (Figure 51G). 
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Figure 51. RanBP2ΔFG restores sumoylation of Borealin in RanBP2 depleted cells. 
(A) Flag-tagged Borealin and His-SUMO2 were coexpressed in HeLa cells treated with siRNA oligonucleotides 
directed against RanBP2 or GL2 as control. In parallel, cells were transfected with either empty myc-vector (-), 
myc-tagged wild-type RanBP2ΔFG (wt) or catalytically inactive RanBP2ΔFG (AA) bearing the mutations L2651A 
and L2653A. Depletion of RanBP2 and expression of myc-tagged RanBP2ΔFG constructs was verified by 
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Western blotting. His-SUMO2 conjugates were recovered on Ni-NTA beads and Western blotting was 
performed with anti-Flag antibodies to detect Borealin-SUMO conjugates. 
(B-E) Overexpression of RanBP2ΔFG causes chromosome missegregation during mitosis. (B) Untransfected 
mitotic control cells stained with Borealin antibodies. (C) HeLa cells were transfected with myc-tagged 
RanBP2ΔFG and stained with myc- and Borealin antibodies. Note massive chromosome missegregation after 
anaphase onset. (D) Experiment as in (C). Lower panel shows co-staining of myc- and tubulin antibodies. (E) 
Experiment as in (C) but the catalytically inactive RanBP2ΔFG construct (RanBP2ΔFG AA) was transfected. DNA 
was stained with DAPI. Scale bar = 10μm. 
(F) RanBP2 protein level at distinct cell cycle stages. HeLa cells were released from a double thymidine block 
into nocodazole and lysates were prepared at different time points after nocodazole release and detected by anti-
RanBP2 antibodies. The mitotic status was assayed by monitoring Cyclin B1 levels. Tubulin protein level serves 
as a loading control. as. = asynchronous growing cells. Data Markus Haindl. 
(G) RanBP2 and Borealin mRNA levels upon cell cycle progression were determined in synchronized HeLa 
cells using quantitative RT-PCR. Data provided by Patrick Déscombes. 
 
RanBP2 mediated Borealin sumoylation is likely to occur before CPC centromere 
binding 
 Interaction of RanBP2 and the CPC was found in taxol arrested cells when both 
components bind to the centromere/kinetochore region, suggesting that sumoylation of 
Borealin occurs during this stage (Figure 49B). Arguing against this, however, we did not 
observe binding of Ubc9 to the RanBP2-CPC complex in this experiment (Figure 49B). To 
address if RanBP2 KT-binding is crucial for Borealin sumoylation we exploited the finding 
that the SUMO E3 ligase is absent from the KT when cells are treated with nocodazole 
(Joseph et al., 2004). Indeed, we observed RanBP2 KT localization in taxol but not in 
nocodazole treated cells. CPC localization was unaffected in both treatments (Figure 52A). 
However, no difference in the sumoylation status of Borealin was detected comparing the two 
conditions (Figure 52B). Thus, Borealin seems to become sumoylated before the CPC targets 
to the centromere.   
 
 
 
 
 
 
 
 
 
RESULTS 
 80
 
  
 
 
 
 
 
 
 
 
Attempts to map the SUMO acceptor site/s of Borealin 
 To asses the function of Borealin sumoylation experiments were performed in order to 
map the SUMO acceptor lysine/s. Spot-blot analysis of Borealin peptides and in vitro 
sumoylation of Borealin fragments spanning 3-6 lysine residues gave inconsistent results 
(data not shown). Surprisingly, we found that every lysine residue present in in vitro 
translated Borealin could serve as a SUMO acceptor site in our assay. (This phenomenon was 
even observed for lysine residues present in protein tags, e.g. the flag-tag). We therefore 
created two Borealin fragments cutting the protein in half and tested these in our in vivo 
sumoylation assay. We observed sumoylation for the C-terminal half of Borealin but not its 
N-terminus (Figure 53A). We next mutated all 12 lysine residues present in the C-terminal 
half (Borealin12KR). Surprisingly, however, this mutant still showed normal levels of 
sumoylation (Figure 53B). Thus, we conclude that a) either more subtle assays are required to 
map the SUMO site of Borealin or b) “jumping” of the SUMO moiety on Borealin can occur.          
 
 
 
 
 
Figure 52. RanBP2 localization to the KT is not required for Borealin sumoylation. 
(A) HeLa cells were treated with the indicated drugs for 16hrs and stained with anti-RanBP2 and anti-Borealin 
antibodies. In the presence of nocodazole RanBP2 is absent from the KT. Bar, 10µm. 
(B) HeLa cells were transfected with His-Borealin and incubated with the indicated drugs for 16hrs. His-
Borealin and His-Borealin-conjugates were detected by Western blotting with anti-Borealin and anti-SUMO2/3 
antibodies. Bands marked by asterisk are interpreted as Borealin-SUMO2/3 degradation products. The mitotic 
status was assayed by monitoring Cyclin B1 levels. Tax. = taxol, noc. = nocodazole. 
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CPC formation and localization are sumoylation independent 
It has been reported very recently that RanBP2-mediated SUMO modification of 
topoisomerse II is required for its localization to centromeres (Dawlaty et al., 2008). In 
contrast, depletion of RanBP2 or Ubc9 did not affect the centromeric localization of Borealin 
(Figure 54A and data not shown), indicating that centromere targeting of the CPC occurs 
independently of Borealin sumoylation. As we were unable to map the exact site of SUMO 
modification we created a non-sumoylatable variant of Borealin, where all 25 lysine residues 
were mutated to arginine (Figure 55A and B) in order to rule out that the above result is due to 
residual amounts of RanBP2 (or Ubc9) left after corresponding siRNA treatment. During 
mitosis, HA-Borealin25KR exhibits wild-type localization to the centromere, rescued the 
phosphorylation of the Aurora B substrate CENP-A and bound to the central spindle in 
anaphase cells (Figure 54B). In line with the notion that the CPC requires the Borealin subunit 
to target to its distinct locations (see Results I and III) HA-Borealin25KR associated with all 
other CPC components (Figure 54C). Interestingly, this mutant fails to exhibit normal 
localization to the nucleolus in interphase cells depleted from endogenous Borealin (Figure 
55C). However, this effect is unlikely due to the loss of SUMO modification, as the general 
inhibition of sumoylation did not affect the nucleolar localization of wild-type Borealin 
(Figure 55D). These data suggest that complex formation of the CPC and localization of the 
complex to the centromere and central spindle during mitosis occur independently of 
sumoylation. Consistent with this idea, general abrogation of SUMO2/3 conjugation by 
expression of SENP2 (Zhang et al., 2008) did not affect localization of Borealin and CPC 
activity (Figure 56A and B). 
Figure 53. The SUMO acceptor site of Borealin could not be mapped. 
(A) Borealin was cut in half and both constructs were tested for in vivo sumoylation as outlined before. Only 
the C-terminal half shows sumoylation. 
(B) All 12 lysine residues present in the C-terminal half were mutated (Borealin12KR) and sumoylation of the 
mutant was analysed. Inconsistently, Borealin12KR was still sumoylated. 
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Figure 54. CPC assembly and localization to the centromere and central spindle are independent of 
Borealin sumoylation. 
(A) RanBP2 does not influence CPC localization to the kinetochore/centromere region and vice versa. HeLa 
cells were treated with indicated siRNA duplexes for 48hrs and stained for RanBP2 and Borealin. Bar = 
10μm. 
(B) HeLa cells were treated with siRNA duplexes specific for the 3´UTR of Borealin and simultaneously 
transfected with HA-Borealin or HA-Borealin25KR. Immunofluorescence was performed with antibodies 
directed against HA, phospho-S7-CENP-A and PRC1. Scale bar = 10μm. 
(C) HeLa cells were transfected with the indicated constructs, arrested in S phase by thymidine treatment and 
released for 10hr to enter mitosis. Mitotic lysates were prepared and immunoprecipitations were performed 
with anti-HA antibodies and probed by Western blotting with the indicated antibodies. Asterisk denotes 
immunoglobuline heavy chain. 
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Figure 55. Construction of a non-sumoylatable mutant of Borealin. 
(A) In vitro sumoylation of Borealin and a Borealin mutant in which all lysine residues have been mutated to 
arginine (Borealin25KR) was performed as outlined in Figure 35. SUMO-Borealin conjugates are indicated by 
arrows. 
(B) Illustration of lysine residues within human, mouse and Xenopus Borealin. Of note, none of the lysine 
residues confers to the proposed minimal SUMO consensus motif KxE/D. 
(C) HeLa cells were treated with siRNA duplexes specific for the 3´UTR of Borealin and simultaneously 
transfected with HA-Borealin or HA-Borealin25KR. Immunofluorescence was performed on interphase cells 
with antibodies directed against HA. 
(D) Experiment as in (C) showing interphase cells expressing HA-Borealin that have been depleted of Ubc9 
(upper panel) or co-transfected with Flag-tagged SENP2. Scale bar = 10µm. 
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Figure 56. Localization and function of the CPC is unaffected in cells overexpressing SENP2. 
(A) HeLa cells were transfected with Flag-SENP2 and incubated for 48hrs. Immunostaining was performed 
with anti-Flag and anti-Borealin antibodies. 
(B) Experiment as in (A) staining for Flag-SENP2 and CENP-E (upper panel) or Flag-SENP2 and phospho-
S7-CENP-A (lower panel). As previously reported, SENP2 overexpression results in a loss of CENP-E from 
kinetochores. However, phospho-S7-CENP-A staining was unaffected. Scale bar = 10µm. 
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SENP3 catalyzes desumoylation of Borealin 
We next asked whether one of the known SUMO specific isopeptidases might be 
involved in the desumoylation of Borealin. Thus, we first searched for a physical interaction 
of Borealin with members of the human SENP family (SENP1, SENP2, SENP3 or SENP5) in 
the yeast two-hybrid system. Among the tested candidates only SENP3 showed binding to 
Borealin (Figure 57A). This finding was corroborated by coimmunopreciptation experiments 
in mammalian cells using Flag-tagged SENP3 and myc-tagged constructs of Borealin. Full-
length Borealin as well as an N-terminal fragment of Borealin (Borealin1-140) coprecipitated 
SENP3, while no interaction was detected between SENP3 and the C-terminal fragment of 
Borealin (Borealin141-280) (Figure 57B).  
 
 
 
 
 
 
 
 
 
 
Figure 57. The SUMO protease SENP3 interacts with Borealin. 
(A) Borealin was tested for interaction with SUMO proteases in directed yeast two-hybrid assays as described 
in Figure 35. 
(B) Flag-tagged SENP3 and myc-tagged constructs of Borealin were coexpressed in HeLa cells.
Immunoprecipitations were performed using anti-myc antibodies. The two fragments of Borealin show a 
different electrophoretic mobility due to different isoelectric points. Asterisks denote immunoglobulins. 
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Consistent with this finding and previously reported data on their subcellular 
distribution, Flag-SENP3 and HA-Borealin exhibit colocalization in the nucleolus in 
interphase cells (Figure 58A). In early mitosis after nucleolar disassembly SENP3 is found 
evenly distributed in the cytosol thus showing partial overlap with Borealin (Figure 58B). In 
late mitosis it accumulates at the reforming nuclear envelope and re-enters the nucleolus 
during cytokinesis (Figure 58C). Noteworthy, the overexpression of Flag-SENP3 did not 
affect the normal localization of endogenous Borealin in distinct mitotic stages. 
 
 
 
 
 
Figure 58. SENP3 and Borealin show overlapping localization. 
(A) SENP3 and Borealin colocalize in interphase nucleoli. HeLa cells were transfected with Flag-SENP3 and 
HA-Borealin. Localization was determined by immunostaining with anti-HA and anti-Flag antibodies. 
(B) Localization of SENP3 during mitosis. HeLa cells were transfected with Flag-tagged SENP3 and 
incubated for 48hrs. Immunostaining was performed with anti- Flag and anti-Borealin antibodies. SENP3 
localizes to the cytoplasm during mitosis and showed partial overlap with Borealin from prophase until 
anaphase.  
(C) During telophase SENP3 accumulates at the reforming nuclear envelope and re-enters the nucleolus 
during cytokinesis. Scale bar = 10μm. 
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To directly analyze whether SENP3 can catalyze desumoylation of Borealin, an in 
vitro demodification assay was performed. Borealin, pre-modified by either SUMO1 or 
SUMO2, was incubated with wild-type or catalytically inactive mutant forms of either SENP3 
or SENP5, the closest homolog of SENP3 in humans. While Borealin-SUMO1 conjugates 
were not influenced by the addition of either SENP (Figure 59A, lane 3-6), the amount of 
Borealin-SUMO2 conjugates was greatly reduced in reactions supplemented with the wild-
type SENP3 protein, but unaffected by the inactive protein (Figure 59A, compare lane 8 and 
9). In comparison, SENP5 only marginally reduced the amount of Borealin-SUMO2 
conjugates (Figure 59A, lane 10). Next we assessed SENP3-catalyzed demodification of 
Borealin in vivo. Confirming and extending the in vitro results, expression of wild-type 
SENP3, but not the inactive mutant, induced an almost complete loss of Borealin-SUMO2 
conjugates (Figure 59B, compare lane 11 and 12), whereas the level of Borealin-SUMO1 
species was not affected (Figure 59A, lane 8 and 9). To further study the involvement of 
endogenous SENP3 in desumoylation of Borealin, His-Borealin was expressed in HeLa cells 
and SENP3 was depleted from cells by siRNA duplexes. Efficient downregulation of the 
protein was verified by immunoblotting with an anti-SENP3 antibody (Figure 59C´). 
Importantly, upon depletion of SENP3 the amount of Borealin-SUMO2/3 conjugates was 
significantly increased. Noteworthy, depletion of SENP5 did not affect Borealin-SUMO2/3 
conjugates, whereas depletion of RanBP2 reduced the amount of sumoylated Borealin (Figure 
59C). Taken together, these data strongly indicate that SENP3 exerts protease activity on 
Borealin and specifically reverts the modification of Borealin by SUMO2/3. 
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Figure 59. SENP3 catalyzes desumoylation of Borealin. 
(A) Flag-tagged versions of wild-type SENP3 (SENP3wt, lane 3 and 8) and SENP5 (SENP5wt, lane 5 and 10) 
or the catalytically inactive mutants (SENP3C532S, lane 4 and 9, and SENP5C713S, lane 6 and 11), generated by 
in vitro translation/transcription, were added to in vitro sumoylated Borealin. The anti-Flag Western blot 
serves as a loading control for the proteases. Note deconjugation of SUMO2/3, but not SUMO1, of Borealin 
when incubated with SENP3wt but not SENP3C532S. Data Markus Haindl. 
(B) Myc-tagged Borealin and His-SUMO constructs were coexpressed with Flag-tagged SENP3wt (lane 2, 5, 8 
and 11) or SENP3C532S (lane 3, 6, 9 and 12) in HeLa cells. His-SUMO conjugates were recovered on Ni-NTA 
beads (lane 7-12) and Western blotting was performed with anti-myc antibodies. Expression of SENP3 
constructs was verified by anti-Flag Western blotting. 
(C and C´) SENP3 depletion leads to accumulation of SUMO2/3 modified Borealin. HeLa cells were 
transfected with His-tagged Borealin and indicated siRNA duplexes, arrested in S-phase by thymidine 
treatment and released for 10hr to enter mitosis. Mitotic lysates were prepared and Ni-NTA precipitation was
performed as described above. Immunoblotting was performed with indicated antibodies to demonstrate 
depletion of corresponding proteins (C´) and monitor the sumoylation status of Borealin (C). The Borealin 
reactive bands at ~45kDa (asterisk in C) is interpreted as a Borealin-SUMO2/3 degradation product. Note that 
knock-down of SENP3, but not SENP5, enhances Borealin sumoylation compared to control depleted cells. In 
contrast, RanBP2 knock-down results in a loss of Borealin modification. 
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Conclusion 
 In a yeast two-hybrid screen for interaction partners of Borealin we identified 
components of the SUMO system. Subsequently, we identified Borealin as a mitotic substrate 
of sumoylation as well as ubiquitination. Borealin is preferentially modified by SUMO2/3 
during early mitosis and found to become demodified at the onset of anaphase. Sumoylation 
of Borealin was shown to be independent of CPC formation and seems to occur before 
centromere targeting. 
Intriguingly, the SUMO E3 ligase RanBP2 interacts with the CPC, stimulates SUMO 
modification of Borealin in vitro and is required for its modification in vivo. The 
overexpression of a catalytically active RanBP2 fragment results in massive chromosome 
missegregation during anaphase, but the critical target responsible for this phenotype is not 
definitively identified. The SUMO acceptor site/s of Borealin could not be mapped but we 
ruled out that sumoylation affects CPC assembly or localization during mitosis. Moreover, we 
found the SUMO protease SENP3 to interact with Borealin and to mediate deconjugation of 
SUMO2/3 from Borealin. Our data thus show RanBP2 and SENP3 to dynamically regulate 
sumoylation of Borealin during mitotic progression.  
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DISCUSSION 
 
A novel module on INCENP required for centromere targeting of the CPC 
It has been well established that INCENP binds the Aurora B kinase via its C-terminal 
IN-box domain. This module of the CPC is required for full kinase activation via a positive 
feed-back loop (Bishop and Schumacher, 2002; Honda et al., 2003; Yasui et al., 2004; Sessa 
et al., 2005). Our data on the INCENP fragment comprising residues 1-58 extends the concept 
of a modular structure of the INCENP protein. A second module assembles on the N-terminus 
of INCENP and is required for centromere targeting of the CPC. (We note, that we did not 
observe any interaction between Survivin and Aurora B, neither in yeast two hybrid assays 
nor in in vivo co-immunoprecipitation, contrasting a previous study (Wheatley et al., 2001) 
which reported in vitro binding of the proteins even under conditions of 3M NaCl). We 
envision a module at the N-terminal end of INCENP rigidly bound to centromeric DNA 
(probably mediated via Borealin) and a flexible active kinase module at the C-terminal end of 
the INCENP protein that regulates centromere/kinetochore assembly and MT-KT interaction 
(Figure 60), possibly via Hec1 phosphorylation (DeLuca et al., 2006). The two modules are 
connected by the long coiled-coil region of INCENP. Supporting evidence for this model has 
been reported in yeast (Sandall et al., 2006).         
 CPC function at the centromere is mediated by the kinase activity of Aurora B. The 
regulation of Aurora B kinase involves its partners within the complex. The concept of 
auxiliary subunits for kinases is not unusual in the cell cycle field and is exemplified best by 
the cyclin-dependent kinases with their associated cyclin subunits. So far, Aurora B has 
appeared to be unusual in requiring association with three additional subunits. It is 
noteworthy, however, that these three subunits appear to act as one functional element (Figure 
35-37). 
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Targeting the CPC to the centromere via Borealin-mediated DNA binding 
The chromosomal passenger proteins bind to the inner centromere during 
prometaphase and metaphase, but the precise mechanism(s) by which the CPC proteins 
localize to this region have not been elucidated previously. Importantly, no 
kinetochore/centromere protein has yet been found whose knock-down results in the loss of 
the CPC from the centromere. Our present data raise the intriguing possibility that CPC 
targeting is ultimately determined by a DNA binding activity associated with Borealin but 
that in vivo this activity is only displayed in the context of a functional ternary complex of 
Borealin with INCENP1-58 and Survivin (Figure 23). This assumption predicts that fragments 
and/or deletion mutants of INCENP1-58, Borealin, or Survivin that do not interact with their 
binding partners of the ternary complex cannot target to the centromere. In agreement with 
this, it has been reported that Borealin fragments that do not bind INCENP as well as an N-
terminal fragment of Survivin lacking the Borealin-binding domain were unable to localize to 
the centromere (Gassmann et al., 2004; Lens et al., 2006a). Furthermore, attempts of restoring 
the CPC by supplementing Aurora B depleted Xenopus egg extract with INCENP, Aurora B, 
and Survivin failed (Vigneron et al., 2004). This result is likely due to the absence of Borealin 
in the corresponding experiment and indicates that localization and stability of the CPC 
requires the Borealin protein. In agreement with our data on Borealin DNA binding, a 
subsequent study (Gao et al., 2008) showed DNA binding of Australin (the Drosophila 
Borealin homolog). In yeast no homolog of Borealin was identified. We suggest that the large 
Figure 60. Model of CPC architecture. 
Our data suggest that Survivin and Borealin directly bind to each other and to the first 58 amino acids of 
INCENP. Aurora B, in contrast, associates with the C-terminal IN-box of INCENP to become fully active, as 
documented previously. We propose that Borealin targets the CPC to the centromere by binding to DNA directly 
but can only do so when present within a functional subcomplex. Aurora B kinase itself is not involved. 
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yeast Survivin protein (Bir1p ~100kDa) combines functions of the smaller Survivin (~16kDa) 
and Borealin (~34kDa) proteins present in higher eukaryotes. It has been proposed that in 
addition to the holo-CPC, Aurora B and INCENP can form a separate, independent complex 
(Gassmann et al., 2004). Data obtained with the ternary INCENP1-58-Survivin-Borealin 
complex suggested that such a complex should not be able to target to the centromere but 
rather be cytoplasmic and this has been confirmed through the analysis of our structure-based 
mutants (Figure 37). The result is consistent with the observation that GFP-Aurora B exhibits 
a dynamic behaviour at the centromere, exchanging rapidly with a cytoplasmic pool (Murata-
Hori et al., 2002). Besides the CPC composition other factors such as specific modification 
states of (peri)centromeric histones (Sullivan and Karpen, 2004) and chromatin structure may 
also contribute to the centromere localization of the complex. Recruitment of the CPC to the 
centromere might therefore include a larger number of regulatory steps than previously 
assumed. Cooperation of these mechanisms may be necessary to ensure that the CPC targets 
specifically to the centromeres rather than the entire chromosome. Interestingly, we have 
observed spreading of the CPC over the entire chromosome in cells depleted of PP2A 
phosphatase or Haspin kinase (data not shown). 
 
Aurora B independent recruitment of the CPC to the centromere  
How can the finding of Aurora B-independent targeting of a CPC subcomplex be 
reconciled with the fact that siRNA-mediated knock-down of Aurora B leads to loss of the 
other CPC components from the centromere? We suggest that the requirement for Aurora B is 
indirect and results from the instability of full-length INCENP in the absence of Aurora B. 
That GFP-INCENP1-58 is stable in the absence of Aurora B suggests that the region that 
confers instability to INCENP must lie within the central coiled-coil domain or the C terminus 
of the protein, the region that interacts with the Aurora B kinase (Bishop and Schumacher, 
2002; Honda et al., 2003; Yasui et al., 2004; Sessa et al., 2005). Furthermore, the rescue 
results with GFP-INCENP1-58 show that expression of the first 58 amino acids of INCENP 
rescues the protein levels of Survivin and Borealin in the transfected cells (Figure 18A). 
Similarly, we found Aurora B levels to be rescued by an INCENP construct that comprises 
the IN-box (Figure 18B). These findings argue that the interaction with INCENP stabilizes its 
binding partners of the CPC. Interestingly, in C. elegans, in contrast to mammalian cells, 
localization of CSC-1 (a remote Borealin homologue), BIR-1 (C. elegans Survivin), and ICP-
1 (C. elegans INCENP) is not dependent on Aurora B (AIR-2), whereas, conversely, AIR-2 
depends on all three for localization (Speliotes et al., 2000; Romano et al., 2003). This 
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difference might be explained by the different sizes of C. elegans and mammalian ICP-
1/INCENP. C. elegans ICP-1 (~70 kDa) is much smaller than mammalian INCENP (~120 
kDa) and its stability might therefore be independent of AIR-2/Aurora B. 
 So far, attempts to target the CPC for cancer therapy have focused on inhibiting 
Aurora B kinase activity (Gautschi et al., 2008). In light of our results, alternative 
antineoplastic reagents could aim at interfering with binding of CPC components to each 
other. In particular, peptides competing with respective protein binding sites within the 
ternary subcomplex might allow to interfere with CPC targeting thus ultimately leading to cell 
death. 
 
The CPC and the tension sensing arm of the SAC 
 The primary signal that activates the SAC has remained a matter of debate (Pinsky and 
Biggins, 2005), but experiments indicate that the checkpoint recognizes the lack of MT 
attachment to the KT and can sense the absence of tension generated on the KT by pulling 
MTs. The interdependence between tension and MT attachment makes it difficult to 
determine whether these signals are separable. Nevertheless, cells depleted of the CPC show a 
mitotic arrest only in response to lacking MT attachment (by nocodazole treatment) but not 
when tension between KTs is abolished (by taxol treatment). The CPC is therefore considered 
to represent the tension sensing arm of the SAC (Tanaka et al., 2002; Musacchio and Salmon, 
2007; Ruchaud et al., 2007). 
We have shown that PICH, a recently described checkpoint protein, is regulated by the 
CPC. In particular, PICH is absent from the centromere/kinetochore in CPC depleted cells but 
is not influenced by Aurora B kinase inhibition. This difference was unique among the tested 
candidates and to our knowledge the requirement for the CPC in localizing centromere/ 
kinetochore components has so far always been assigned to the enzymatic activity of Aurora 
B (Ditchfield et al., 2003; Hauf et al., 2003; Pouwels et al., 2007; Emanuele et al., 2008). As 
PICH localization could not be rescued with the ternary INCENP1-58-Survivin-Borealin 
subcomplex, the region of the CPC required for PICH centromere/kinetochore binding must 
be present within INCENP59-919 or the Aurora B protein. The established rescue assay should 
allow for the identification of the corresponding region of the CPC. We also tested if PICH 
localization depends on the the sumoylation status of Borealin and found that the lysine-less 
Borealin mutant (Borealin25KR) could rescue the centromere/kinetochore localization of PICH 
(data not shown). 
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Interestingly, the CPC is also involved in regulating PICH localization to the 
chromosome arms (Figure 31). The CPC, PICH and Plk1 have all been demonstrated to 
regulate chromosome arm cohesion. While Plk1 phosphorylates the SA2 subunit of the 
cohesin complex, thereby releasing it from the chromatin (Sumara et al., 2002; Gimenez-
Abian et al., 2004; Hauf et al., 2005), PICH is essential to localize Plk1 to the chromosome 
arms (Santamaria et al., 2007) and cells depleted of PICH show closed chromosome arms 
(Leng et al., 2008). The requirement for the CPC in the resolution of arm cohesion has been 
reported previously (Losada et al., 2002; Gimenez-Abian et al., 2004) but the molecular basis 
has remained elusive. We envision that the CPC is required for PICH to localize to 
chromosome arms. This in turn then recruits Plk1 to release cohesin via phosphorylation of 
SA2. 
The SAC is regulated by PICH supposedly via the KT recruitment of Mad2. 
Furthermore, PICH has been hypothesized to sense tension due to its unique localization 
between sister KTs (Baumann et al., 2007). As the CPC is required for 
centromere/kinetochore targeting of PICH we tested if the SAC override seen in CPC 
depleted cells treated with taxol but not nocodazole might be assigned to PICH 
centromere/kinetochore localization. However, we observed absence of the protein from the 
centromere/kinetochore in both conditions. Remarkably, the checkpoint protein Mad2 that 
similarly depends on the CPC was re-directed to the KT in Aurora B depleted cells that have 
been treated with nocodazole. The difference in Mad2 KT binding provides an explanation for 
the different response of CPC depleted cells to the two MT poisons. These results also 
indicated that Mad2 KT localization is independent of PICH centromere/kinetochore 
recruitment. We did not observe any influence of CPC depletion on thread formation of 
PICH. Similar to what was shown for the microtubule depolymerising kinesin MCAK 
(Andrews et al., 2004; Lan et al., 2004; Ohi et al., 2004), we speculate that upon stretching of 
the inner centromere region (due to bipolar attachment and pulling MTs), negative regulation 
of PICH by the CPC is lost (and PICH association with forming threads can occur when 
anaphase commences). 
 
More than one chromosomal passenger complex? 
A recent study has claimed the existence of at least two chromosomal passenger 
complexes in mitotic HeLa cells (Gassmann et al., 2004). Immunoprecipitation of 
endogenous Borealin pulled down essentially all of the Survivin, about half of the Aurora B, 
and about two thirds of the INCENP. Re-precipitation of the unbound fraction with an 
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antibody to Aurora B brought down the remainder of the kinase plus most of the soluble 
INCENP, but no further detectable Borealin or Survivin. The interpretation was that a holo-
complex of INCENP, Aurora B, Borealin and Survivin and a subcomplex of Aurora B plus 
INCENP exist. We have found that IN-box mediated binding of INCENP to Aurora B 
stabilizes the kinase (Figure 18B). An engineered INCENP-Aurora B complex did not 
phophorylate CENP-A or localize to any defined structure during mitosis. Evaluation of other 
engineered subcomplexes did show identical results. Thus, to us it seems that during mitosis 
only the holo-CPC can fulfil functions required for mitotic progression but targeting of the 
complex to the centromere occurs independently of Aurora B. The above mentioned data on 
sequential immunoprecipitation of chromosomal passenger proteins could easily be explained 
by different binding affinities between the proteins. The fact that in the absence of Borealin 
and Survivin the Aurora B kinase and INCENP are competent in binding to each other has 
previously been shown  (Honda et al., 2003; Sessa et al., 2005) (see also yeast two-hybrid 
data in Figure 12A). 
Data on the oligomerization status of chromosomal passenger proteins have been 
controversial. Borealin can bind to itself in yeast-two hybrid assay (data not shown), in vitro 
and in vivo (Figure 13). Within the CPC, however, Borealin is monomeric (Figure 35). 
Recombinant Survivin forms dimers in solution (Chantalat et al., 2000; Muchmore et al., 
2000; Verdecia et al., 2000) and can form higher order structures in vivo. Via molecular 
mimicry its dimeric interface is occupied by Borealin within the CPC resulting in a 1:1:1 
stochiometry of Borealin, Survivin and INCENP (Figure 35). Intriguingly, in vitro a 
homodimeric complex comprising two molecules of Survivin and two molecules of Borealin 
can be reconstituted (data by Dr. Arockia Jeyaprakash). At this point it is not clear if this 
molecule is a classical Survivin dimer with two associated Borealin molecules or if its 
architecture is different. Is a Survivin-Borealin homodimer relevant in vivo and/or is there a 
relevant role for a Survivin dimer? A possible answer might be found outside mitosis. In 
interphase cells Survivin is found in the cytoplasm while INCENP and Borealin are nuclear. 
In particular, Borealin resides in the nucleolus. This scenario would probably allow for 
Survivin dimerization and a number of studies have suggested that Survivin´s antiapoptotic 
function is indeed exerted from the cytoplasm. Therefore a possible explanation for some of 
the controversy surrounding Survivin function during mitosis versus its role in regulating 
apoptosis (Altieri, 2006; Lens et al., 2006b) might lie within its dimerization status. In this 
context it is interesting to note that the sumoylation of Borealin does not seem to require its 
interaction with the CPC (Figure 47). Hence, SUMO modified Borealin might function 
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independently of the CPC (e.g. outside mitosis). However, the tight control of its modification 
at the metaphase to anaphase transition (Figure 48) rather points to a CPC dependent role. 
Determination of the oligomerization status of sumoylated Borealin might reveal further 
aspects of the modification. In light of a recent report on the activation of Aurora B by the 
chromosomal enrichment of CPC (Kelly et al., 2007), it is possible that in the presence of 
appropriate interacting proteins at the centromeres and central spindle, the CPC components 
might assemble into a larger complex of oligomeric nature to regulate mitotic progression. In 
contrast to their closely related localization during mitosis, the nucleocytoplasmic localization 
of the chromosomal passenger proteins before NEB is largely unrelated (Rodriguez et al., 
2006) and indicates that the functional unit in interphase cells might not be the holo-CPC.  
 
Central spindle and midbody binding of the CPC: spindle transfer? 
One of the most striking observations regarding the CPC is its dynamic localization. 
However, only few factors are known that regulate the passage of the CPC from the 
centromere to the central spindle and midbody. In yeast, the dephosphorylation of Cdk1 sites 
on INCENP seems to be a pre-requisite for spindle transfer (Pereira and Schiebel, 2003) and 
this might be a regulatory mechanism in human cells, too (Murata-Hori et al., 2002). 
Additionally, cells depleted of the kinesin motor protein Mklp2 do not show transfer of the 
CPC from the centromere to the central spindle (Gruneberg et al., 2004). Although the term 
“spindle transfer” is widely used when referring to CPC localization a real transfer from one 
location to the other has not been proven yet. In contrast, our data on the Borealin fragment 
comprising residues 10-109 shows that spindle and midbody binding can occur independently 
of prior centromere targeting (Figure 34). Interestingly, this mutant showed proper 
cytokinesis (during the first round of division) arguing that the function of the CPC during 
cytokinesis is excecuted from the central spindle and midbody. In agreement with this, a study 
in Drosophila secondary spermatocytes mutants that lack chromosomes revealed Aurora B 
localization to the spindle and midbody during anaphase and cytokinesis, respectively 
(Bucciarelli et al., 2003). Thus, centromere and central spindle/midbody bound CPC may 
represent two independent pools of the complex that are differently regulated.   
Like centromere recruitment, spindle and midbody binding of the CPC is independent 
of Aurora B kinase activity (Ditchfield et al., 2003; Hauf et al., 2003). But Aurora B kinase 
activity is needed to build a functional mitotic spindle (Murata-Hori et al., 2002; Guse et al., 
2005). The ternary INCENP1-58-Survivin-Borealin subcomplex as well as all other engineered 
subcomplexes that missed one of the core components INCENP, Survivin or Borealin were 
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unable to target to the central spindle or midbody. In contrast, Aurora B was dispensable for 
centromere targeting. This raises the question if Aurora B kinase is only a passive passenger 
carried by the core CPC components? To rigorously rule out a role for Aurora B in localizing 
the complex to the spindle, an INCENP mutant defective in Aurora B binding should be 
monitored in anaphase cells. Based on the INCENP-Aurora B structure (Sessa et al., 2005) 
the mutant INCENPF825A, F837A might make this experiment feasible.  
The overall charge of the molecular surface of the CPC is important for central spindle 
and midbody binding. A charge-reversal of two conserved clusters on different proteins of the 
CPC (INCENP and Borealin) in different directions (negative cluster mutated to positive and 
vice versa) led to chromatin binding of the CPC in anaphase (Figure 38). How does the 
surface charge of the CPC influence its localization? First, corresponding mutations might 
have affected Cdk1 mediated phosphorylation of the complex required for its “transfer”. Of 
note, T59, which we have identified as a Cdk1 site on INCENP (Figure 10), is in close 
proximity to the mutated INCENP residues. Second, it is tempting to speculate that the 
mutated CPC versions are no longer recognized as appropriate cargo-proteins for their 
putative kinesin Mklp2 at the central spindle. Strikingly, all scenarios mentioned above where 
defects in spindle binding of the CPC in anaphase are observed exhibit one common feature; 
the CPC does not mislocalize to the cytoplasm but is associated with the chromatin. Is this 
due to the inability to leave the chromatin (trap hypothesis) or does this localization reflect the 
default localization when spindle binding is perturbed (acceptor hypothesis)? One possible 
way to address this point is to introduce corresponding charge-reversal mutations in the 
context of the Borealin10-109 mutant that does localize to the spindle but not to the centromere. 
A recruitment to the centromere would clearly be in favour of the trap hypothesis.       
 
MAP kinase mediated regulation of the CPC 
Inhibition of MAP kinase has been shown to override a SAC dependent arrest in 
Xenopus extract and cultured human cells (Takenaka et al., 1997; Takenaka et al., 1998). 
Additionally, it has been shown in HeLa cells that activated Erk kinase targets to the KT 
(Shapiro et al., 1998). A collaboration with the laboratory of Marsha Rosner revealed that 
cells depleted of Raf-kinase inhibitory protein (RKIP) showed decreased Aurora B kinase 
activity (Eves et al., 2006). Herein, we further show that within the CPC, Borealin is a target 
of Erk kinase mediated phophorylation in vitro. The identified Erk kinase site, residue T106 
of Borealin, shows phosphorylation from prophase until metaphase consistent with Erk kinase 
being active at the centromere/kinetochore. Of note, Mps1 mediated phosphorylation of 
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Borealin was recently shown to influence Aurora B kinase activity (Jelluma et al., 2008) and 
Mps1 is a substrate of MAP kinase (Zhao and Chen, 2006; Borysova et al., 2008). Thus, the 
observed influence of the MAP kinase pathway on Aurora B might be indirectly mediated by 
Mps1. We could not link phosphorylation of T106 of Borealin to a change in Aurora B kinase 
activity and inhibitor treatment did not unequivocally show that T106 is a site of Erk kinase 
phosphorylation. However, the phospho-T106-Borealin antibody might proof useful as a 
mitotic marker once the corresponding kinase has been identified. 
 
Sumoylation of Borealin 
The data reported herein define a mitotic pathway of SUMO2/3 conjugation/ 
deconjugation on the CPC component Borealin (Figure 61). Importantly, this pathway is 
controlled by the E3 SUMO ligase RanBP2 and the SUMO-specific protease SENP3 (Figure 
61). Modification of Borealin occurs at up to three lysine residues, but we were unable to 
assign distinct residues for attachment of SUMO. Notably, none of the 25 lysine residues of 
Borealin is embedded in a KxE/D motif, which serves as a preferential SUMO attachment site 
in the majority of SUMO substrates (Geiss-Friedlander and Melchior, 2007). Individual and 
combinatorial mutations of highly conserved lysine residues did not abolish the modification 
in the assays we used. A possible explanation for this phenomenon might be “jumping” of the 
SUMO moiety, a mechanism that has been described for ubiquitin. Interestingly, recent work 
in yeast described sumoylation of Bir1p, the yeast relative of Survivin (Montpetit et al., 
2006). We show that Survivin is not a major target of SUMO modification in human cells. 
Remarkably, however, yeast lacks a Borealin homolog and we have proposed above that the 
functions of human Survivin and Borealin are combined in the single yeast Bir1p protein. 
Therefore, these data support the idea that sumoylation of the CPC is an evolutionarily 
conserved mechanism. However, the functional impact of SUMO on CPC activity in both 
lower and higher eukaryotes remains to be elucidated. The defect in nucleolar targeting of the 
lysine-less Borealin mutant might be linked to other lysine-based modifications. We also 
show that Borealin is a target of ubiquitination (Figure 46). An exciting new aspect in the 
SUMO/ubiquitin field is the emerging interplay of both modification systems on a given 
target protein. Of note, recent work has shown that a balanced non-degradative ubiquitination-
deubiquitination cycle of Survivin is required for the chromosome segregation function of the 
CPC at the centromere (Vong et al., 2005). Modification of Borealin and Survivin by SUMO 
and ubiquitin, respectively, thus provides an example, for both modification systems targeting 
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distinct components of a multiprotein complex. An interesting new concept that awaits to be 
confirmed for other complexes. 
Interestingly, as demonstrated for CENP-E, dynamic association of centromeric 
proteins to these structures also involves non-covalent interactions between a SUMO-
modified acceptor protein and a specific binding partner, which harbours a SUMO interaction 
motif (SIM) (Zhang et al., 2008). Thus, one may envision that the attachment of the SUMO 
moiety to Borealin may provide a centromeric docking site for a yet to be identified SIM-
containing binding partner. Indeed, we have shown that the CPC constitutes one of the most 
upstream components of centromere/kinetochore assembly (Figure 24). Continuing our 
collaboration with the laboratory of Elena Conti we are currently trying to crystallize Borealin 
in complex with SUMO2/3 (Dr. Arockia Jeyaprakash).  
Borealin-SUMO2/3 conjugates are most prominent in early mitosis when the CPC is 
associated with the centromere, suggesting that the SUMO modified fraction of Borealin is 
associated with these structures. This would be in line with observations from Xenopus egg 
extracts and human cells, which show that during prometaphase/metaphase SUMO2/3 is 
found at centromeres and chromatin, whereas SUMO1 localizes to the mitotic spindle and the 
spindle midzone (Azuma et al., 2003; Ayaydin and Dasso, 2004; Zhang et al., 2008). The loss 
of Borealin sumoylation observed during later mitotic phases (around anaphase onset), when 
the CPC translocates to the central spindle, is in agreement with SUMO2/3 being chromatin 
associated also during these stages (Zhang et al., 2008). The importance of SUMO function at 
the kinetochore/centromere is underscored by the recent finding that overexpression of 
SENP2 in HeLa cells leads to a loss of SUMO2/3 from these structures and induces a 
prometaphase-like arrest, due to a failure in kinetochore targeting of the microtubule motor 
CENP-E (Zhang et al., 2008) and see (Figure 56).  
 
The SUMO pathway components RanBP2 and SENP3 during mitosis 
We have identified Borealin as a physiological target for RanBP2-mediated 
sumoylation. RanBP2 is found at the cytoplasmic site of the nuclear pore in interphase cells, 
but redistributes to the mitotic spindle and the KT upon entry of cells into mitosis (Joseph et 
al., 2002; Joseph et al., 2004). Similarly to what was shown for topoisomerase II (Dawlaty et 
al., 2008), we found that RanBP2 associates with the CPC in mitosis, stimulates SUMO 
modification of Borealin in vitro and is essential for Borealin sumoylation in vivo. However, 
displacing RanBP2 from the KT by means of nocodazole treatment did not abolish Borealin 
sumoylation (Figure 52). Additionally, Borealin mutants defective in Survivin or INCENP 
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binding, respectively, show SUMO modification (Figure 47) even though they do not target to 
the centromere (Figure 36D). Moreover, Borealin as well as topoisomerase II bind to the inner 
centromere. RanBP2-mediated sumoylation of both proteins might therefore occur before 
centromere binding. In contrast to what was observed for topoisomerase II, sumoylation of 
Borealin does not seem to be required for centromere targeting of the CPC. Strikingly, a 
drastic defect in chromosome segregation is seen upon ectopic overexpression of the 
catalytically fragment of RanBP2 in anaphase cells while no defects were observed with the 
catalytically inactive fragment (Figure 51B-E). The misregulation should therefore be based 
on misregulated (upregulated) sumoylation of RanBP2 targets at this stage. So far, Borealin 
and topoisomerases II are the only substrates identified in vivo and remarkably, the depletion 
phenotype of both proteins is indeed characterized by chromosome missegregation (among 
other defects). 
The dynamics of sumoylation are controlled by SUMO proteases and the importance 
of SUMO deconjugation is illustrated by genetic data from yeast and mice showing that, like 
conjugation, deconjugation is needed for viability. In yeast, Ulp1 has an essential role in the 
G2/M phase of the cell cycle, while Ulp2, which appears to be particularly important for the 
depolymerization of SUMO chains, is involved in the control of chromosome cohesion at 
centromeric regions (Li and Hochstrasser, 1999; Bachant et al., 2002). In mammalian cells, 
depletion of SENP5, the closest homolog of SENP3 causes a cytokinesis defect indicating that 
SENP5 functions in mitosis (Di Bacco et al., 2006). Noteworthy, however, depletion of 
SENP5 did not affect Borealin-SUMO2/3 conjugates and did not interfere with CPC 
localization or function (our unpublished observation), indicating that the defect in 
cytokinesis is not related to an altered CPC function. Accordingly, SENP5 did not bind to 
Borealin and exhibited only a low catalytic activity towards Borealin-SUMO2/3 conjugates in 
vitro. By contrast, we identified SENP3 as a specific interaction partner of Borealin and show 
that SENP3 catalyzes the removal of SUMO2/3 from Borealin both in vitro and in vivo. Thus, 
SENP3 features an activity that catalyzes desumoylation of Borealin in mitosis. The 
preferential activity of SENP3 towards SUMO2/3 conjugates confirms previous reports 
(Nishida et al., 2000; Gong and Yeh, 2006; Haindl et al., 2008) and strengthens the concept 
of a functional divergence of distinct SUMO forms in mitosis. In interphase cells SENP3 is 
found in the nucleolus, where it functions as an essential factor of ribosome biogenesis 
(Haindl et al., 2008), but little is known about SENP3 function during mitosis. Interestingly, 
SENP3 was recently identified in a siRNA based screen as a potential component of the SAC 
(Stegmeier et al., 2007). However, depletion of SENP3 did not interfere with CPC targeting 
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to the centromere or activity of the CPC at these sites (our unpublished observation) 
suggesting that SENP3 affects SAC function independently of CPC recruitment to the 
centromere. Moreover, a proteomic study identified SENP3 at the mitotic spindle (Sauer et 
al., 2005), indicating that the protease might act to desumoylate spindle associated 
components. Notably, Borealin becomes desumoylated at the time the CPC transfers to the 
central spindle in anaphase. Because cell cycle progression and ribosome biogenesis are 
tightly interconnected (Dez and Tollervey, 2004), SENP3 may represent a critical factor that 
coordinates both processes. Identification of novel SENP3 targets may thus shed more light 
on the question of how the SUMO system regulates key mitotic processes. It is also 
interesting to speculate that RanBP2 and SENP3 form a (mitotic?) couple that dynamically 
regulates the sumoylation of other target proteins than Borealin.  
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 61. Model of Borealin sumoylation. 
(A) Sumoylation of Borealin is prominent in early mitosis when the CPC is bound to the centromere but lost 
as cells enter anaphase and the complex associates with the central spindle. 
(B) Sumoylation of Borealin is regulated by the SUMO E3 ligase RanBP2 and the SUMO protease SENP3. 
The modification may occur in the context of the CPC or be independent of complex formation (as depicted 
here). 
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MATERIALS AND METHODS 
 
Cloning procedures 
All cloning procedures were performed according to standard techniques as described 
in Molecular Cloning, A Laboratory Manual, 2nd edition, Sambrook, J., Fritsch, E.F., 
Maniatis, T., Cold Spring Harbor Laboratory Press, 1989 and Current Protocols in Molecular 
Biology, Wiley, 1999. Restriction enzyme reactions were carried out as specified by the 
suppliers (NEB, Ipswich, MA) and ligation reactions were done using Rapid Ligation Kit 
(Roche Diagnostics Mannheim, Germany). Extraction of DNA from agarose gels and 
preparation of plasmid DNA were performed using standard kits purchased from Qiagen 
according to the manufacturer’s instructions. For PCR reactions, Pfu DNA polymerase was 
used as recommended by the manufacturer (Stratagene, La Jolla, CA) and reactions were 
carried out in a RoboCycler Gradient 96 (Stratagene, La Jolla, CA). Site-directed mutagenesis 
was carried out using the QuickChange Mutagenis Kit (Stratagene, La Jolla, CA). All PCR 
products obtained were analysed by sequencing (Medigenomix, Martinsried, Germany). See 
Appendix for table of plasmids that have been constructed during the course of this work. 
 
Expression and purification of recombinant proteins 
For gene fusions with the hexa-histidine tag (His-tag), Survivin and Borealin cDNAs 
were cloned into pQE vectors (QIAGEN, Hilden, Germany). For fusion to the maltose 
binding protein (MBP), Borealin and INCENP1-58 cDNA were cloned into the pMAL vector 
(New England Biolabs, Beverly, MA). Glutathione S-transferase (GST) was expressed from 
the pGEX vector (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom), and 
GST-His-Survivin was a gift of Dr. Francis Barr. His-Plk1 purified from insect cells was a 
gift of Christoph Baumann. MBP-Borealin was expressed in E. coli BL21 cells by induction 
with 1mM IPTG for 4h at 30°C. All other recombinant proteins were expressed by induction 
with 0.1mM IPTG at 18°C overnight. His-, GST-, and MBP-fusion proteins were purified 
according to standard protocols. Purified proteins were dialyzed over night at 4°C in PBS and 
subsequently frozen at -80°C in 10% glycerol. 
 
In vitro kinase assay 
To obtain active Aurora B kinase, ten 15cm plates of Sf9 insect cells were co-infected 
with 1mL of the P3 baculoviruses of His-tagged Aurora B present in pHI100-His and GST-
tagged INCENP present in pHI100-GST. After incubation for 60h, cells were harvested spun 
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down at 500rpm for 5min and washed once with cold PBS. The pellet was resuspended in 
10mL lysis buffer (50mM Na-phosphate pH7.8, 150mM NaCl, 1%IGEPAL, 0.1mM ATP, 
5mM ß-mercaptoetahnol, 1mM NaF, 20mM ß-gycerolphosphate, protease inhibitor cocktail 
tablets) pipetted twice through a needle (0.40 x 20mm) and incubated on ice for 30min. 
Lysates were then spun down using an ultracentrifuge (27000rpm for 35min in a SW40 rotor). 
The supernatant was added to a 25mL plastic-column (Qiagen) and 300µL pure GST beads 
were added. The column was incubated on a rotating wheel at 4°C for 2h. Subsequently, the 
column was allowed to empty by gravity flow and washed three times with lysis buffer. 50µL 
of elution buffer (lysis buffer + 20mM glutathione) was added to obtain eluate fractions.  
For in vitro kinase assays, the active Aurora B-INCENP complex or Cdk1/cyclin B1 
(Upstate, Charlottesville, VA) and respective substrates at ~100ng were incubated in BRB80 
buffer (80mM Pipes, pH 6.8, 1mM MgCl2, 1mM EGTA). For Erk2 kinase (Upstate, 
Charlottesville, VA) reactions Erk2 kinase buffer was used (20mM Hepes pH7.4, 10mM 
MgCl2, 1mM DTT, 0.2mM Na3VO4, 5mM para-nitrophenylphosphate). CaM kinase reactions 
were carried out using a CaM kinase kit (NEB) according to manufacturer´s instruction. 
Kinase reactions were carried out at 30°C for 60min in these buffers supplemented with 
10μM ATP and 2μCi [γ-32P] ATP (Amersham Corp.). Reactions were stopped by the 
addition of SDS sample buffer and heating at 95°C for 5min. Protein samples were separated 
by SDS–PAGE followed by Coomassie Blue staining. The gels were dried on filter paper and 
32P incorporation was visualized by autoradiography. 
 
Antibody production 
In order to produce Borealin specific antibodies, the His-tagged protein was expressed 
in E. coli from pQE81L vectors (Qiagen) and purified under denaturing conditions over a 
Ni2+-NTA column (Qiagen). Following further purification on a preparative 12% SDS-PAGE 
gel, 250μg of Borealin was injected several times into New Zealand white rabbits (Charles 
River Laboratories, Romans, France). The obtained sera were checked for Borealin reactivity 
by Western blotting and immunofluorescence. 
Phosphospecific antibodies directed against a peptide of Borealin pT106 (H-
AEAIQT(PO3H2)PLKS-OH) were raised in New Zealand white rabbits (Charles River 
Laboratories, Romans, France) and then isolated from a protein-A purified IgG fraction of the 
serum over the same peptide immobilized on Sulfolink resin according to the manufacturer’s 
instructions (Pierce Biotechnology, PERBIO Science GmbH, Bonn, Germany). 
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Cell culture and synchronisation 
HeLa S3, U2OS, 293T, and COS-7 cells were grown at 37°C under 5% CO2 in 
DMEM (Invitrogen), supplemented with 10% FCS and penicillin-streptomycin (100 IU/ml 
and 100μg/ml, respectively). Sf9 insect cells were grown at 30°C in TC-100 medium 
supplemented with penicillin-streptomycin (100 IU/ml and 100μg/ml, respectively). 
Cell cycle arrest of HeLaS3 cells in S-phase was induced by thymidine treatment 
(2mM) for 16hr. Mitotic cell cycle arrest in prometaphase was induced by nocodazole 
(0.5µg/mL) or taxol (10µM) treatment for 16hr. Mitotic cells were collected by mitotic shake 
off. Aurora B kinase activity was efficiently blocked by using ZM447439 inhibitor (Tocris) at 
10µM. The proteasome inhibitor MG132 (Calbiochem) was used at 20µM. 
 
Transient transfection and siRNA 
Plasmid transfections were performed using FuGENE6® transfection reagent (Roche 
Diagnostics, Indianapolis, IN, USA) according to the manufacturer’s instructions. SiRNA 
duplexes were transfected using Oligofectamine (Invitrogen, Carlsbad, CA) as described 
previously (Elbashir et al., 2001). Sequences of siRNA duplexes used in this study 
(Dharmacon RNA Technologies, Lafayette, CO and Qiagen, Hilden, Germany) are listed in 
Appendix. 
 
siRNA rescue assays 
For rescue experiments, siRNA and plasmid transfection were performed in parallel. 
Cells were incubated for the indicated times and subsequently fixed for immunostaining. For 
rescue assays on chromosomal passenger proteins 30 mitotic, nontransfected cells on each 
coverslip were analyzed for the presence of chromosomal passenger proteins by staining with 
the appropriate antibodies. Slides were discarded if more than two of these 30 cells showed 
chromosomal passenger staining (siRNA efficiency higher than 94%). On the remaining 
coverslips, transfected mitotic cells were analyzed for staining of indicated proteins. Each 
rescue experiment was done in triplicate. To biochemically analyze the potential of GFP-
INCENP constructs to rescue Aurora B levels in a background free of endogenous INCENP, 
HeLa S3 cells were treated with siRNA oligonucleotides and transfected with corresponding 
constructs as described above. INCENP wild-type and deletion constructs were cloned into a 
modified version of pcDNA4/TO (Invitrogen) encoding the enhanced green fluorescent 
protein (EGFP)-tag and puromycin resistance (a gift from Dr. Francis Barr). Puromycin was 
added at 2µg/ml to enrich for transfected cells 24hrs before lysate preparation.  
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In vitro binding assay 
5µg of purified His-Borealin, GST-His-Survivin, or 10µg of purified GST was bound 
to Ni-NTA agarose (QIAGEN) or glutathione-Sepharose beads (GE Healthcare), respectively, 
in binding buffer (20mM Tris-Cl, pH 8.0, 150mM NaCl, 1mM DTT, and 0.1% (vol/vol) 
Triton X-100) for 2h at 4°C. After incubation, the beads were washed two times in binding 
buffer. Binding partners were added at 10µg/ml (MBP-INCENP1-58 and MBP-Borealin) or 
20µg/ml (MBP), respectively, in binding buffer. Zn2+ was added to a final concentration of 
20mM where indicated. Samples were incubated on a rotating wheel at 4°C for 2h. The beads 
were washed three times with binding buffer, boiled in 2xSDS sample buffer, and analyzed by 
SDS-PAGE. For DNA-binding assays, 5µg of purified protein (Histone H3, His-Survivin, 
His-Borealin, MBP-Borealin, MBP-INCENP1-58, GST-Cdc20, and His-Plk1) or 10µg of 
purified protein (MBP) was added into binding buffer (50mM Tris-Cl, pH 8.0, 4mM MgCl2, 
1mM DTT, 150mM NaCl, and 0.1% (vol/vol) Triton X-100) and bound to calf-thymus 
double-stranded DNAcellulose (Sigma-Aldrich) for 2h at 4°C. Zn2+ was added at 20mM 
where indicated. DNA-cellulose was washed three times with binding buffer, boiled in 2xSDS 
sample buffer, and analyzed by SDS-PAGE. 
 
Immunofluorescence microscopy 
Cells were grown on coverslips and either fixed with 3% paraformaldehyde 
(immunostaining for kinetochore associated proteins) for 10min at RT followed by a 5min 
permeabilisation with 0.5 % Triton-X100 at 4°C or fixed in –20°C methanol (immunostaining 
for centrosomal and phospho-specific antibodies). Primary antibodies used in this study are 
listed in the Appendix and were detected with Alexa-Fluor-488-(green) and Alexa-Fluor-555-
(red) conjugated antibodies. DNA was stained with 2μg/ml DAPI. Cover slips were mounted 
in phenylenediamine in 90% glycerol. 
Immunofluorescence microscopy was performed using a Zeiss Axioplan II microscope 
(Carl Zeiss, Jena, Germany) equipped with an Apochromat 63x oil immersion objective, and 
images were acquired using a Micromax charge coupled device (CCD) camera (model CCD-
1300-Y; Princeton Instruments, Trenton, NJ) and MetaView software (Visitron Systems, 
Puchheim, Germany). Alternatively, a Deltavision microscope on a Nikon Eclipse TE200 
base (Applied Precision, Issaquah, WA) equipped with an Apo 60x/1.4 oil immersion 
objective and a CoolSnap HQ camera (Photometrics) was used for collecting 0.2μm distanced 
optical sections in the z-axis. Images at single focal planes were processed with a 
deconvolution algorithm (Nikon_60x_140_12601.otf). Settings were conservative, with noise 
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filtering set to medium and 3 deconvolution cycles. Images were projected into one picture 
using the Softworx software (Applied Precision). Exposure times and settings for image 
processing (deconvolution) were constant for all samples to be compared within any given 
experiment. Images were cropped in Adobe Photoshop CS and then sized and placed in 
figures using Adobe Illustrator CS (Adobe Systems, Mountain View, CA).  
 
Coimmunoprecipitation 
For coimmunoprecipitation of endogenous or overexpressed chromosomal passenger 
proteins HeLa S3 cells in 15cm dishes were synchronized by thymidine release (unless 
otherwise stated) followed by mitotic shake-off to enrich for mitotic cells. Cell pellets were 
washed in PBS twice and subsequently lysed in 500µl of lysis buffer (50mM Tris, pH 7.4, 
400mM NaCl, 40mM ß-glycerol phosphate, 10mM NaF, 0.5% (vol/vol) IGEPAL, 0.1% 
deoxycholate, 30µg/ml RNase, 80U/ml micrococcal nuclease (Sigma-Aldrich), 2mM 
Prefabloc, protease inhibitor cocktail tablets (Roche Diagnostics, Mannheim, Germany), 
100µM ATP, 100µM MgCl2, 100nM okadaic acid, and 0.3mM Na-vanadate) for 30min at 
4°C on ice. Antibodies and corresponding IgG´s as control were either coupled to Affi-Prep 
Protein A Support beads (Bio-Rad Laboratories) if antibodies were raised in rabbits, or to 
Protein G beads (Pierce Biotechnology, Rockford, IL) if antibodies were of mouse origin. 
GFP-tagged proteins were precipitated from the cleared lysate with sheep anti-GFP 
antibodies, Flag-tagged proteins with anti-Flag (M2) antibodies, Myc-tagged proteins with 
anti-Myc (9E10) antibodies and HA-tagged proteins with anti-HA (12CA5) antibodies. 
Respective beads, antibodies and the cleared lysate were incubated on a rotating wheel for 2h 
at 4°C. Immune complexes were spun down, washed 3 times in lysis buffer and subsequently 
boiled in SDS sample buffer. To test for a Borealin-SENP3 interaction COS-7 cells were 
simultaneously transfected with myc-tagged Borealin and Flag-tagged SENP3 constructs and 
immunoprecipitations were done as described above using anti-Myc antibodies (9E10). 
 
In vitro sumoylation 
Proteins were generated by in vitro transcription/translation in the presence of 35S-
labeled methionine using the TNT Quick Coupled T7 kit (Promega). Sumoylation was carried 
out using the Sumoylation control kit (LAE biotech). In experiments using recombinant 
RanBP2∆FG (Biomol) the amount of Aos1/Uba2 and Ubc9 was reduced to 100nM and 70nM, 
respectively. For in vitro demodification assays Flag-tagged proteases, generated by in vitro 
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transcription/translation, were added to an in vitro modification reaction after incubation and 
samples were incubated for an additional 90min at 30°C.  
  
In vivo sumoylation 
Following transfection of respective constructs, HeLa S3 or COS-7 cells were 
incubated for 48h and Ni-NTA precipitations were done as described (Muller et al., 2000). In 
experiments, where protein knock-down was performed siRNA duplexes were simultaneously 
transfected. Depletion of proteins was verified by Western blotting using input fractions. 
To demonstrate endogenous sumoylation HeLa S3 cells were arrested by a 16h taxol 
treatment before harvesting. Lysates were prepared in buffer A (50mM Tris/HCl pH 7.5, 
150mM NaCl, 1% NP-40, 0,5% sodium deoxycholate, 0.1% SDS, 1mM DTT, 10mM CaCl2, 
200u/mL micrococcal nuclease (Fermentas), 10mM NEM (Pierce) and protease inhibitor 
cocktail tablets) and subjected to immunoprecipitation with 10µg SUMO2/3 antibody or 
control mouse IgG. 
 
Cell cycle dependent sumoylation 
HeLa S3 cells were transfected with His-tagged Borealin and incubated for 30h. 
Thymidine or taxol were added at a concentration of 2mM and 1µM, respectively and cells 
were incubated for an additional 16h. Taxol arrested cells were released into 10µM MG132 
for one hour to obtain metaphase cells. To harvest anaphase/telophase cells, corresponding 
cell populations were released from this block for 25 and 50min, respectively. Cell lysates and 
Ni-NTA pull-downs were performed as described above. 
 
Yeast-two hybrid analysis 
Yeast two-hybrid screens for Borealin and INCENP1-530 were performed according to 
the yeast protocol handbook (Clontech). For the directed interaction screening, yeast colonies 
were selected by pACT2 (Leu-) and pFBT9 (Trp-) selection markers for plasmid uptake on 
plates lacking these amino acids (–LW). Specific interaction between the GAL4 activation 
domain (AD) and the GAL4 binding domain (BD) and subsequent expression of markers 
(His-/Ade-) was monitored by streaking yeasts on QDO selective plates (Quadruple Drop Out: 
Leu-/Trp-/His-/Ade-). Construct were tested in the same assay for self activation first by 
cotransfection with an empty vector.  
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In vitro coupled transcription translation 
The respective proteins were produced by in vitro coupled transcription translation 
(IVT) in the presence of 35S-methionine using the TNT T7 Quick Coupled Transcription/ 
Translation System (Promega, Madison, WI, USA) by incubation at 37°C for 90min. 
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APPENDIX 
 
I. List of plasmids 
 
Name Gene Insert Tag Vector Expression 
UK  1 INCENP wt GFP peGFPC2 mammalian expression 
UK  2 INCENP wt myc 
pcDNA3.1 3x myc 
A mammalian expression 
UK  3 INCENP wt flag pcDNA3.1 flag A mammalian expression 
UK  4 INCENP wt GAL-BD pFBT9 Y2H 
UK  5 INCENP wt GAL-AD pACT2 Y2H 
UK  6 INCENP wt   pCR II topo cloning vector 
UK  7 INCENP INCENP (1-58) GFP peGFP C2 mammalian expression 
UK  8 INCENP INCENP (1-68) GFP peGFP C2 mammalian expression 
UK  9 INCENP INCENP (1-77) GFP peGFP C2 mammalian expression 
UK 10 INCENP INCENP (1-68 T59D) GFP peGFP C2 mammalian expression 
UK 11 INCENP INCENP (1-68 T59A) GFP peGFP C2 mammalian expression 
UK 12 INCENP INCENP (1-77 S72A) GFP peGFP C2 mammalian expression 
UK 13 INCENP INCENP (1-77 S72D) GFP peGFP C2 mammalian expression 
UK 14 INCENP INCENP (1-530) GFP peGFP C2 mammalian expression 
UK 15 INCENP INCENP (531-789) GFP peGFP C2 mammalian expression 
UK 16 INCENP INCENP (790-919) GFP peGFP C2 mammalian expression 
UK 17 INCENP INCENP (1-790) GFP peGFP C2 mammalian expression 
UK 18 INCENP INCENP (59-919) GFP peGFP C2 mammalian expression 
UK 19 INCENP INCENP (69-919) GFP peGFP C2 mammalian expression 
UK 20 INCENP INCENP (T59A T412A) GFP peGFP C2 mammalian expression 
UK 21 INCENP INCENP (T59D T412D) GFP peGFP C2 mammalian expression 
UK 22 INCENP INCENP (T219A,S275A) GFP peGFP C2 mammalian expression 
UK 23 INCENP INCENP (S832A,T833A) GFP peGFP C2 mammalian expression 
UK 24 INCENP 
INCENP (T219A,S275A,Y822A, 
S828A,S832A,T833A) GFP peGFP C2 mammalian expression 
UK 25 INCENP INCENP (1-58)   pCR II topo cloning vector 
UK 26 INCENP INCENP (1-68)   pCR II topo cloning vector 
UK 27 INCENP INCENP (1-77)   pCR II topo cloning vector 
UK 28 INCENP INCENP (1-68 T59D)   pCR II topo cloning vector 
UK 29 INCENP INCENP (1-68 T59A)   pCR II topo cloning vector 
UK 30 INCENP INCENP (1-77 S72A)   pCR II topo cloning vector 
UK 31 INCENP INCENP (1-77 S72D)   pCR II topo cloning vector 
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UK 32 INCENP INCENP (1-530)   pCR II topo cloning vector 
UK 33 INCENP INCENP (531-789)   pCR II topo cloning vector 
UK 34 INCENP INCENP (790-919)   pCR II topo cloning vector 
UK 35 INCENP INCENP (1-790)   pCR II topo cloning vector 
UK 36 INCENP INCENP (59-919)   pCR II topo cloning vector 
UK 37 INCENP INCENP (69-919)   pCR II topo cloning vector 
UK 38 INCENP INCENP (T59A T412A)   pCR II topo cloning vector 
UK 39 INCENP INCENP (T59D T412D)   pCR II topo cloning vector 
UK 40 INCENP INCENP (T219A,S275A)   pCR II topo cloning vector 
UK 41 INCENP INCENP (S832A)   pCR II topo cloning vector 
UK 42 INCENP INCENP (T833A)   pCR II topo cloning vector 
UK 43 INCENP INCENP (S832A,T833A)   pCR II topo cloning vector 
UK 44 INCENP 
INCENP (T219A,S275A,Y822A, 
S828A,S832A,T833A)   pCR II topo cloning vector 
UK 45 INCENP INCENP (1-530) myc 
pcDNA3.1 3x myc 
A mammalian expression 
UK 46 INCENP INCENP (531-789) myc 
pcDNA3.1 3x myc 
A mammalian expression 
UK 47 INCENP INCENP (790-919) myc 
pcDNA3.1 3x myc 
A mammalian expression 
UK 48 INCENP INCENP (1-77) myc 
pcDNA3.1 3x myc 
A mammalian expression 
UK 49 INCENP INCENP (1-68) myc 
pcDNA3.1 3x myc 
A mammalian expression 
UK 50 INCENP INCENP (1-530) BD  pFBT9 Y2H 
UK 51 INCENP INCENP (531-789) BD pFBT9 Y2H 
UK 52 INCENP INCENP (790-919) BD pFBT9 Y2H 
UK 53 INCENP INCENP (1-530 T59A) BD pFBT9 Y2H 
UK 54 INCENP INCENP (1-530 T412A) BD pFBT9 Y2H 
UK 55 INCENP INCENP (1-530 T59A,T412A) BD pGBT9 Y2H 
UK 56 INCENP INCENP (1-530) AD pACT2 Y2H 
UK 57 INCENP INCENP (531-789) AD pACT2 Y2H 
UK 58 INCENP INCENP (790-919) AD pACT2 Y2H 
UK 59 INCENP wt MBP pMAL bacterial expression 
UK 60 INCENP INCENP (1-58) MBP pMAL bacterial expression 
UK 61 INCENP INCENP (1-68) MBP pMAL bacterial expression 
UK 62 INCENP INCENP (1-77) MBP pMAL bacterial expression 
UK 63 INCENP INCENP (1-68 T59A) MBP pMAL bacterial expression 
UK 64 INCENP INCENP (1-77 S72A) MBP pMAL bacterial expression 
UK 65 INCENP INCENP (790-919) 
MBP-
HIS pMALHis bacterial expression 
UK 66 Aurora B wt   pCRII topo  cloning vector 
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UK 67 Aurora B Aurora B (Y12D)   pCRII topo  cloning vector 
UK 68 Aurora B Aurora B (Y12F)   pCRII topo  cloning vector 
UK 69 Aurora B wt flag pcDNA3.1 flag A mammalian expression 
UK 70 Aurora B wt myc 
pcDNA3.1 3x myc 
A mammalian expression 
UK 71 Aurora B Aurora B (Y12D) GFP peGFPC2 mammalian expression 
UK 72 Aurora B Aurora B (Y12F) GFP peGFPC2 mammalian expression 
UK 73 Aurora B wt GFP peGFPC2 mammalian expression 
UK 74 Aurora B wt 
MBP-
HIS pMALHis bacterial expression 
UK 75 Aurora B wt   pAct2 Y2H 
UK 76 Aurora B wt   pFBT9 Y2H 
UK 77 Survivin wt flag pcDNA3.1 flag A mammalian expression 
UK 78 Survivin wt myc 
pcDNA3.1 3x myc 
A mammalian expression 
UK 79 Survivin wt HIS pQE 32L  bacterial expression 
UK 80 Survivin wt   pACT2 Y2H 
UK 81 Survivin wt   pFBT9 Y2H 
UK 82 Aurora C wt flag pcDNA3.1 flag mammalian expression 
UK 83 Aurora C wt GFP peGFP  mammalian expression 
UK 84 Borealin wt myc 
pcDNA3.1 3xmyc 
C mammalian expression 
UK 85 Borealin Borealin (S165A) myc 
pcDNA3.1 3xmyc 
C mammalian expression 
UK 86 Borealin Borealin (S219A) myc 
pcDNA3.1 3xmyc 
C mammalian expression 
UK 87 Borealin Borealin (S165A, S219A) myc 
pcDNA3.1 3xmyc 
C mammalian expression 
UK 88 Borealin Borealin (S165, S219, T106, T204 AAAA) myc 
pcDNA3.1 3xmyc 
C mammalian expression 
UK 89 Borealin Borealin (T106A) myc 
pcDNA3.1 3xmyc 
C mammalian expression 
UK 90 Borealin Borealin (T204A) myc 
pcDNA3.1 3xmyc 
C mammalian expression 
UK 91 Borealin Borealin (T106, T204 AA) myc 
pcDNA3.1 3xmyc 
C mammalian expression 
UK 92 Borealin Borealin (T106E) myc 
pcDNA3.1 3xmyc 
C mammalian expression 
UK 93 Borealin Borealin (T204E) myc 
pcDNA3.1 3xmyc 
C mammalian expression 
UK 94 Borealin Borealin (T106E, T204E) myc 
pcDNA3.1 3xmyc 
C mammalian expression 
UK 95 Borealin wt   pFBT9 Y2H 
UK 96 Borealin wt   pGAD Y2H 
UK 97 Borealin wt HIS pAcHIS-Tev insect expression 
UK 98 Borealin wt HIS pQE81L bacterial expression 
UK 99 Borealin wt GST pGEX bacterial expression 
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UK 100 Borealin wt MBP pMAL bacterial expression 
UK 101 Borealin Borealin (S165A) HIS pQE81L bacterial expression 
UK 102 Borealin Borealin (S219A) HIS pQE81L bacterial expression 
UK 103 Borealin Borealin (S165A, S219A) HIS pQE81L bacterial expression 
UK 104 Borealin Borealin (S165, S219, T106, T204 AAAA) HIS pQE81L bacterial expression 
UK 105 Borealin Borealin (T106A) HIS pQE81L bacterial expression 
UK 106 Borealin Borealin (T204A) HIS pQE81L bacterial expression 
UK 107 Borealin Borealin (T106, T204 AA) HIS pQE81L bacterial expression 
UK 108 Borealin wt flag pcDNA3.1 flag C  mammalian expression 
UK 109 INCENP INCENP1-58 GFP 
pcDNA4/TO eGFP 
puro mammalian expression 
UK 110 INCENP INCENP full-lenght GFP 
pcDNA4/TO eGFP 
puro mammalian expression 
UK 111 INCENP INCENP 59-919 GFP 
pcDNA4/TO eGFP 
puro mammalian expression 
UK 112 Borealin Borealin 1-55 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 113 Borealin Borealin 30-105 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 114 Borealin Borealin 55-140 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 115 Borealin Borealin 105-155 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 116 Borealin Borealin 140-170 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 117 Borealin Borealin 155-230 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 118 Borealin Borealin 170-280 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 119 Borealin Borealin 1-55 GAL-BD pFBT9 Y2H 
UK 120 Borealin Borealin 30-105 GAL-BD pFBT9 Y2H 
UK 121 Borealin Borealin 55-140 GAL-BD pFBT9 Y2H 
UK 122 Borealin Borealin 105-155 GAL-BD pFBT9 Y2H 
UK 123 Borealin Borealin 140-170 GAL-BD pFBT9 Y2H 
UK 124 Borealin Borealin 155-230 GAL-BD pFBT9 Y2H 
UK 125 Borealin Borealin 170-280 GAL-BD pFBT9 Y2H 
UK 126 Sumo1 full-lenght GAL-BD pFBT9 Y2H 
UK 127 Sumo2 full-lenght GAL-BD pFBT9 Y2H 
UK 128 Sumo1 full-lenght GAL_AD pAct2 Y2H 
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UK 129 Sumo2 full-lenght GAL_AD pGAD C1 Y2H 
UK 130 PIAS-y full-lenght GAL-BD pFBT9 Y2H 
UK 131 PIAS3 full-lenght GAL-AD pGAD C1 Y2H 
UK 132 Borealin Borealin 1-105 GAL_BD pFBT9 Y2H 
UK 133 Borealin Borealin 105-170 GAL_BD pFBT9 Y2H 
UK 134 Borealin Borealin 1-140 GAL_BD pFBT9 Y2H 
UK 135 Borealin Borealin 140-280 GAL_BD pFBT9 Y2H 
UK 136 Borealin Borealin 1-105 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 137 Borealin Borealin 105-170 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 138 Borealin Borealin 1-140 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 139 Borealin Borealin 140-280 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 140 
PIASx-
alpha full-lenght GAL-BD pFBT9 Y2H 
UK 141 Borealin Borealin 10-109 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 142 Borealin Borealin 110-280 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 143 Borealin Borealin 10-57 myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 144 INCENP INCENP F22R, L34R GFP peGFPC2 mammalian expression 
UK 145 INCENP INCENP E35,36,39,40R GFP peGFPC2 mammalian expression 
UK 146 Borealin Borealin R35E, L46Y myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 147 Borealin Borealin W70E, F74E myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 148 Borealin Borealin R17,19E, K20E myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 149 Borealin full-lenght myc-HIS 
pcDNA4/TO/myc-
HIS mammalian expression 
UK 150 Borealin  (K20,48,109,112,162,183,198,225,263,264R) myc-HIS 
pcDNA4/TO/myc-
HIS 
mammalian expression 
) 
UK 151 Borealin full-lenght Cherry 
pcDNA3.1 Cherry-
C mammalian expression 
UK 152 Borealin full-lenght 25KR (all lysines >arginine) Cherry 
pcDNA3.1 Cherry-
C mammalian expression 
UK 153 Borealin full-lenght His pcDNA3.1-His-C mammalian expression 
UK 154 Borealin full-lenght (lysine in spacer eliminated) His pcDNA3.1-His-C mammalian expression 
UK 155 Borealin full-lenght 25 KR (all lysines >arginine) His pcDNA3.1 His-C mammalian expression 
UK 157 Borealin full-lenght HA pcDNA3.1 HA-C mammalian expression 
UK 158 Borealin full-lenght 25 KR (all lysines >arginine) HA pcDNA3.1 HA-C mammalian expression 
UK 159 RanBP2 RanBP2deltaFG GAL-AD pGAD C1 Y2H 
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UK 160 RanBP2 RanBP2deltaFG GAL-BD pFBT9 Y2H 
UK 161 RanBP2 RanBP2deltaFG GFP peGFPC2 mammalian expression 
UK 162 RanBP2 RanBP2deltaFG myc 
pcDNA3.1-3xmyc-
C mammalian expression 
UK 163 RanBP2 RanBP2deltaFG  Myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 164 AuroraB Aurora B K106R  GFP peGFPC1 
mammalian 
expression;((kinase 
dead) 
UK 165 Pc2 Pc2 full-length AD pGAD Y2H 
UK 166 Pc2 Pc2 full-length Myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 167 SUMO2 SUMO2 flag pCI mammalian expression 
UK 168 SENP3 SENP3 full-length flag pCI mammalian expression 
UK 169 SENP3 SENP3 full-length C532S  flag pCI 
mammalian 
expression;(protease 
dead) 
UK 170 SENP5 SENP5 full-length flag pCI mammalian expression 
UK 171 
Borealin-
SUMO2 
fusion Borealin-SUMO2 fusion flag pCI mammalian expression 
UK 172 
SUMO1-
Borealin 
fusion SUMO1-Borealin fusion Myc 
pcDNA3.1 3xmyc-
C mammalian expression 
UK 173 AuroraB Aurora B delta 1-66 flag pcDNA3.1 flag-A mammalian expression 
UK 174 AuroraB Aurora B delta 1-66 GFP peGFPC2 mammalian expression 
UK 175 SUMO1 SUMO1-GA BD pGBD Y2H 
UK 176 SUMO2 SUMO2-GA BD pGBD Y2H 
UK 177 Centrin-1 Centrin-1 full-length BD pFBT9 Y2H 
UK 178 Centrin-2 Centrin-2 full-length BD pFBT9 Y2H 
UK 179 Centrin-3 Centrin-3 full-length BD pFBT9 Y2H 
UK 180 Centrin-1 Centrin-1 full-length AD pAct2 Y2H 
UK 181 Centrin-2 Centrin-2 full-length AD pAct2 Y2H 
UK 182 Centrin-3 Centrin-3 full-length AD pAct2 Y2H 
UK 183 Centrin-2 Centrin-2 full-length Cflag pcDNA3.1-Cflag mammalian expression 
UK 184 Centrin-2 Centrin-2 R16,K17,R18  GFP peGFPC2 mammalian expression 
UK 185 Centrin-2 Centrin-2 full-length GFP peGFPC2 mammalian expression 
UK 186 Centrin-2 Centrin-2 K22,30,65,66,103 GFP peGFPC2 mammalian expression 
UK 187 Centrin-1 Centrin-1 full-length Myc 
pcDNA3.1 3xmyc-
A mammalian expression 
UK 188 Centrin-2 Centrin-2 full-length Myc 
pcDNA3.1 3xmyc-
A mammalian expression 
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UK 189 Centrin-3 Centrin-3 full-length Myc 
pcDNA3.1 3xmyc-
A mammalian expression 
UK 190 Centrin-2 Centrin-2 K22R Myc 
pcDNA3.1 3xmyc-
A mammalian expression 
UK 191 Centrin-2 Centrin-2 K65,66R Myc 
pcDNA3.1 3xmyc-
A mammalian expression 
UK 192 Centrin-2 Centrin-2 K103R Myc 
pcDNA3.1 3xmyc-
A mammalian expression 
UK 193 Centrin-2 Centrin-2 K22,30,65,66,103 Myc 
pcDNA3.1 3xmyc-
A mammalian expression 
UK 194 Centrin-2 Centrin-2 K65,66,103R Myc 
pcDNA3.1 3xmyc-
A mammalian expression 
UK 195 Centrin-2 Centrin-2 K22,30,65,66R Myc 
pcDNA3.1 3xmyc-
A mammalian expression 
UK 196 Centrin-2 Centrin-2 K30,65,66R Myc 
pcDNA3.1 3xmyc-
A mammalian expression 
UK 197 Centrin-2 Centrin-2 R16,K17,R18  Myc 
pcDNA3.1 3xmyc-
A mammalian expression 
UK 198 Centrin-2 Centrin-2 full-length Myc pcDNA3.1 His-A mammalian expression 
UK 199 XPC XPC full-length flag pReceiver-M11 mammalian expression 
UK 200 Centrin-2 Centrin-2 full-length flag pcDNA3.1flag mammalian expression 
UK 201 Centrin-2 Centrin-2 R16,K17,R18  flag pcDNA3.1flag mammalian expression 
UK 202 Centrin-2 Centrin2   pcDNA3 mammalian expression 
UK 203 Centrin-2 Centrin-2 (5KR)   pcDNA3 mammalian expression 
UK 204 Centrin-2 Centrin-2 (5KR) GFP peGFPN3 mammalian expression 
UK 205 Centrin-2 Centrin-2 GFP peGFPN3 mammalian expression 
 
APPENDIX 
 117
II. List of siRNA oligonucleotide sequences 
 
 
mRNA target Sequence 
INCENP 5´-GGCTTGGCCAGGTGTATATdTdT-3´  (Klein et al., 2006) 
Aurora B 5´-GGAAAGAAGGGATCCCTAAdTdT-3´  (Klein et al., 2006) 
Aurora-C 5´-GCTGAATCATTTCATACCAdTdT-3´  (Klein et al., 2006) 
Survivin Qiagen, cat. no. SI02652958    (Klein et al., 2006) 
Borealin 5´-AGGTAGAGCTGTCTGTTCAdTdT-3´  (Klein et al., 2006) 
hMis12 5´-GGACATTTTGATAACCTTTdTdT-3´  (Goshima et al., 2003)  
Cenp-A 5´-CTCGTGGTGTGGACTTCAAdTdT-3´ 
Haspin 5´-GGCATCTGATGCTGAAAAGdTdT-3´  (Dai et al., 2006) 
Plk1 5´-CGAGCTGCTTAATGACGAGdTdT-3´  (Baumann et al., 2007) 
Eg5 5´-CTAGATGGCTTTCTCAGTAdTdT-3´  (Baumann et al., 2007) 
Cenp-E 5´-ACTGGAGAGCAGTAAGAGTdTdT-3´ 
RKIP 5´-GGUGGCGUCCUUCCGUAAAdTdT-3´  (Eves et al., 2006) 
MCAK 5´-GGTATCTGCTGGCTCTAAAdTdT-3´ 
TD-60 5´-AAGAGATGAAAGTGAGACTdTdT-3´  (Mollinari et al., 2003 ) 
XPC 5´-TCAGCAGATGGTCCAGCAAdTdT-3´ 
Centrin-2 5´-GCACATGTAACTAGATTTAdTdT-3´ 
Ubc9_1 5´-GGGATTGGTTTGGCAAGAAdTdT-3´ 
Ubc9_SM 5´-GCAGAGGCCTACACGATTTdTdT-3´  (Klein et al., 2009) 
PIAS2 5´-AAGATACTAAGCCCACATTdTdT-3´  (Yang et al., 2004 ) 
SUMO1 Santa Cruz cat. no. sc-29498A  
SUMO1 5´-GGTGAATATATTAAACTCAdTdT-3´ 
SUMO2/3 5´-GTCAATGAGGCAGATCAGAdTdT-3´ 
RanBP2 5´-GGACAGTGGGATTGTAGTGdTdT-3´  (Joseph et al., 2004) 
hPc2_1 5´-CGTGGGAACCGGAGGAGAAdTdT-3´    
hPc2_2 5´-GTTTGTACGTGGTGTTATTdTdT-3´ 
Senp3(Q3) 5´-GGCAGAGGCGGTAAAGAAAdTdT-3´   Qiagen 
Senp3 (9) 5´-CTGGCCCTGTCTCAGCCATdTdT-3´  (Stegmeier et al., 2007) 
Senp5_2 5´-GAACATCGTTCTAATACCAdTdT-3´  (Klein et al., 2009) 
Senp5_3 5´-AGAAAGCTCTTCAAATCCAdTdT-3´ 
PDCD7 5´-GCAGCCGCTGATGGCGTACdTdT-3´  (Will et al., 2002 ) 
GL2 (Elbashir et al., 2001) 
Lamin-A (Elbashir et al., 2001) 
Kif3A Qiagen, cat. no. SI02655415 
Kif3A_2 Qiagen, cat. no. SI03019765 
Kif3B Qiagen, cat. no. SI02655303 
Kif3B_2 Qiagen, cat. no. SI03019772 
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III. List of antibodies 
Antigen Species Dilution IF Dilution  WB Company 
Aurora B M 1:500 1:250 BD Bioscience 
Aurora C R - 1:200 Zymed 
BubRI M 1:500 1:500 Chemicon 
pCenp-A (Ser7) R 1:500 - upstate 
Cenp-A M 1:1000 1:1000 MoBiTec 
Survivin R 1:1000 1:1000 abcam 
Survivin M 1:1000 1:500 Santa Cruz 
Flag (M2) M 1:2000 1:1000 SIGMA 
MBP M - 1:250 NEB 
pHistoneH3 (Ser10) R 1:3000 1:2000 upstate 
PIAS2 M - 1:250 SIGMA 
Ubc9 M - 1:1000 BD Transduction Laboratories 
SUMO1 (21C7) M 1:2000 1:500 Zymed 
His M - 1:500 Amersham Bioscience 
Ubc9 G - 1:1000 Santa Cruz 
Hec1 M 1:1000 1:1000 GeneTex 
Senp5 R - 1:500 Gift from Ed Yeh 
Senp3 R - 1:500 Gift from Stephan Muller 
Borealin R 1:2000 1:2000 Homemade 
pBorealin (Thr106) R 1:500  Homemade 
SUMO2/3 M 1:1000 1:500 ABGENT 
RanBP2 G 1:500 1:500 Gift from Frauke Melchior 
RanGAP1 G 1:500 1:500 Gift from Frauke Melchior 
RanGAP1 M 1:500 1:500 Zymed 
GFP M  undiluted Homemade 
Myc (9E10) M undiluted undiluted Homemade 
Topoisomerase IIα M 1:2000 1:2000 Stressgen 
HA (12CA5) M undiluted undiluted Homemade 
HA (16B12) M 1:2000 1:1000 COVANCE 
PRC1 R 1:1000 - Santa Cruz 
pVimentin (Ser72) R 1:500 - EPITOMICS 
Centrin-2 R 1:1000 1:1000 Homemade 
γ-tubulin M 1:1000 1:1000 SIGMA 
α-tubulin 
(FITC labeled) 
M 1:1000 - Santa Cruz 
XPC M 1:500 1:500 GeneTex 
XPC R 1:1000 1:1000 Santa Cruz 
CPDs M 1:3000  MBL 
6-4PPs M 1:400  MBL 
Plk1 M undiluted undiluted Homemade 
MCAK R 1:1000 1:1000 Gift from Thomas Mayer 
BubI M 1:1000 1:1000 Homemade 
Astrin R 1:2000 1:1000 Homemade 
PICH Rat 1:1000 - Homemade 
Cenp-B M undiluted - ATCC 
pBubRI (S676) R 1:2000  Homemade 
Mad2 R 1:500 1:500 Bethyl laboratories 
Eg5 R  1:500 Homemade 
Cenp-E G 1:500  Santa Cruz 
CyclinB1 M  1:1000 upstate 
CREST H 1:5000  Immunovision 
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IV. Abbreviations 
 
All units are abbreviated according to the International Unit System. 
 
aa: amino acid 
AD: activation domain 
BD: binding domain 
Cdk: cyclin-dependent kinase 
BSA: bovine serum albumin 
CPC: chromosomal passenger complex 
C-terminus; carboxy-terminus 
DAPI: 4´,6-diamidino-2-phenylindole 
DTT: dithiothreitol 
E. coli: Escherichia coli 
ECL: enhanced chemiluminescence 
EDTA: ethylene-dinitrilo-tetraacetic acid 
EGTA: ethylene-gycol-tetraacetic acid 
FCS: Fetal calf serum 
GFP: green fluorescent protein 
GST: glutathione S-transferase IF: immunofluorescence 
h:hour 
IgG: Immunoglobulin G 
INCENP: inner centromere protein 
IP: immunoprecipitation 
IPTG: isopropyl-beta-D-thiogalactopyranoside 
kDa: kilo Dalton 
KT: kinetochore 
Mad: mitotic arrest deficient 
MAP: mitogen activated protein  
MBP: maltose binding protein 
min: minute(s) 
MT: microtubule 
N-terminus: amino-terminus 
PBS: Phosphate-buffered saline 
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PCR: Polymerase chain reaction 
PICH: Plk1-interacting checkpoint helicase 
PIPES: 1,4-Piperazinediethanesulfonic acid 
Plk: Polo-like kinase 
PMSF: phenylmethylsulfonyl fluoride 
RT: room temperature 
SAC: spindle assembly checkpoint 
SDS-PAGE: Sodium dodecylsulfate polyacrylamid gelelectrophoresis 
siRNA: small interference ribonucleic acid 
T106: threonine at position 106 
wt: wildtype 
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